id	sid	tid	token	lemma	pos
ajlm-89	1	1	article	article	PROPN
ajlm-89	1	2	information	information	NOUN
ajlm-89	1	3	authors	author	NOUN
ajlm-89	1	4	:	:	PUNCT
ajlm-89	1	5	rita	rita	PROPN
ajlm-89	1	6	o.	o.	PROPN
ajlm-89	1	7	oladele1	oladele1	PROPN
ajlm-89	2	1	rashidi	rashidi	PROPN
ajlm-89	2	2	a.	a.	PROPN
ajlm-89	2	3	bakare1	bakare1	VERB
ajlm-89	3	1	michael	michael	PROPN
ajlm-89	3	2	a.	a.	PROPN
ajlm-89	3	3	petrou2	petrou2	PROPN
ajlm-89	4	1	oyinlola	oyinlola	PROPN
ajlm-89	5	1	o.	o.	PROPN
ajlm-89	5	2	oduyebo3	oduyebo3	PROPN
ajlm-89	6	1	malcolm	malcolm	PROPN
ajlm-89	6	2	richardson4	richardson4	PROPN
ajlm-89	6	3	affiliations	affiliation	NOUN
ajlm-89	6	4	:	:	PUNCT
ajlm-89	6	5	1department	1department	NUM
ajlm-89	6	6	of	of	ADP
ajlm-89	6	7	medical	medical	ADJ
ajlm-89	6	8	microbiology	microbiology	NOUN
ajlm-89	6	9	and	and	CCONJ
ajlm-89	6	10	parasitology	parasitology	NOUN
ajlm-89	6	11	,	,	PUNCT
ajlm-89	6	12	university	university	NOUN
ajlm-89	6	13	college	college	NOUN
ajlm-89	6	14	hospital	hospital	NOUN
ajlm-89	6	15	,	,	PUNCT
ajlm-89	6	16	nigeria2department	nigeria2department	ADV
ajlm-89	6	17	of	of	ADP
ajlm-89	6	18	microbiology	microbiology	NOUN
ajlm-89	6	19	,	,	PUNCT
ajlm-89	6	20	hammersmith	hammersmith	PROPN
ajlm-89	6	21	hospital	hospital	NOUN
ajlm-89	6	22	,	,	PUNCT
ajlm-89	6	23	imperial	imperial	ADJ
ajlm-89	6	24	college	college	NOUN
ajlm-89	6	25	,	,	PUNCT
ajlm-89	6	26	london	london	PROPN
ajlm-89	6	27	3department	3department	NUM
ajlm-89	6	28	of	of	ADP
ajlm-89	6	29	medical	medical	ADJ
ajlm-89	6	30	microbiology	microbiology	NOUN
ajlm-89	6	31	,	,	PUNCT
ajlm-89	6	32	college	college	NOUN
ajlm-89	6	33	of	of	ADP
ajlm-89	6	34	medicine	medicine	NOUN
ajlm-89	6	35	,	,	PUNCT
ajlm-89	6	36	university	university	NOUN
ajlm-89	6	37	of	of	ADP
ajlm-89	6	38	lagos	lagos	PROPN
ajlm-89	6	39	,	,	PUNCT
ajlm-89	6	40	nigeria	nigeria	PROPN
ajlm-89	6	41	4mycology	4mycology	NUM
ajlm-89	6	42	reference	reference	NOUN
ajlm-89	6	43	laboratory	laboratory	NOUN
ajlm-89	6	44	,	,	PUNCT
ajlm-89	6	45	university	university	PROPN
ajlm-89	6	46	of	of	ADP
ajlm-89	6	47	manchester	manchester	PROPN
ajlm-89	6	48	,	,	PUNCT
ajlm-89	6	49	united	united	ADJ
ajlm-89	6	50	kingdom	kingdom	PROPN
ajlm-89	6	51	correspondence	correspondence	NOUN
ajlm-89	6	52	to	to	ADP
ajlm-89	6	53	:	:	PUNCT
ajlm-89	6	54	rita	rita	PROPN
ajlm-89	6	55	oladele	oladele	PROPN
ajlm-89	6	56	postal	postal	PROPN
ajlm-89	6	57	address	address	PROPN
ajlm-89	6	58	:	:	PUNCT
ajlm-89	6	59	department	department	NOUN
ajlm-89	6	60	of	of	ADP
ajlm-89	6	61	medical	medical	ADJ
ajlm-89	6	62	microbiology	microbiology	NOUN
ajlm-89	6	63	and	and	CCONJ
ajlm-89	6	64	parasitology	parasitology	NOUN
ajlm-89	6	65	,	,	PUNCT
ajlm-89	6	66	college	college	NOUN
ajlm-89	6	67	of	of	ADP
ajlm-89	6	68	medicine	medicine	NOUN
ajlm-89	6	69	,	,	PUNCT
ajlm-89	6	70	university	university	NOUN
ajlm-89	6	71	of	of	ADP
ajlm-89	6	72	lagos	lagos	PROPN
ajlm-89	6	73	,	,	PUNCT
ajlm-89	6	74	pmb	pmb	PROPN
ajlm-89	6	75	12003	12003	NUM
ajlm-89	6	76	,	,	PUNCT
ajlm-89	6	77	nigeria	nigeria	PROPN
ajlm-89	6	78	dates	date	NOUN
ajlm-89	6	79	:	:	PUNCT
ajlm-89	6	80	received	receive	VERB
ajlm-89	6	81	:	:	PUNCT
ajlm-89	6	82	28	28	NUM
ajlm-89	6	83	nov	nov	PROPN
ajlm-89	6	84	.	.	PROPN
ajlm-89	6	85	2012	2012	NUM
ajlm-89	6	86	accepted	accept	VERB
ajlm-89	6	87	:	:	PUNCT
ajlm-89	6	88	06	06	NUM
ajlm-89	6	89	nov	nov	PROPN
ajlm-89	6	90	.	.	PROPN
ajlm-89	6	91	2013	2013	NUM
ajlm-89	6	92	published	publish	VERB
ajlm-89	6	93	:	:	PUNCT
ajlm-89	6	94	06	06	NUM
ajlm-89	6	95	aug	aug	PROPN
ajlm-89	6	96	.	.	PROPN
ajlm-89	6	97	2014	2014	NUM
ajlm-89	6	98	how	how	SCONJ
ajlm-89	6	99	to	to	PART
ajlm-89	6	100	cite	cite	VERB
ajlm-89	6	101	this	this	DET
ajlm-89	6	102	article	article	NOUN
ajlm-89	6	103	:	:	PUNCT
ajlm-89	6	104	oladele	oladele	PROPN
ajlm-89	6	105	ro	ro	PROPN
ajlm-89	6	106	,	,	PUNCT
ajlm-89	6	107	bakare	bakare	PROPN
ajlm-89	6	108	ra	ra	PROPN
ajlm-89	6	109	,	,	PUNCT
ajlm-89	6	110	petrou	petrou	PROPN
ajlm-89	6	111	ma	ma	PROPN
ajlm-89	6	112	,	,	PUNCT
ajlm-89	6	113	oduyebo	oduyebo	PROPN
ajlm-89	6	114	oo	oo	PROPN
ajlm-89	6	115	,	,	PUNCT
ajlm-89	6	116	richardson	richardson	PROPN
ajlm-89	6	117	m.	m.	PROPN
ajlm-89	6	118	candidaemia	candidaemia	PROPN
ajlm-89	6	119	in	in	ADP
ajlm-89	6	120	a	a	DET
ajlm-89	6	121	tertiary	tertiary	ADJ
ajlm-89	6	122	hospital	hospital	NOUN
ajlm-89	6	123	in	in	ADP
ajlm-89	6	124	nigeria	nigeria	PROPN
ajlm-89	6	125	.	.	PUNCT
ajlm-89	7	1	afr	afr	PROPN
ajlm-89	7	2	j	j	PROPN
ajlm-89	7	3	lab	lab	PROPN
ajlm-89	7	4	med	med	PROPN
ajlm-89	7	5	.	.	PUNCT
ajlm-89	7	6	2014;3(1	2014;3(1	NUM
ajlm-89	7	7	)	)	PUNCT
ajlm-89	7	8	,	,	PUNCT
ajlm-89	7	9	art	art	NOUN
ajlm-89	7	10	.	.	PUNCT
ajlm-89	8	1	#	#	SYM
ajlm-89	8	2	89	89	NUM
ajlm-89	8	3	,	,	PUNCT
ajlm-89	8	4	5	5	NUM
ajlm-89	8	5	pages	page	NOUN
ajlm-89	8	6	.	.	PUNCT
ajlm-89	9	1	http://dx.doi.org/10.4102/a	http://dx.doi.org/10.4102/a	VERB
ajlm-89	9	2	jlm.v3i1.89	jlm.v3i1.89	PROPN
ajlm-89	9	3	copyright	copyright	NOUN
ajlm-89	9	4	notice	notice	NOUN
ajlm-89	9	5	:	:	PUNCT
ajlm-89	10	1	©	©	PROPN
ajlm-89	10	2	2014	2014	NUM
ajlm-89	10	3	.	.	PUNCT
ajlm-89	11	1	the	the	DET
ajlm-89	11	2	authors	author	NOUN
ajlm-89	11	3	.	.	PUNCT
ajlm-89	12	1	licensee	licensee	NOUN
ajlm-89	12	2	:	:	PUNCT
ajlm-89	12	3	aosis	aosis	NOUN
ajlm-89	12	4	openjournals	openjournal	NOUN
ajlm-89	12	5	.	.	PUNCT
ajlm-89	13	1	this	this	PRON
ajlm-89	13	2	is	be	AUX
ajlm-89	13	3	an	an	DET
ajlm-89	13	4	open	open	ADJ
ajlm-89	13	5	access	access	NOUN
ajlm-89	13	6	article	article	NOUN
ajlm-89	13	7	distributed	distribute	VERB
ajlm-89	13	8	under	under	ADP
ajlm-89	13	9	the	the	DET
ajlm-89	13	10	terms	term	NOUN
ajlm-89	13	11	of	of	ADP
ajlm-89	13	12	the	the	DET
ajlm-89	13	13	creative	creative	ADJ
ajlm-89	13	14	commons	common	NOUN
ajlm-89	13	15	attribution	attribution	NOUN
ajlm-89	13	16	license	license	NOUN
ajlm-89	13	17	,	,	PUNCT
ajlm-89	13	18	which	which	PRON
ajlm-89	13	19	permits	permit	VERB
ajlm-89	13	20	unrestricted	unrestricted	ADJ
ajlm-89	13	21	use	use	NOUN
ajlm-89	13	22	,	,	PUNCT
ajlm-89	13	23	distribution	distribution	NOUN
ajlm-89	13	24	,	,	PUNCT
ajlm-89	13	25	and	and	CCONJ
ajlm-89	13	26	reproduction	reproduction	NOUN
ajlm-89	13	27	in	in	ADP
ajlm-89	13	28	any	any	DET
ajlm-89	13	29	medium	medium	NOUN
ajlm-89	13	30	,	,	PUNCT
ajlm-89	13	31	provided	provide	VERB
ajlm-89	13	32	the	the	DET
ajlm-89	13	33	original	original	ADJ
ajlm-89	13	34	work	work	NOUN
ajlm-89	13	35	is	be	AUX
ajlm-89	13	36	properly	properly	ADV
ajlm-89	13	37	cited	cite	VERB
ajlm-89	13	38	.	.	PUNCT
ajlm-89	14	1	candidaemia	candidaemia	NOUN
ajlm-89	14	2	in	in	ADP
ajlm-89	14	3	a	a	DET
ajlm-89	14	4	tertiary	tertiary	ADJ
ajlm-89	14	5	hospital	hospital	NOUN
ajlm-89	14	6	in	in	ADP
ajlm-89	14	7	nigeria	nigeria	PROPN
ajlm-89	14	8	in	in	ADP
ajlm-89	14	9	this	this	DET
ajlm-89	14	10	original	original	ADJ
ajlm-89	14	11	research	research	NOUN
ajlm-89	14	12	...	...	PUNCT
ajlm-89	14	13	open	open	ADJ
ajlm-89	14	14	access	access	NOUN
ajlm-89	14	15	•	•	ADP
ajlm-89	14	16	abstract	abstract	ADJ
ajlm-89	14	17	•	•	NUM
ajlm-89	14	18	introduction	introduction	NOUN
ajlm-89	14	19	•	•	NUM
ajlm-89	14	20	research	research	NOUN
ajlm-89	14	21	method	method	NOUN
ajlm-89	14	22	and	and	CCONJ
ajlm-89	14	23	design	design	NOUN
ajlm-89	14	24	•	•	NUM
ajlm-89	14	25	results	result	NOUN
ajlm-89	14	26	•	•	ADP
ajlm-89	14	27	ethical	ethical	ADJ
ajlm-89	14	28	considerations	consideration	NOUN
ajlm-89	14	29	   	   	SPACE
ajlm-89	14	30	•	•	NUM
ajlm-89	14	31	potential	potential	ADJ
ajlm-89	14	32	benefits	benefit	NOUN
ajlm-89	14	33	and	and	CCONJ
ajlm-89	14	34	hazards	hazard	NOUN
ajlm-89	14	35	•	•	PRON
ajlm-89	14	36	trustworthiness	trustworthiness	NOUN
ajlm-89	14	37	•	•	NUM
ajlm-89	14	38	discussion	discussion	NOUN
ajlm-89	14	39	•	•	NOUN
ajlm-89	14	40	limitations	limitation	NOUN
ajlm-89	14	41	of	of	ADP
ajlm-89	14	42	the	the	DET
ajlm-89	14	43	study	study	NOUN
ajlm-89	14	44	•	•	NUM
ajlm-89	14	45	conclusion	conclusion	NOUN
ajlm-89	14	46	•	•	NUM
ajlm-89	14	47	acknowledgements	acknowledgement	NOUN
ajlm-89	14	48	   	   	SPACE
ajlm-89	14	49	•	•	NOUN
ajlm-89	14	50	competing	compete	VERB
ajlm-89	14	51	interests	interest	NOUN
ajlm-89	14	52	   	   	SPACE
ajlm-89	14	53	•	•	NUM
ajlm-89	14	54	authors	author	NOUN
ajlm-89	14	55	’	'	PUNCT
ajlm-89	14	56	contributions	contribution	NOUN
ajlm-89	14	57	•	•	NUM
ajlm-89	14	58	references	reference	NOUN
ajlm-89	14	59	abstract	abstract	ADJ
ajlm-89	14	60	top	top	PROPN
ajlm-89	14	61	↑	↑	PROPN
ajlm-89	14	62	background	background	NOUN
ajlm-89	14	63	:	:	PUNCT
ajlm-89	14	64	candidaemia	candidaemia	NOUN
ajlm-89	14	65	is	be	AUX
ajlm-89	14	66	a	a	DET
ajlm-89	14	67	widely	widely	ADV
ajlm-89	14	68	-	-	PUNCT
ajlm-89	14	69	studied	study	VERB
ajlm-89	14	70	and	and	CCONJ
ajlm-89	14	71	reviewed	review	VERB
ajlm-89	14	72	topic	topic	NOUN
ajlm-89	14	73	in	in	ADP
ajlm-89	14	74	the	the	DET
ajlm-89	14	75	developed	developed	ADJ
ajlm-89	14	76	world	world	NOUN
ajlm-89	14	77	;	;	PUNCT
ajlm-89	14	78	however	however	ADV
ajlm-89	14	79	,	,	PUNCT
ajlm-89	14	80	there	there	PRON
ajlm-89	14	81	is	be	VERB
ajlm-89	14	82	a	a	DET
ajlm-89	14	83	dearth	dearth	NOUN
ajlm-89	14	84	of	of	ADP
ajlm-89	14	85	information	information	NOUN
ajlm-89	14	86	on	on	ADP
ajlm-89	14	87	nosocomial	nosocomial	ADJ
ajlm-89	14	88	candidaemia	candidaemia	NOUN
ajlm-89	14	89	in	in	ADP
ajlm-89	14	90	nigeria	nigeria	PROPN
ajlm-89	14	91	,	,	PUNCT
ajlm-89	14	92	despite	despite	SCONJ
ajlm-89	14	93	the	the	DET
ajlm-89	14	94	increasing	increase	VERB
ajlm-89	14	95	use	use	NOUN
ajlm-89	14	96	of	of	ADP
ajlm-89	14	97	more	more	ADV
ajlm-89	14	98	invasive	invasive	ADJ
ajlm-89	14	99	therapeutic	therapeutic	ADJ
ajlm-89	14	100	modalities	modality	NOUN
ajlm-89	14	101	,	,	PUNCT
ajlm-89	14	102	immunosuppressive	immunosuppressive	ADJ
ajlm-89	14	103	agents	agent	NOUN
ajlm-89	14	104	and	and	CCONJ
ajlm-89	14	105	increasing	increase	VERB
ajlm-89	14	106	incidence	incidence	NOUN
ajlm-89	14	107	of	of	ADP
ajlm-89	14	108	immunosuppression	immunosuppression	NOUN
ajlm-89	14	109	as	as	ADP
ajlm-89	14	110	a	a	DET
ajlm-89	14	111	result	result	NOUN
ajlm-89	14	112	of	of	ADP
ajlm-89	14	113	malignancies	malignancy	NOUN
ajlm-89	14	114	and	and	CCONJ
ajlm-89	14	115	hiv.objectives	hiv.objective	NOUN
ajlm-89	14	116	:	:	PUNCT
ajlm-89	14	117	to	to	PART
ajlm-89	14	118	determine	determine	VERB
ajlm-89	14	119	the	the	DET
ajlm-89	14	120	hospital	hospital	NOUN
ajlm-89	14	121	-	-	PUNCT
ajlm-89	14	122	based	base	VERB
ajlm-89	14	123	frequency	frequency	NOUN
ajlm-89	14	124	of	of	ADP
ajlm-89	14	125	candidaemia	candidaemia	NOUN
ajlm-89	14	126	in	in	ADP
ajlm-89	14	127	a	a	DET
ajlm-89	14	128	tertiary	tertiary	ADJ
ajlm-89	14	129	hospital	hospital	NOUN
ajlm-89	14	130	in	in	ADP
ajlm-89	14	131	ibadan	ibadan	PROPN
ajlm-89	14	132	,	,	PUNCT
ajlm-89	14	133	nigeria	nigeria	PROPN
ajlm-89	14	134	.	.	PUNCT
ajlm-89	14	135	method	method	PROPN
ajlm-89	14	136	:	:	PUNCT
ajlm-89	14	137	this	this	PRON
ajlm-89	14	138	was	be	AUX
ajlm-89	14	139	a	a	DET
ajlm-89	14	140	prospective	prospective	ADJ
ajlm-89	14	141	descriptive	descriptive	ADJ
ajlm-89	14	142	study	study	NOUN
ajlm-89	14	143	which	which	PRON
ajlm-89	14	144	included	include	VERB
ajlm-89	14	145	230	230	NUM
ajlm-89	14	146	immunosuppressed	immunosuppressed	ADJ
ajlm-89	14	147	patients	patient	NOUN
ajlm-89	14	148	.	.	PUNCT
ajlm-89	15	1	all	all	DET
ajlm-89	15	2	isolates	isolate	NOUN
ajlm-89	15	3	were	be	AUX
ajlm-89	15	4	identified	identify	VERB
ajlm-89	15	5	to	to	ADP
ajlm-89	15	6	the	the	DET
ajlm-89	15	7	species	species	NOUN
ajlm-89	15	8	level	level	NOUN
ajlm-89	15	9	using	use	VERB
ajlm-89	15	10	both	both	CCONJ
ajlm-89	15	11	conventional	conventional	ADJ
ajlm-89	15	12	and	and	CCONJ
ajlm-89	15	13	automated	automate	VERB
ajlm-89	15	14	methods	method	NOUN
ajlm-89	15	15	.	.	PUNCT
ajlm-89	16	1	thereafter	thereafter	ADV
ajlm-89	16	2	,	,	PUNCT
ajlm-89	16	3	all	all	DET
ajlm-89	16	4	candida	candida	NOUN
ajlm-89	16	5	species	specie	NOUN
ajlm-89	16	6	isolated	isolate	VERB
ajlm-89	16	7	were	be	AUX
ajlm-89	16	8	tested	test	VERB
ajlm-89	16	9	for	for	ADP
ajlm-89	16	10	antifungal	antifungal	ADJ
ajlm-89	16	11	susceptibility	susceptibility	NOUN
ajlm-89	16	12	using	use	VERB
ajlm-89	16	13	the	the	DET
ajlm-89	16	14	broth	broth	NOUN
ajlm-89	16	15	microdilution	microdilution	NOUN
ajlm-89	16	16	method	method	NOUN
ajlm-89	16	17	.	.	PUNCT
ajlm-89	17	1	results	result	NOUN
ajlm-89	17	2	:	:	PUNCT
ajlm-89	17	3	candidaemia	candidaemia	NOUN
ajlm-89	17	4	occurred	occur	VERB
ajlm-89	17	5	in	in	ADP
ajlm-89	17	6	12	12	NUM
ajlm-89	17	7	(	(	PUNCT
ajlm-89	17	8	5.21	5.21	NUM
ajlm-89	17	9	%	%	NOUN
ajlm-89	17	10	)	)	PUNCT
ajlm-89	17	11	of	of	ADP
ajlm-89	17	12	the	the	DET
ajlm-89	17	13	230	230	NUM
ajlm-89	17	14	study	study	NOUN
ajlm-89	17	15	patients	patient	NOUN
ajlm-89	17	16	,	,	PUNCT
ajlm-89	17	17	with	with	ADP
ajlm-89	17	18	c.	c.	PROPN
ajlm-89	17	19	tropicalis	tropicalis	PROPN
ajlm-89	17	20	accounting	account	VERB
ajlm-89	17	21	for	for	ADP
ajlm-89	17	22	50	50	NUM
ajlm-89	17	23	%	%	NOUN
ajlm-89	17	24	of	of	ADP
ajlm-89	17	25	the	the	DET
ajlm-89	17	26	infections	infection	NOUN
ajlm-89	17	27	.	.	PUNCT
ajlm-89	18	1	four	four	NUM
ajlm-89	18	2	patients	patient	NOUN
ajlm-89	18	3	(	(	PUNCT
ajlm-89	18	4	33.3	33.3	NUM
ajlm-89	18	5	%	%	NOUN
ajlm-89	18	6	)	)	PUNCT
ajlm-89	18	7	presented	present	VERB
ajlm-89	18	8	with	with	ADP
ajlm-89	18	9	c.	c.	PROPN
ajlm-89	18	10	parapsilosis	parapsilosis	PROPN
ajlm-89	18	11	,	,	PUNCT
ajlm-89	18	12	one	one	NUM
ajlm-89	18	13	(	(	PUNCT
ajlm-89	18	14	8.3	8.3	NUM
ajlm-89	18	15	%	%	NOUN
ajlm-89	18	16	)	)	PUNCT
ajlm-89	18	17	with	with	ADP
ajlm-89	18	18	c.	c.	NOUN
ajlm-89	18	19	albicans	albican	NOUN
ajlm-89	18	20	and	and	CCONJ
ajlm-89	18	21	one	one	NUM
ajlm-89	18	22	(	(	PUNCT
ajlm-89	18	23	8.3	8.3	NUM
ajlm-89	18	24	%	%	NOUN
ajlm-89	18	25	)	)	PUNCT
ajlm-89	18	26	with	with	ADP
ajlm-89	18	27	a	a	DET
ajlm-89	18	28	mixed	mixed	ADJ
ajlm-89	18	29	infection	infection	NOUN
ajlm-89	18	30	of	of	ADP
ajlm-89	18	31	c.	c.	NOUN
ajlm-89	18	32	albicans	albican	NOUN
ajlm-89	18	33	and	and	CCONJ
ajlm-89	18	34	c.	c.	PROPN
ajlm-89	18	35	tropicalis	tropicalis	PROPN
ajlm-89	18	36	.	.	PUNCT
ajlm-89	19	1	all	all	DET
ajlm-89	19	2	12	12	NUM
ajlm-89	19	3	isolates	isolate	NOUN
ajlm-89	19	4	were	be	AUX
ajlm-89	19	5	sensitive	sensitive	ADJ
ajlm-89	19	6	to	to	ADP
ajlm-89	19	7	fluconazole	fluconazole	NOUN
ajlm-89	19	8	(	(	PUNCT
ajlm-89	19	9	minimal	minimal	ADJ
ajlm-89	19	10	inhibitory	inhibitory	ADJ
ajlm-89	19	11	concentration	concentration	NOUN
ajlm-89	19	12	<	<	X
ajlm-89	19	13	8	8	NUM
ajlm-89	19	14	mg	mg	NUM
ajlm-89	19	15	/	/	SYM
ajlm-89	19	16	ml	ml	NOUN
ajlm-89	19	17	)	)	PUNCT
ajlm-89	19	18	.	.	PUNCT
ajlm-89	20	1	univariate	univariate	ADJ
ajlm-89	20	2	analysis	analysis	NOUN
ajlm-89	20	3	revealed	reveal	VERB
ajlm-89	20	4	that	that	SCONJ
ajlm-89	20	5	old	old	ADJ
ajlm-89	20	6	age	age	NOUN
ajlm-89	20	7	,	,	PUNCT
ajlm-89	20	8	multiple	multiple	ADJ
ajlm-89	20	9	surgeries	surgery	NOUN
ajlm-89	20	10	and	and	CCONJ
ajlm-89	20	11	long	long	ADJ
ajlm-89	20	12	-	-	PUNCT
ajlm-89	20	13	term	term	NOUN
ajlm-89	20	14	hospitalisation	hospitalisation	NOUN
ajlm-89	20	15	were	be	AUX
ajlm-89	20	16	significant	significant	ADJ
ajlm-89	20	17	contributing	contribute	VERB
ajlm-89	20	18	factors	factor	NOUN
ajlm-89	20	19	for	for	ADP
ajlm-89	20	20	the	the	DET
ajlm-89	20	21	occurrence	occurrence	NOUN
ajlm-89	20	22	of	of	ADP
ajlm-89	20	23	candidaemia	candidaemia	NOUN
ajlm-89	20	24	.	.	PUNCT
ajlm-89	21	1	eleven	eleven	NUM
ajlm-89	21	2	(	(	PUNCT
ajlm-89	21	3	91.7	91.7	NUM
ajlm-89	21	4	%	%	NOUN
ajlm-89	21	5	)	)	PUNCT
ajlm-89	21	6	of	of	ADP
ajlm-89	21	7	the	the	DET
ajlm-89	21	8	12	12	NUM
ajlm-89	21	9	patients	patient	NOUN
ajlm-89	21	10	with	with	ADP
ajlm-89	21	11	candidaemia	candidaemia	NOUN
ajlm-89	21	12	had	have	VERB
ajlm-89	21	13	candida	candida	PROPN
ajlm-89	21	14	colonisation	colonisation	NOUN
ajlm-89	21	15	of	of	ADP
ajlm-89	21	16	other	other	ADJ
ajlm-89	21	17	sterile	sterile	ADJ
ajlm-89	21	18	sites	site	NOUN
ajlm-89	21	19	including	include	VERB
ajlm-89	21	20	the	the	DET
ajlm-89	21	21	bladder	bladder	NOUN
ajlm-89	21	22	,	,	PUNCT
ajlm-89	21	23	peritoneum	peritoneum	NOUN
ajlm-89	21	24	and	and	CCONJ
ajlm-89	21	25	trachea	trachea	PROPN
ajlm-89	21	26	.	.	PUNCT
ajlm-89	22	1	furthermore	furthermore	ADV
ajlm-89	22	2	,	,	PUNCT
ajlm-89	22	3	bivariate	bivariate	ADJ
ajlm-89	22	4	analysis	analysis	NOUN
ajlm-89	22	5	revealed	reveal	VERB
ajlm-89	22	6	that	that	SCONJ
ajlm-89	22	7	mucositis	mucositis	NOUN
ajlm-89	22	8	(	(	PUNCT
ajlm-89	22	9	p	p	X
ajlm-89	22	10	=	=	NOUN
ajlm-89	22	11	0.019	0.019	NUM
ajlm-89	22	12	)	)	PUNCT
ajlm-89	22	13	and	and	CCONJ
ajlm-89	22	14	diarrhoea	diarrhoea	NOUN
ajlm-89	22	15	(	(	PUNCT
ajlm-89	22	16	p	p	X
ajlm-89	22	17	=	=	NOUN
ajlm-89	22	18	0.017	0.017	NUM
ajlm-89	22	19	)	)	PUNCT
ajlm-89	22	20	were	be	AUX
ajlm-89	22	21	significantly	significantly	ADV
ajlm-89	22	22	associated	associate	VERB
ajlm-89	22	23	with	with	ADP
ajlm-89	22	24	an	an	DET
ajlm-89	22	25	increased	increase	VERB
ajlm-89	22	26	risk	risk	NOUN
ajlm-89	22	27	of	of	ADP
ajlm-89	22	28	candidaemia	candidaemia	NOUN
ajlm-89	22	29	.	.	PUNCT
ajlm-89	23	1	the	the	DET
ajlm-89	23	2	crude	crude	ADJ
ajlm-89	23	3	mortality	mortality	NOUN
ajlm-89	23	4	rate	rate	NOUN
ajlm-89	23	5	of	of	ADP
ajlm-89	23	6	candidaemia	candidaemia	NOUN
ajlm-89	23	7	was	be	AUX
ajlm-89	23	8	91.7	91.7	NUM
ajlm-89	23	9	%	%	NOUN
ajlm-89	23	10	.	.	PUNCT
ajlm-89	24	1	conclusion	conclusion	NOUN
ajlm-89	24	2	:	:	PUNCT
ajlm-89	24	3	this	this	DET
ajlm-89	24	4	study	study	NOUN
ajlm-89	24	5	highlights	highlight	VERB
ajlm-89	24	6	the	the	DET
ajlm-89	24	7	significance	significance	NOUN
ajlm-89	24	8	of	of	ADP
ajlm-89	24	9	nosocomial	nosocomial	ADJ
ajlm-89	24	10	candidaemia	candidaemia	NOUN
ajlm-89	24	11	and	and	CCONJ
ajlm-89	24	12	the	the	DET
ajlm-89	24	13	need	need	NOUN
ajlm-89	24	14	for	for	ADP
ajlm-89	24	15	proactive	proactive	ADJ
ajlm-89	24	16	laboratory	laboratory	NOUN
ajlm-89	24	17	investigation	investigation	NOUN
ajlm-89	24	18	and	and	CCONJ
ajlm-89	24	19	clinical	clinical	ADJ
ajlm-89	24	20	management	management	NOUN
ajlm-89	24	21	of	of	ADP
ajlm-89	24	22	this	this	DET
ajlm-89	24	23	life	life	NOUN
ajlm-89	24	24	-	-	PUNCT
ajlm-89	24	25	threatening	threaten	VERB
ajlm-89	24	26	disease	disease	NOUN
ajlm-89	24	27	.	.	PUNCT
ajlm-89	25	1	introduction	introduction	NOUN
ajlm-89	25	2	top	top	PROPN
ajlm-89	25	3	↑	↑	PROPN
ajlm-89	25	4	since	since	SCONJ
ajlm-89	25	5	the	the	DET
ajlm-89	25	6	1980s	1980s	NUM
ajlm-89	26	1	,	,	PUNCT
ajlm-89	26	2	candida	candida	NOUN
ajlm-89	26	3	infections	infection	NOUN
ajlm-89	26	4	have	have	AUX
ajlm-89	26	5	become	become	VERB
ajlm-89	26	6	a	a	DET
ajlm-89	26	7	growing	grow	VERB
ajlm-89	26	8	problem.1,2,3,4	problem.1,2,3,4	ADJ
ajlm-89	26	9	martin	martin	PROPN
ajlm-89	26	10	et	et	PROPN
ajlm-89	26	11	al	al	PROPN
ajlm-89	26	12	.	.	PROPN
ajlm-89	26	13	reported	report	VERB
ajlm-89	26	14	a	a	DET
ajlm-89	26	15	207	207	NUM
ajlm-89	26	16	%	%	NOUN
ajlm-89	26	17	increase	increase	NOUN
ajlm-89	26	18	in	in	ADP
ajlm-89	26	19	incidence	incidence	NOUN
ajlm-89	26	20	between	between	ADP
ajlm-89	26	21	1979	1979	NUM
ajlm-89	26	22	and	and	CCONJ
ajlm-89	26	23	2000	2000	NUM
ajlm-89	26	24	in	in	ADP
ajlm-89	26	25	the	the	DET
ajlm-89	26	26	united	united	PROPN
ajlm-89	26	27	states.5	states.5	PROPN
ajlm-89	26	28	morbidity	morbidity	NOUN
ajlm-89	26	29	rates	rate	NOUN
ajlm-89	26	30	in	in	ADP
ajlm-89	26	31	immunocompromised	immunocompromise	VERB
ajlm-89	26	32	patients	patient	NOUN
ajlm-89	26	33	are	be	AUX
ajlm-89	26	34	as	as	ADV
ajlm-89	26	35	high	high	ADJ
ajlm-89	26	36	as	as	ADP
ajlm-89	26	37	50%.6,7	50%.6,7	NUM
ajlm-89	26	38	patients	patient	NOUN
ajlm-89	26	39	with	with	ADP
ajlm-89	26	40	underlying	underlie	VERB
ajlm-89	26	41	clinical	clinical	ADJ
ajlm-89	26	42	conditions	condition	NOUN
ajlm-89	26	43	,	,	PUNCT
ajlm-89	26	44	such	such	ADJ
ajlm-89	26	45	as	as	ADP
ajlm-89	26	46	haematological	haematological	ADJ
ajlm-89	26	47	malignancies	malignancy	NOUN
ajlm-89	26	48	,	,	PUNCT
ajlm-89	26	49	long	long	ADJ
ajlm-89	26	50	-	-	PUNCT
ajlm-89	26	51	term	term	NOUN
ajlm-89	26	52	intensive	intensive	ADJ
ajlm-89	26	53	care	care	NOUN
ajlm-89	26	54	unit	unit	NOUN
ajlm-89	26	55	(	(	PUNCT
ajlm-89	26	56	icu	icu	PROPN
ajlm-89	26	57	)	)	PUNCT
ajlm-89	26	58	stays	stay	NOUN
ajlm-89	26	59	and	and	CCONJ
ajlm-89	26	60	prematurity	prematurity	NOUN
ajlm-89	26	61	,	,	PUNCT
ajlm-89	26	62	are	be	AUX
ajlm-89	26	63	at	at	ADP
ajlm-89	26	64	high	high	ADJ
ajlm-89	26	65	risk	risk	NOUN
ajlm-89	26	66	for	for	ADP
ajlm-89	26	67	candidaemia	candidaemia	NOUN
ajlm-89	26	68	.	.	PUNCT
ajlm-89	27	1	independent	independent	ADJ
ajlm-89	27	2	risk	risk	NOUN
ajlm-89	27	3	factors	factor	NOUN
ajlm-89	27	4	for	for	ADP
ajlm-89	27	5	infection	infection	NOUN
ajlm-89	27	6	include	include	VERB
ajlm-89	27	7	treatment	treatment	NOUN
ajlm-89	27	8	with	with	ADP
ajlm-89	27	9	broad	broad	ADJ
ajlm-89	27	10	-	-	PUNCT
ajlm-89	27	11	spectrum	spectrum	NOUN
ajlm-89	27	12	antibacterial	antibacterial	ADJ
ajlm-89	27	13	agents	agent	NOUN
ajlm-89	27	14	,	,	PUNCT
ajlm-89	27	15	immunosuppressive	immunosuppressive	ADJ
ajlm-89	27	16	therapy	therapy	NOUN
ajlm-89	27	17	and/or	and/or	CCONJ
ajlm-89	27	18	parenteral	parenteral	ADJ
ajlm-89	27	19	nutrition	nutrition	NOUN
ajlm-89	27	20	;	;	PUNCT
ajlm-89	27	21	prior	prior	ADJ
ajlm-89	27	22	haemodialysis	haemodialysis	NOUN
ajlm-89	27	23	;	;	PUNCT
ajlm-89	27	24	and	and	CCONJ
ajlm-89	27	25	having	having	AUX
ajlm-89	27	26	implanted	implant	VERB
ajlm-89	27	27	prosthetic	prosthetic	ADJ
ajlm-89	27	28	devices.8,9,10,1112candidaemia	devices.8,9,10,1112candidaemia	NOUN
ajlm-89	27	29	poses	pose	VERB
ajlm-89	27	30	a	a	DET
ajlm-89	27	31	complex	complex	ADJ
ajlm-89	27	32	clinical	clinical	ADJ
ajlm-89	27	33	puzzle	puzzle	NOUN
ajlm-89	27	34	.	.	PUNCT
ajlm-89	28	1	firstly	firstly	ADV
ajlm-89	28	2	,	,	PUNCT
ajlm-89	28	3	blood	blood	NOUN
ajlm-89	28	4	culture	culture	NOUN
ajlm-89	28	5	,	,	PUNCT
ajlm-89	28	6	the	the	DET
ajlm-89	28	7	gold	gold	ADJ
ajlm-89	28	8	standard	standard	NOUN
ajlm-89	28	9	for	for	ADP
ajlm-89	28	10	diagnosis	diagnosis	NOUN
ajlm-89	28	11	and	and	CCONJ
ajlm-89	28	12	treatment	treatment	NOUN
ajlm-89	28	13	of	of	ADP
ajlm-89	28	14	candidaemia	candidaemia	NOUN
ajlm-89	28	15	,	,	PUNCT
ajlm-89	28	16	is	be	AUX
ajlm-89	28	17	positive	positive	ADJ
ajlm-89	28	18	in	in	ADP
ajlm-89	28	19	less	less	ADJ
ajlm-89	28	20	than	than	ADP
ajlm-89	28	21	50	50	NUM
ajlm-89	28	22	%	%	NOUN
ajlm-89	28	23	of	of	ADP
ajlm-89	28	24	infected	infected	ADJ
ajlm-89	28	25	patients	patient	NOUN
ajlm-89	28	26	and	and	CCONJ
ajlm-89	28	27	takes	take	VERB
ajlm-89	28	28	several	several	ADJ
ajlm-89	28	29	days	day	NOUN
ajlm-89	28	30	for	for	ADP
ajlm-89	28	31	a	a	DET
ajlm-89	28	32	diagnosis.13	diagnosis.13	NOUN
ajlm-89	28	33	second	second	ADJ
ajlm-89	28	34	,	,	PUNCT
ajlm-89	28	35	trends	trend	NOUN
ajlm-89	28	36	in	in	ADP
ajlm-89	28	37	incidence	incidence	NOUN
ajlm-89	28	38	and	and	CCONJ
ajlm-89	28	39	species	specie	NOUN
ajlm-89	28	40	distribution	distribution	NOUN
ajlm-89	28	41	differ	differ	VERB
ajlm-89	28	42	between	between	ADP
ajlm-89	28	43	geographical	geographical	ADJ
ajlm-89	28	44	zones	zone	NOUN
ajlm-89	28	45	and	and	CCONJ
ajlm-89	28	46	healthcare	healthcare	NOUN
ajlm-89	28	47	facilities.14	facilities.14	PROPN
ajlm-89	28	48	thirdly	thirdly	ADV
ajlm-89	28	49	,	,	PUNCT
ajlm-89	28	50	some	some	DET
ajlm-89	28	51	species	specie	NOUN
ajlm-89	28	52	of	of	ADP
ajlm-89	28	53	candida	candida	PROPN
ajlm-89	28	54	are	be	AUX
ajlm-89	28	55	resistant	resistant	ADJ
ajlm-89	28	56	to	to	ADP
ajlm-89	28	57	fluconazole	fluconazole	NOUN
ajlm-89	28	58	.	.	PUNCT
ajlm-89	29	1	without	without	ADP
ajlm-89	29	2	rapid	rapid	ADJ
ajlm-89	29	3	diagnosis	diagnosis	NOUN
ajlm-89	29	4	and	and	CCONJ
ajlm-89	29	5	treatment	treatment	NOUN
ajlm-89	29	6	,	,	PUNCT
ajlm-89	29	7	the	the	DET
ajlm-89	29	8	consequences	consequence	NOUN
ajlm-89	29	9	are	be	AUX
ajlm-89	29	10	clear	clear	ADJ
ajlm-89	29	11	:	:	PUNCT
ajlm-89	29	12	a	a	DET
ajlm-89	29	13	20	20	NUM
ajlm-89	29	14	%	%	NOUN
ajlm-89	29	15	increase	increase	NOUN
ajlm-89	29	16	in	in	ADP
ajlm-89	29	17	mortality	mortality	NOUN
ajlm-89	29	18	was	be	AUX
ajlm-89	29	19	found	find	VERB
ajlm-89	29	20	in	in	ADP
ajlm-89	29	21	cases	case	NOUN
ajlm-89	29	22	where	where	SCONJ
ajlm-89	29	23	antifungal	antifungal	ADJ
ajlm-89	29	24	therapy	therapy	NOUN
ajlm-89	29	25	was	be	AUX
ajlm-89	29	26	delayed	delay	VERB
ajlm-89	29	27	for	for	ADP
ajlm-89	29	28	more	more	ADJ
ajlm-89	29	29	than	than	ADP
ajlm-89	29	30	12	12	NUM
ajlm-89	29	31	hours.15,16	hours.15,16	NOUN
ajlm-89	29	32	as	as	SCONJ
ajlm-89	29	33	there	there	PRON
ajlm-89	29	34	is	be	VERB
ajlm-89	29	35	insufficient	insufficient	ADJ
ajlm-89	29	36	data	datum	NOUN
ajlm-89	29	37	on	on	ADP
ajlm-89	29	38	nosocomial	nosocomial	ADJ
ajlm-89	29	39	candidaemia	candidaemia	NOUN
ajlm-89	29	40	in	in	ADP
ajlm-89	29	41	nigeria	nigeria	PROPN
ajlm-89	29	42	,	,	PUNCT
ajlm-89	29	43	we	we	PRON
ajlm-89	29	44	conducted	conduct	VERB
ajlm-89	29	45	a	a	DET
ajlm-89	29	46	prospective	prospective	ADJ
ajlm-89	29	47	study	study	NOUN
ajlm-89	29	48	to	to	PART
ajlm-89	29	49	establish	establish	VERB
ajlm-89	29	50	the	the	DET
ajlm-89	29	51	frequency	frequency	NOUN
ajlm-89	29	52	of	of	ADP
ajlm-89	29	53	candidaemia	candidaemia	NOUN
ajlm-89	29	54	,	,	PUNCT
ajlm-89	29	55	predisposing	predispose	VERB
ajlm-89	29	56	factors	factor	NOUN
ajlm-89	29	57	and	and	CCONJ
ajlm-89	29	58	the	the	DET
ajlm-89	29	59	susceptibility	susceptibility	NOUN
ajlm-89	29	60	of	of	ADP
ajlm-89	29	61	candida	candida	PROPN
ajlm-89	29	62	spp	spp	NOUN
ajlm-89	29	63	.	.	PUNCT
ajlm-89	30	1	to	to	ADP
ajlm-89	30	2	fluconazole	fluconazole	NOUN
ajlm-89	30	3	.	.	PUNCT
ajlm-89	31	1	research	research	NOUN
ajlm-89	31	2	method	method	NOUN
ajlm-89	31	3	and	and	CCONJ
ajlm-89	31	4	design	design	VERB
ajlm-89	31	5	top	top	ADJ
ajlm-89	31	6	↑	↑	NOUN
ajlm-89	31	7	conducted	conduct	VERB
ajlm-89	31	8	from	from	ADP
ajlm-89	31	9	01	01	NUM
ajlm-89	31	10	september	september	PROPN
ajlm-89	31	11	2008	2008	NUM
ajlm-89	31	12	to	to	ADP
ajlm-89	31	13	30	30	NUM
ajlm-89	31	14	august	august	PROPN
ajlm-89	31	15	2009	2009	NUM
ajlm-89	31	16	at	at	ADP
ajlm-89	31	17	university	university	NOUN
ajlm-89	31	18	college	college	NOUN
ajlm-89	31	19	hospital	hospital	NOUN
ajlm-89	31	20	,	,	PUNCT
ajlm-89	31	21	a	a	DET
ajlm-89	31	22	960	960	NUM
ajlm-89	31	23	-	-	PUNCT
ajlm-89	31	24	bed	bed	NOUN
ajlm-89	31	25	,	,	PUNCT
ajlm-89	31	26	tertiary	tertiary	ADJ
ajlm-89	31	27	referral	referral	ADJ
ajlm-89	31	28	centre	centre	NOUN
ajlm-89	31	29	in	in	ADP
ajlm-89	31	30	ibadan	ibadan	PROPN
ajlm-89	31	31	,	,	PUNCT
ajlm-89	31	32	nigeria	nigeria	PROPN
ajlm-89	31	33	,	,	PUNCT
ajlm-89	31	34	this	this	DET
ajlm-89	31	35	study	study	NOUN
ajlm-89	31	36	enrolled	enrol	VERB
ajlm-89	31	37	230	230	NUM
ajlm-89	31	38	immunosuppressed	immunosuppressed	ADJ
ajlm-89	31	39	patients	patient	NOUN
ajlm-89	31	40	who	who	PRON
ajlm-89	31	41	had	have	AUX
ajlm-89	31	42	been	be	AUX
ajlm-89	31	43	admitted	admit	VERB
ajlm-89	31	44	at	at	ADP
ajlm-89	31	45	least	least	ADV
ajlm-89	31	46	10	10	NUM
ajlm-89	31	47	days	day	NOUN
ajlm-89	31	48	prior	prior	ADV
ajlm-89	31	49	to	to	ADP
ajlm-89	31	50	the	the	DET
ajlm-89	31	51	start	start	NOUN
ajlm-89	31	52	of	of	ADP
ajlm-89	31	53	the	the	DET
ajlm-89	31	54	study	study	NOUN
ajlm-89	31	55	and	and	CCONJ
ajlm-89	31	56	had	have	VERB
ajlm-89	31	57	persistent	persistent	ADJ
ajlm-89	31	58	pyrexia	pyrexia	NOUN
ajlm-89	31	59	(	(	PUNCT
ajlm-89	31	60	temperature	temperature	NOUN
ajlm-89	31	61	>	>	X
ajlm-89	31	62	38	38	NUM
ajlm-89	31	63	 	 	SPACE
ajlm-89	31	64	°	°	NOUN
ajlm-89	31	65	c	c	NOUN
ajlm-89	31	66	)	)	PUNCT
ajlm-89	31	67	.	.	PUNCT
ajlm-89	32	1	study	study	NOUN
ajlm-89	32	2	subjects	subject	NOUN
ajlm-89	32	3	included	include	VERB
ajlm-89	32	4	patients	patient	NOUN
ajlm-89	32	5	presenting	present	VERB
ajlm-89	32	6	with	with	ADP
ajlm-89	32	7	haematological	haematological	ADJ
ajlm-89	32	8	malignancies	malignancy	NOUN
ajlm-89	32	9	;	;	PUNCT
ajlm-89	32	10	icu	icu	PROPN
ajlm-89	32	11	patients	patient	NOUN
ajlm-89	32	12	;	;	PUNCT
ajlm-89	32	13	very	very	ADV
ajlm-89	32	14	low	low	ADJ
ajlm-89	32	15	birth	birth	NOUN
ajlm-89	32	16	weight	weight	NOUN
ajlm-89	32	17	(	(	PUNCT
ajlm-89	32	18	vlbw	vlbw	NOUN
ajlm-89	32	19	)	)	PUNCT
ajlm-89	32	20	premature	premature	ADJ
ajlm-89	32	21	neonates	neonate	NOUN
ajlm-89	32	22	(	(	PUNCT
ajlm-89	32	23	temperature	temperature	NOUN
ajlm-89	32	24	>	>	X
ajlm-89	32	25	38	38	NUM
ajlm-89	32	26	 	 	SPACE
ajlm-89	32	27	°	°	NOUN
ajlm-89	32	28	c	c	NOUN
ajlm-89	32	29	or	or	CCONJ
ajlm-89	32	30	<	<	X
ajlm-89	32	31	35	35	NUM
ajlm-89	32	32	 	 	SPACE
ajlm-89	32	33	°	°	NOUN
ajlm-89	32	34	c	c	NOUN
ajlm-89	32	35	)	)	PUNCT
ajlm-89	32	36	;	;	PUNCT
ajlm-89	32	37	patients	patient	NOUN
ajlm-89	32	38	who	who	PRON
ajlm-89	32	39	had	have	AUX
ajlm-89	32	40	undergone	undergo	VERB
ajlm-89	32	41	multiple	multiple	ADJ
ajlm-89	32	42	abdominal	abdominal	ADJ
ajlm-89	32	43	surgical	surgical	ADJ
ajlm-89	32	44	procedures	procedure	NOUN
ajlm-89	32	45	during	during	ADP
ajlm-89	32	46	their	their	PRON
ajlm-89	32	47	current	current	ADJ
ajlm-89	32	48	admission	admission	NOUN
ajlm-89	32	49	;	;	PUNCT
ajlm-89	32	50	diabetic	diabetic	ADJ
ajlm-89	32	51	patients	patient	NOUN
ajlm-89	32	52	with	with	ADP
ajlm-89	32	53	persistent	persistent	ADJ
ajlm-89	32	54	pyrexia	pyrexia	NOUN
ajlm-89	32	55	;	;	PUNCT
ajlm-89	32	56	and	and	CCONJ
ajlm-89	32	57	hiv	hiv	PROPN
ajlm-89	32	58	patients	patient	NOUN
ajlm-89	32	59	.	.	PUNCT
ajlm-89	33	1	the	the	DET
ajlm-89	33	2	patients	patient	NOUN
ajlm-89	33	3	’	’	PART
ajlm-89	33	4	underlying	underlie	VERB
ajlm-89	33	5	diseases	disease	NOUN
ajlm-89	33	6	were	be	AUX
ajlm-89	33	7	classified	classify	VERB
ajlm-89	33	8	broadly	broadly	ADV
ajlm-89	33	9	,	,	PUNCT
ajlm-89	33	10	as	as	SCONJ
ajlm-89	33	11	can	can	AUX
ajlm-89	33	12	be	be	AUX
ajlm-89	33	13	seen	see	VERB
ajlm-89	33	14	in	in	ADP
ajlm-89	33	15	table	table	NOUN
ajlm-89	33	16	1	1	NUM
ajlm-89	33	17	.	.	PUNCT
ajlm-89	33	18	exclusion	exclusion	NOUN
ajlm-89	33	19	criteria	criterion	NOUN
ajlm-89	33	20	included	include	VERB
ajlm-89	33	21	non	non	ADJ
ajlm-89	33	22	-	-	ADJ
ajlm-89	33	23	consenting	consenting	ADJ
ajlm-89	33	24	patients	patient	NOUN
ajlm-89	33	25	,	,	PUNCT
ajlm-89	33	26	patients	patient	NOUN
ajlm-89	33	27	without	without	ADP
ajlm-89	33	28	clinical	clinical	ADJ
ajlm-89	33	29	signs	sign	NOUN
ajlm-89	33	30	of	of	ADP
ajlm-89	33	31	infection	infection	NOUN
ajlm-89	33	32	and	and	CCONJ
ajlm-89	33	33	patients	patient	NOUN
ajlm-89	33	34	already	already	ADV
ajlm-89	33	35	receiving	receive	VERB
ajlm-89	33	36	empirical	empirical	ADJ
ajlm-89	33	37	antifungal	antifungal	ADJ
ajlm-89	33	38	therapy	therapy	NOUN
ajlm-89	33	39	.	.	PUNCT
ajlm-89	34	1	probability	probability	NOUN
ajlm-89	34	2	proportionate	proportionate	ADJ
ajlm-89	34	3	to	to	ADP
ajlm-89	34	4	size	size	NOUN
ajlm-89	34	5	was	be	AUX
ajlm-89	34	6	used	use	VERB
ajlm-89	34	7	to	to	PART
ajlm-89	34	8	estimate	estimate	VERB
ajlm-89	34	9	the	the	DET
ajlm-89	34	10	number	number	NOUN
ajlm-89	34	11	of	of	ADP
ajlm-89	34	12	patients	patient	NOUN
ajlm-89	34	13	selected	select	VERB
ajlm-89	34	14	per	per	ADP
ajlm-89	34	15	targeted	target	VERB
ajlm-89	34	16	study	study	NOUN
ajlm-89	34	17	population	population	NOUN
ajlm-89	34	18	group.17	group.17	PROPN
ajlm-89	34	19	table	table	NOUN
ajlm-89	35	1	1	1	NUM
ajlm-89	35	2	:	:	PUNCT
ajlm-89	35	3	demographic	demographic	ADJ
ajlm-89	35	4	characteristics	characteristic	NOUN
ajlm-89	35	5	of	of	ADP
ajlm-89	35	6	patients	patient	NOUN
ajlm-89	35	7	studied	study	VERB
ajlm-89	35	8	and	and	CCONJ
ajlm-89	35	9	underlying	underlying	ADJ
ajlm-89	35	10	diseases	disease	NOUN
ajlm-89	35	11	.	.	PUNCT
ajlm-89	36	1	participation	participation	NOUN
ajlm-89	36	2	in	in	ADP
ajlm-89	36	3	the	the	DET
ajlm-89	36	4	study	study	NOUN
ajlm-89	36	5	was	be	AUX
ajlm-89	36	6	voluntary	voluntary	ADJ
ajlm-89	36	7	and	and	CCONJ
ajlm-89	36	8	,	,	PUNCT
ajlm-89	36	9	after	after	ADP
ajlm-89	36	10	receiving	receive	VERB
ajlm-89	36	11	written	write	VERB
ajlm-89	36	12	consent	consent	NOUN
ajlm-89	36	13	from	from	ADP
ajlm-89	36	14	the	the	DET
ajlm-89	36	15	patients	patient	NOUN
ajlm-89	36	16	or	or	CCONJ
ajlm-89	36	17	their	their	PRON
ajlm-89	36	18	immediate	immediate	ADJ
ajlm-89	36	19	relatives	relative	NOUN
ajlm-89	36	20	,	,	PUNCT
ajlm-89	36	21	the	the	DET
ajlm-89	36	22	investigators	investigator	NOUN
ajlm-89	36	23	explained	explain	VERB
ajlm-89	36	24	the	the	DET
ajlm-89	36	25	study	study	NOUN
ajlm-89	36	26	in	in	ADP
ajlm-89	36	27	both	both	CCONJ
ajlm-89	36	28	english	english	PROPN
ajlm-89	36	29	and	and	CCONJ
ajlm-89	36	30	yoruba	yoruba	PROPN
ajlm-89	36	31	and	and	CCONJ
ajlm-89	36	32	then	then	ADV
ajlm-89	36	33	administered	administer	VERB
ajlm-89	36	34	a	a	DET
ajlm-89	36	35	semi	semi	ADJ
ajlm-89	36	36	-	-	ADJ
ajlm-89	36	37	structured	structured	ADJ
ajlm-89	36	38	questionnaire	questionnaire	NOUN
ajlm-89	36	39	,	,	PUNCT
ajlm-89	36	40	adapted	adapt	VERB
ajlm-89	36	41	from	from	ADP
ajlm-89	36	42	a	a	DET
ajlm-89	36	43	european	european	PROPN
ajlm-89	36	44	confederation	confederation	PROPN
ajlm-89	36	45	of	of	ADP
ajlm-89	36	46	medical	medical	ADJ
ajlm-89	36	47	mycology	mycology	NOUN
ajlm-89	36	48	intensive	intensive	ADJ
ajlm-89	36	49	care	care	NOUN
ajlm-89	36	50	unit	unit	NOUN
ajlm-89	36	51	(	(	PUNCT
ajlm-89	36	52	ecmm	ecmm	PROPN
ajlm-89	36	53	icu	icu	PROPN
ajlm-89	36	54	)	)	PUNCT
ajlm-89	36	55	form	form	NOUN
ajlm-89	36	56	.	.	PUNCT
ajlm-89	37	1	the	the	DET
ajlm-89	37	2	questionnaire	questionnaire	NOUN
ajlm-89	37	3	was	be	AUX
ajlm-89	37	4	divided	divide	VERB
ajlm-89	37	5	into	into	ADP
ajlm-89	37	6	three	three	NUM
ajlm-89	37	7	sections	section	NOUN
ajlm-89	37	8	:	:	PUNCT
ajlm-89	37	9	socio	socio	NOUN
ajlm-89	37	10	-	-	PUNCT
ajlm-89	37	11	demographic	demographic	ADJ
ajlm-89	37	12	data	datum	NOUN
ajlm-89	37	13	;	;	PUNCT
ajlm-89	37	14	medical	medical	ADJ
ajlm-89	37	15	and	and	CCONJ
ajlm-89	37	16	surgical	surgical	ADJ
ajlm-89	37	17	history	history	NOUN
ajlm-89	37	18	(	(	PUNCT
ajlm-89	37	19	based	base	VERB
ajlm-89	37	20	on	on	ADP
ajlm-89	37	21	known	know	VERB
ajlm-89	37	22	risk	risk	NOUN
ajlm-89	37	23	factors	factor	NOUN
ajlm-89	37	24	for	for	ADP
ajlm-89	37	25	candidaemia	candidaemia	NOUN
ajlm-89	37	26	)	)	PUNCT
ajlm-89	37	27	;	;	PUNCT
ajlm-89	37	28	and	and	CCONJ
ajlm-89	37	29	laboratory	laboratory	NOUN
ajlm-89	37	30	findings	finding	NOUN
ajlm-89	37	31	.	.	PUNCT
ajlm-89	38	1	candidaemia	candidaemia	PROPN
ajlm-89	38	2	was	be	AUX
ajlm-89	38	3	defined	define	VERB
ajlm-89	38	4	as	as	ADP
ajlm-89	38	5	being	be	AUX
ajlm-89	38	6	the	the	DET
ajlm-89	38	7	isolation	isolation	NOUN
ajlm-89	38	8	of	of	ADP
ajlm-89	38	9	candida	candida	PROPN
ajlm-89	38	10	species	specie	NOUN
ajlm-89	38	11	from	from	ADP
ajlm-89	38	12	at	at	ADV
ajlm-89	38	13	least	least	ADV
ajlm-89	38	14	one	one	NUM
ajlm-89	38	15	positive	positive	ADJ
ajlm-89	38	16	blood	blood	NOUN
ajlm-89	38	17	culture	culture	NOUN
ajlm-89	38	18	sample	sample	NOUN
ajlm-89	38	19	in	in	ADP
ajlm-89	38	20	patients	patient	NOUN
ajlm-89	38	21	with	with	ADP
ajlm-89	38	22	clinical	clinical	ADJ
ajlm-89	38	23	signs	sign	NOUN
ajlm-89	38	24	of	of	ADP
ajlm-89	38	25	bloodstream	bloodstream	NOUN
ajlm-89	38	26	infection	infection	NOUN
ajlm-89	38	27	.	.	PUNCT
ajlm-89	39	1	two	two	NUM
ajlm-89	39	2	venous	venous	ADJ
ajlm-89	39	3	blood	blood	NOUN
ajlm-89	39	4	samples	sample	NOUN
ajlm-89	39	5	of	of	ADP
ajlm-89	39	6	five	five	NUM
ajlm-89	39	7	 	 	SPACE
ajlm-89	39	8	ml	ml	NOUN
ajlm-89	39	9	each	each	PRON
ajlm-89	39	10	were	be	AUX
ajlm-89	39	11	collected	collect	VERB
ajlm-89	39	12	from	from	ADP
ajlm-89	39	13	each	each	DET
ajlm-89	39	14	patient	patient	NOUN
ajlm-89	39	15	.	.	PUNCT
ajlm-89	40	1	ten	ten	NUM
ajlm-89	40	2	millilitres	millilitre	NOUN
ajlm-89	40	3	of	of	ADP
ajlm-89	40	4	blood	blood	NOUN
ajlm-89	40	5	was	be	AUX
ajlm-89	40	6	added	add	VERB
ajlm-89	40	7	to	to	ADP
ajlm-89	40	8	each	each	DET
ajlm-89	40	9	bactec	bactec	ADJ
ajlm-89	40	10	blood	blood	NOUN
ajlm-89	40	11	culture	culture	NOUN
ajlm-89	40	12	bottle	bottle	NOUN
ajlm-89	40	13	and	and	CCONJ
ajlm-89	40	14	incubated	incubate	VERB
ajlm-89	40	15	at	at	ADP
ajlm-89	40	16	37	37	NUM
ajlm-89	40	17	 	 	SPACE
ajlm-89	40	18	°	°	NOUN
ajlm-89	40	19	c	c	NOUN
ajlm-89	40	20	using	use	VERB
ajlm-89	40	21	a	a	DET
ajlm-89	40	22	bactec	bactec	ADJ
ajlm-89	40	23	9050	9050	NUM
ajlm-89	40	24	blood	blood	NOUN
ajlm-89	40	25	culture	culture	NOUN
ajlm-89	40	26	system	system	NOUN
ajlm-89	40	27	(	(	PUNCT
ajlm-89	40	28	becton	becton	PROPN
ajlm-89	40	29	dickinson	dickinson	PROPN
ajlm-89	40	30	,	,	PUNCT
ajlm-89	40	31	inc	inc	PROPN
ajlm-89	40	32	.	.	PROPN
ajlm-89	40	33	,	,	PUNCT
ajlm-89	40	34	sparks	spark	VERB
ajlm-89	40	35	,	,	PUNCT
ajlm-89	40	36	md	md	PROPN
ajlm-89	40	37	,	,	PUNCT
ajlm-89	40	38	usa	usa	PROPN
ajlm-89	40	39	)	)	PUNCT
ajlm-89	40	40	,	,	PUNCT
ajlm-89	40	41	an	an	DET
ajlm-89	40	42	automated	automate	VERB
ajlm-89	40	43	system	system	NOUN
ajlm-89	40	44	that	that	PRON
ajlm-89	40	45	contains	contain	VERB
ajlm-89	40	46	antibiotic	antibiotic	ADJ
ajlm-89	40	47	-	-	PUNCT
ajlm-89	40	48	absolving	absolve	VERB
ajlm-89	40	49	resins	resin	NOUN
ajlm-89	40	50	,	,	PUNCT
ajlm-89	40	51	allowing	allow	VERB
ajlm-89	40	52	for	for	ADP
ajlm-89	40	53	the	the	DET
ajlm-89	40	54	culturing	culturing	NOUN
ajlm-89	40	55	of	of	ADP
ajlm-89	40	56	blood	blood	NOUN
ajlm-89	40	57	from	from	ADP
ajlm-89	40	58	patients	patient	NOUN
ajlm-89	40	59	on	on	ADP
ajlm-89	40	60	antibiotics	antibiotic	NOUN
ajlm-89	40	61	without	without	ADP
ajlm-89	40	62	discontinuing	discontinue	VERB
ajlm-89	40	63	treatment	treatment	NOUN
ajlm-89	40	64	.	.	PUNCT
ajlm-89	41	1	additional	additional	ADJ
ajlm-89	41	2	advantages	advantage	NOUN
ajlm-89	41	3	of	of	ADP
ajlm-89	41	4	this	this	DET
ajlm-89	41	5	system	system	NOUN
ajlm-89	41	6	are	be	AUX
ajlm-89	41	7	its	its	PRON
ajlm-89	41	8	rapid	rapid	ADJ
ajlm-89	41	9	turnaround	turnaround	NOUN
ajlm-89	41	10	time	time	NOUN
ajlm-89	41	11	and	and	CCONJ
ajlm-89	41	12	increased	increase	VERB
ajlm-89	41	13	yield	yield	NOUN
ajlm-89	41	14	compared	compare	VERB
ajlm-89	41	15	with	with	ADP
ajlm-89	41	16	the	the	DET
ajlm-89	41	17	conventional	conventional	ADJ
ajlm-89	41	18	,	,	PUNCT
ajlm-89	41	19	manual	manual	ADJ
ajlm-89	41	20	blood	blood	NOUN
ajlm-89	41	21	culture	culture	NOUN
ajlm-89	41	22	system	system	NOUN
ajlm-89	41	23	.	.	PUNCT
ajlm-89	42	1	positive	positive	ADJ
ajlm-89	42	2	samples	sample	NOUN
ajlm-89	42	3	were	be	AUX
ajlm-89	42	4	examined	examine	VERB
ajlm-89	42	5	microscopically	microscopically	ADV
ajlm-89	42	6	using	use	VERB
ajlm-89	42	7	direct	direct	ADJ
ajlm-89	42	8	gram	gram	NOUN
ajlm-89	42	9	staining	stain	VERB
ajlm-89	42	10	;	;	PUNCT
ajlm-89	42	11	those	those	PRON
ajlm-89	42	12	showing	show	VERB
ajlm-89	42	13	yeast	yeast	NOUN
ajlm-89	42	14	were	be	AUX
ajlm-89	42	15	cultured	cultured	ADJ
ajlm-89	42	16	onto	onto	ADP
ajlm-89	42	17	sabouraud	sabouraud	NOUN
ajlm-89	42	18	’s	’s	PART
ajlm-89	42	19	dextrose	dextrose	NOUN
ajlm-89	42	20	agar	agar	NOUN
ajlm-89	42	21	(	(	PUNCT
ajlm-89	42	22	oxoid	oxoid	PROPN
ajlm-89	42	23	,	,	PUNCT
ajlm-89	42	24	uk	uk	PROPN
ajlm-89	42	25	)	)	PUNCT
ajlm-89	42	26	and	and	CCONJ
ajlm-89	42	27	chromagar	chromagar	ADJ
ajlm-89	42	28	candida	candida	PROPN
ajlm-89	42	29	(	(	PUNCT
ajlm-89	42	30	chromagar	chromagar	ADJ
ajlm-89	42	31	,	,	PUNCT
ajlm-89	42	32	france	france	PROPN
ajlm-89	42	33	)	)	PUNCT
ajlm-89	42	34	.	.	PUNCT
ajlm-89	43	1	the	the	DET
ajlm-89	43	2	germ	germ	NOUN
ajlm-89	43	3	tube	tube	NOUN
ajlm-89	43	4	test	test	NOUN
ajlm-89	43	5	was	be	AUX
ajlm-89	43	6	used	use	VERB
ajlm-89	43	7	for	for	ADP
ajlm-89	43	8	presumptive	presumptive	ADJ
ajlm-89	43	9	diagnosis	diagnosis	NOUN
ajlm-89	43	10	of	of	ADP
ajlm-89	43	11	c.	c.	NOUN
ajlm-89	43	12	albicans	albican	NOUN
ajlm-89	43	13	,	,	PUNCT
ajlm-89	43	14	but	but	CCONJ
ajlm-89	43	15	all	all	DET
ajlm-89	43	16	isolates	isolate	NOUN
ajlm-89	43	17	were	be	AUX
ajlm-89	43	18	identified	identify	VERB
ajlm-89	43	19	to	to	ADP
ajlm-89	43	20	the	the	DET
ajlm-89	43	21	species	species	NOUN
ajlm-89	43	22	level	level	NOUN
ajlm-89	43	23	using	use	VERB
ajlm-89	43	24	api	api	NOUN
ajlm-89	43	25	20c	20c	PROPN
ajlm-89	43	26	aux	aux	X
ajlm-89	43	27	and/or	and/or	CCONJ
ajlm-89	43	28	i	i	PROPN
ajlm-89	43	29	d	d	PROPN
ajlm-89	43	30	32c	32c	PROPN
ajlm-89	44	1	automated	automate	VERB
ajlm-89	44	2	strip	strip	NOUN
ajlm-89	44	3	detection	detection	NOUN
ajlm-89	44	4	(	(	PUNCT
ajlm-89	44	5	biomerieux	biomerieux	PROPN
ajlm-89	44	6	vitek	vitek	PROPN
ajlm-89	44	7	,	,	PUNCT
ajlm-89	44	8	inc	inc	PROPN
ajlm-89	44	9	.	.	PROPN
ajlm-89	44	10	,	,	PUNCT
ajlm-89	44	11	st	st	PROPN
ajlm-89	44	12	louis	louis	PROPN
ajlm-89	44	13	,	,	PUNCT
ajlm-89	44	14	mo	mo	PROPN
ajlm-89	44	15	,	,	PUNCT
ajlm-89	44	16	usa	usa	PROPN
ajlm-89	44	17	)	)	PUNCT
ajlm-89	44	18	.	.	PUNCT
ajlm-89	45	1	susceptibility	susceptibility	NOUN
ajlm-89	45	2	testing	testing	NOUN
ajlm-89	45	3	to	to	ADP
ajlm-89	45	4	fluconazole	fluconazole	NOUN
ajlm-89	45	5	was	be	AUX
ajlm-89	45	6	performed	perform	VERB
ajlm-89	45	7	using	use	VERB
ajlm-89	45	8	the	the	DET
ajlm-89	45	9	broth	broth	NOUN
ajlm-89	45	10	microdilution	microdilution	NOUN
ajlm-89	45	11	method	method	NOUN
ajlm-89	45	12	in	in	ADP
ajlm-89	45	13	accordance	accordance	NOUN
ajlm-89	45	14	with	with	ADP
ajlm-89	45	15	the	the	DET
ajlm-89	45	16	clinical	clinical	ADJ
ajlm-89	45	17	and	and	CCONJ
ajlm-89	45	18	laboratory	laboratory	NOUN
ajlm-89	45	19	standards	standard	NOUN
ajlm-89	45	20	institute	institute	PROPN
ajlm-89	45	21	(	(	PUNCT
ajlm-89	45	22	clsi	clsi	NOUN
ajlm-89	45	23	)	)	PUNCT
ajlm-89	45	24	recommendations	recommendation	NOUN
ajlm-89	45	25	(	(	PUNCT
ajlm-89	45	26	m27	m27	PROPN
ajlm-89	45	27	-	-	PUNCT
ajlm-89	45	28	a2).18	a2).18	PROPN
ajlm-89	45	29	stock	stock	NOUN
ajlm-89	45	30	inocula	inoculum	NOUN
ajlm-89	45	31	were	be	AUX
ajlm-89	45	32	prepared	prepare	VERB
ajlm-89	45	33	by	by	ADP
ajlm-89	45	34	adding	add	VERB
ajlm-89	45	35	24–48	24–48	NUM
ajlm-89	45	36	-	-	PUNCT
ajlm-89	45	37	hour	hour	NOUN
ajlm-89	45	38	-	-	PUNCT
ajlm-89	45	39	old	old	ADJ
ajlm-89	45	40	test	test	NOUN
ajlm-89	45	41	candida	candida	NOUN
ajlm-89	45	42	to	to	ADP
ajlm-89	45	43	roswell	roswell	PROPN
ajlm-89	45	44	park	park	PROPN
ajlm-89	45	45	memorial	memorial	PROPN
ajlm-89	45	46	institute	institute	PROPN
ajlm-89	45	47	(	(	PUNCT
ajlm-89	45	48	rpmi	rpmi	NOUN
ajlm-89	45	49	)	)	PUNCT
ajlm-89	45	50	broth	broth	NOUN
ajlm-89	45	51	and	and	CCONJ
ajlm-89	45	52	adjusting	adjust	VERB
ajlm-89	45	53	to	to	ADP
ajlm-89	45	54	a	a	DET
ajlm-89	45	55	0.5	0.5	NUM
ajlm-89	45	56	mcfarland	mcfarland	PROPN
ajlm-89	45	57	standard	standard	NOUN
ajlm-89	45	58	.	.	PUNCT
ajlm-89	46	1	the	the	DET
ajlm-89	46	2	stock	stock	NOUN
ajlm-89	46	3	inocula	inocula	NOUN
ajlm-89	46	4	were	be	AUX
ajlm-89	46	5	diluted	dilute	VERB
ajlm-89	46	6	1:1000	1:1000	NUM
ajlm-89	46	7	and	and	CCONJ
ajlm-89	46	8	100	100	NUM
ajlm-89	46	9	μl	μl	ADP
ajlm-89	46	10	of	of	ADP
ajlm-89	46	11	each	each	PRON
ajlm-89	46	12	was	be	AUX
ajlm-89	46	13	added	add	VERB
ajlm-89	46	14	to	to	ADP
ajlm-89	46	15	two	two	NUM
ajlm-89	46	16	-	-	PUNCT
ajlm-89	46	17	fold	fold	VERB
ajlm-89	46	18	100	100	NUM
ajlm-89	46	19	μl	μl	ADP
ajlm-89	46	20	dilutions	dilution	NOUN
ajlm-89	46	21	(	(	PUNCT
ajlm-89	46	22	ranging	range	VERB
ajlm-89	46	23	from	from	ADP
ajlm-89	46	24	0.12	0.12	NUM
ajlm-89	46	25	to	to	ADP
ajlm-89	46	26	64	64	NUM
ajlm-89	46	27	μg	μg	NOUN
ajlm-89	46	28	/	/	SYM
ajlm-89	46	29	ml	ml	NOUN
ajlm-89	46	30	)	)	PUNCT
ajlm-89	46	31	of	of	ADP
ajlm-89	46	32	fluconazole	fluconazole	NOUN
ajlm-89	46	33	on	on	ADP
ajlm-89	46	34	the	the	DET
ajlm-89	46	35	microtitre	microtitre	NOUN
ajlm-89	46	36	plate	plate	NOUN
ajlm-89	46	37	as	as	ADV
ajlm-89	46	38	well	well	ADV
ajlm-89	46	39	as	as	ADP
ajlm-89	46	40	to	to	ADP
ajlm-89	46	41	a	a	DET
ajlm-89	46	42	drug	drug	NOUN
ajlm-89	46	43	-	-	PUNCT
ajlm-89	46	44	free	free	ADJ
ajlm-89	46	45	medium	medium	NOUN
ajlm-89	46	46	.	.	PUNCT
ajlm-89	47	1	after	after	ADP
ajlm-89	47	2	incubating	incubate	VERB
ajlm-89	47	3	the	the	DET
ajlm-89	47	4	microtitre	microtitre	NOUN
ajlm-89	47	5	plates	plate	NOUN
ajlm-89	47	6	at	at	ADP
ajlm-89	47	7	35	35	NUM
ajlm-89	47	8	 	 	SPACE
ajlm-89	47	9	°	°	NOUN
ajlm-89	47	10	c	c	NOUN
ajlm-89	47	11	for	for	ADP
ajlm-89	47	12	24–48	24–48	NUM
ajlm-89	47	13	hours	hour	NOUN
ajlm-89	47	14	,	,	PUNCT
ajlm-89	47	15	the	the	DET
ajlm-89	47	16	amount	amount	NOUN
ajlm-89	47	17	of	of	ADP
ajlm-89	47	18	growth	growth	NOUN
ajlm-89	47	19	in	in	ADP
ajlm-89	47	20	a	a	DET
ajlm-89	47	21	well	well	NOUN
ajlm-89	47	22	containing	contain	VERB
ajlm-89	47	23	the	the	DET
ajlm-89	47	24	antifungal	antifungal	ADJ
ajlm-89	47	25	agent	agent	NOUN
ajlm-89	47	26	was	be	AUX
ajlm-89	47	27	compared	compare	VERB
ajlm-89	47	28	with	with	ADP
ajlm-89	47	29	the	the	DET
ajlm-89	47	30	amount	amount	NOUN
ajlm-89	47	31	of	of	ADP
ajlm-89	47	32	growth	growth	NOUN
ajlm-89	47	33	in	in	ADP
ajlm-89	47	34	an	an	DET
ajlm-89	47	35	antifungal	antifungal	NOUN
ajlm-89	47	36	-	-	PUNCT
ajlm-89	47	37	free	free	ADJ
ajlm-89	47	38	,	,	PUNCT
ajlm-89	47	39	growth	growth	NOUN
ajlm-89	47	40	-	-	PUNCT
ajlm-89	47	41	control	control	NOUN
ajlm-89	47	42	well	well	ADV
ajlm-89	47	43	.	.	PUNCT
ajlm-89	48	1	the	the	DET
ajlm-89	48	2	minimum	minimum	ADJ
ajlm-89	48	3	inhibitory	inhibitory	ADJ
ajlm-89	48	4	concentration	concentration	NOUN
ajlm-89	48	5	(	(	PUNCT
ajlm-89	48	6	mic	mic	ADJ
ajlm-89	48	7	)	)	PUNCT
ajlm-89	48	8	was	be	AUX
ajlm-89	48	9	the	the	DET
ajlm-89	48	10	lowest	low	ADJ
ajlm-89	48	11	concentration	concentration	NOUN
ajlm-89	48	12	of	of	ADP
ajlm-89	48	13	antifungal	antifungal	ADJ
ajlm-89	48	14	agent	agent	NOUN
ajlm-89	48	15	that	that	PRON
ajlm-89	48	16	visibly	visibly	ADV
ajlm-89	48	17	inhibited	inhibit	VERB
ajlm-89	48	18	50	50	NUM
ajlm-89	48	19	%	%	NOUN
ajlm-89	48	20	growth	growth	NOUN
ajlm-89	48	21	of	of	ADP
ajlm-89	48	22	the	the	DET
ajlm-89	48	23	organism	organism	NOUN
ajlm-89	48	24	.	.	PUNCT
ajlm-89	49	1	isolates	isolate	NOUN
ajlm-89	49	2	with	with	ADP
ajlm-89	49	3	an	an	DET
ajlm-89	49	4	mic	mic	ADJ
ajlm-89	49	5	<	<	X
ajlm-89	49	6	8	8	NUM
ajlm-89	49	7	mg	mg	NUM
ajlm-89	49	8	/	/	SYM
ajlm-89	49	9	ml	ml	NOUN
ajlm-89	49	10	were	be	AUX
ajlm-89	49	11	considered	consider	VERB
ajlm-89	49	12	to	to	PART
ajlm-89	49	13	be	be	AUX
ajlm-89	49	14	susceptible	susceptible	ADJ
ajlm-89	49	15	to	to	ADP
ajlm-89	49	16	fluconazole	fluconazole	NOUN
ajlm-89	49	17	;	;	PUNCT
ajlm-89	49	18	isolates	isolate	NOUN
ajlm-89	49	19	with	with	ADP
ajlm-89	49	20	an	an	DET
ajlm-89	49	21	mic	mic	NOUN
ajlm-89	49	22	>	>	X
ajlm-89	49	23	64	64	NUM
ajlm-89	49	24	mg	mg	NUM
ajlm-89	49	25	/	/	SYM
ajlm-89	49	26	ml	ml	NOUN
ajlm-89	49	27	were	be	AUX
ajlm-89	49	28	resistant.18	resistant.18	VERB
ajlm-89	49	29	those	those	PRON
ajlm-89	49	30	with	with	ADP
ajlm-89	49	31	an	an	DET
ajlm-89	49	32	mic	mic	NOUN
ajlm-89	49	33	from	from	ADP
ajlm-89	49	34	16–32	16–32	NUM
ajlm-89	49	35	mg	mg	NUM
ajlm-89	49	36	/	/	SYM
ajlm-89	49	37	ml	ml	NOUN
ajlm-89	49	38	were	be	AUX
ajlm-89	49	39	fluconazole	fluconazole	ADJ
ajlm-89	49	40	susceptible	susceptible	ADJ
ajlm-89	49	41	dose	dose	NOUN
ajlm-89	49	42	-	-	PUNCT
ajlm-89	49	43	dependent	dependent	ADJ
ajlm-89	49	44	(	(	PUNCT
ajlm-89	49	45	s	s	NOUN
ajlm-89	49	46	-	-	PUNCT
ajlm-89	49	47	dd).18	dd).18	ADJ
ajlm-89	49	48	quality	quality	NOUN
ajlm-89	49	49	control	control	NOUN
ajlm-89	49	50	was	be	AUX
ajlm-89	49	51	ensured	ensure	VERB
ajlm-89	49	52	by	by	ADP
ajlm-89	49	53	the	the	DET
ajlm-89	49	54	inclusion	inclusion	NOUN
ajlm-89	49	55	of	of	ADP
ajlm-89	49	56	clsi	clsi	NOUN
ajlm-89	49	57	-	-	PUNCT
ajlm-89	49	58	recommended	recommend	VERB
ajlm-89	49	59	quality	quality	NOUN
ajlm-89	49	60	control	control	NOUN
ajlm-89	49	61	strains	strain	VERB
ajlm-89	49	62	candida	candida	PROPN
ajlm-89	49	63	parapsilopsis	parapsilopsis	NOUN
ajlm-89	49	64	atcc	atcc	NOUN
ajlm-89	49	65	22019	22019	NUM
ajlm-89	49	66	(	(	PUNCT
ajlm-89	49	67	mic	mic	ADJ
ajlm-89	49	68	range	range	NOUN
ajlm-89	49	69	2–8	2–8	NUM
ajlm-89	49	70	mg	mg	NUM
ajlm-89	49	71	/	/	SYM
ajlm-89	49	72	ml	ml	NOUN
ajlm-89	49	73	)	)	PUNCT
ajlm-89	49	74	and	and	CCONJ
ajlm-89	49	75	candida	candida	PROPN
ajlm-89	49	76	krusei	krusei	NOUN
ajlm-89	49	77	atcc	atcc	PROPN
ajlm-89	49	78	6258	6258	NUM
ajlm-89	49	79	(	(	PUNCT
ajlm-89	49	80	mic	mic	ADJ
ajlm-89	49	81	range	range	NOUN
ajlm-89	49	82	16–64	16–64	NUM
ajlm-89	49	83	mg	mg	NUM
ajlm-89	49	84	/	/	SYM
ajlm-89	49	85	ml	ml	NOUN
ajlm-89	49	86	)	)	PUNCT
ajlm-89	49	87	.	.	PUNCT
ajlm-89	50	1	quantitative	quantitative	ADJ
ajlm-89	50	2	data	datum	NOUN
ajlm-89	50	3	from	from	ADP
ajlm-89	50	4	the	the	DET
ajlm-89	50	5	questionnaire	questionnaire	NOUN
ajlm-89	50	6	were	be	AUX
ajlm-89	50	7	entered	enter	VERB
ajlm-89	50	8	into	into	ADP
ajlm-89	50	9	microsoft	microsoft	PROPN
ajlm-89	50	10	excel	excel	PROPN
ajlm-89	50	11	2003	2003	NUM
ajlm-89	50	12	(	(	PUNCT
ajlm-89	50	13	v11.0	v11.0	PROPN
ajlm-89	50	14	)	)	PUNCT
ajlm-89	50	15	(	(	PUNCT
ajlm-89	50	16	microsoft	microsoft	PROPN
ajlm-89	50	17	,	,	PUNCT
ajlm-89	50	18	redmond	redmond	PROPN
ajlm-89	50	19	,	,	PUNCT
ajlm-89	50	20	wa	wa	PROPN
ajlm-89	50	21	)	)	PUNCT
ajlm-89	50	22	and	and	CCONJ
ajlm-89	50	23	spss	sps	VERB
ajlm-89	50	24	15.0	15.0	NUM
ajlm-89	50	25	for	for	ADP
ajlm-89	50	26	windows	window	NOUN
ajlm-89	50	27	(	(	PUNCT
ajlm-89	50	28	spss	spss	PROPN
ajlm-89	50	29	inc	inc	PROPN
ajlm-89	50	30	.	.	PROPN
ajlm-89	50	31	,	,	PUNCT
ajlm-89	50	32	chicago	chicago	PROPN
ajlm-89	50	33	,	,	PUNCT
ajlm-89	50	34	2006	2006	NUM
ajlm-89	50	35	)	)	PUNCT
ajlm-89	50	36	was	be	AUX
ajlm-89	50	37	used	use	VERB
ajlm-89	50	38	for	for	ADP
ajlm-89	50	39	the	the	DET
ajlm-89	50	40	analysis	analysis	NOUN
ajlm-89	50	41	.	.	PUNCT
ajlm-89	51	1	the	the	DET
ajlm-89	51	2	univariate	univariate	ADJ
ajlm-89	51	3	analysis	analysis	NOUN
ajlm-89	51	4	used	use	VERB
ajlm-89	51	5	descriptive	descriptive	ADJ
ajlm-89	51	6	statistics	statistic	NOUN
ajlm-89	51	7	and	and	CCONJ
ajlm-89	51	8	tables	table	NOUN
ajlm-89	51	9	,	,	PUNCT
ajlm-89	51	10	including	include	VERB
ajlm-89	51	11	frequency	frequency	NOUN
ajlm-89	51	12	distribution	distribution	NOUN
ajlm-89	51	13	;	;	PUNCT
ajlm-89	51	14	and	and	CCONJ
ajlm-89	51	15	the	the	DET
ajlm-89	51	16	bivariate	bivariate	ADJ
ajlm-89	51	17	analysis	analysis	NOUN
ajlm-89	51	18	used	use	VERB
ajlm-89	51	19	the	the	DET
ajlm-89	51	20	chi	chi	ADJ
ajlm-89	51	21	-	-	PUNCT
ajlm-89	51	22	square	square	ADJ
ajlm-89	51	23	test	test	NOUN
ajlm-89	51	24	with	with	ADP
ajlm-89	51	25	statistical	statistical	ADJ
ajlm-89	51	26	significance	significance	NOUN
ajlm-89	51	27	set	set	VERB
ajlm-89	51	28	at	at	ADP
ajlm-89	51	29	p	p	NOUN
ajlm-89	51	30	<	<	X
ajlm-89	51	31	0.05	0.05	NUM
ajlm-89	51	32	.	.	PUNCT
ajlm-89	51	33	results	result	VERB
ajlm-89	51	34	top	top	PROPN
ajlm-89	51	35	↑	↑	NOUN
ajlm-89	51	36	of	of	ADP
ajlm-89	51	37	the	the	DET
ajlm-89	51	38	230	230	NUM
ajlm-89	51	39	study	study	NOUN
ajlm-89	51	40	patients	patient	NOUN
ajlm-89	51	41	,	,	PUNCT
ajlm-89	51	42	the	the	DET
ajlm-89	51	43	median	median	ADJ
ajlm-89	51	44	age	age	NOUN
ajlm-89	51	45	was	be	AUX
ajlm-89	51	46	18	18	NUM
ajlm-89	51	47	years	year	NOUN
ajlm-89	51	48	,	,	PUNCT
ajlm-89	51	49	with	with	ADP
ajlm-89	51	50	27.5	27.5	NUM
ajlm-89	51	51	%	%	NOUN
ajlm-89	51	52	(	(	PUNCT
ajlm-89	51	53	n	n	NOUN
ajlm-89	51	54	=	=	SYM
ajlm-89	51	55	63	63	NUM
ajlm-89	51	56	)	)	PUNCT
ajlm-89	51	57	being	be	AUX
ajlm-89	51	58	less	less	ADJ
ajlm-89	51	59	than	than	ADP
ajlm-89	51	60	one	one	NUM
ajlm-89	51	61	year	year	NOUN
ajlm-89	51	62	old	old	ADJ
ajlm-89	51	63	and	and	CCONJ
ajlm-89	51	64	10.9	10.9	NUM
ajlm-89	51	65	%	%	NOUN
ajlm-89	51	66	(	(	PUNCT
ajlm-89	51	67	n	n	NOUN
ajlm-89	51	68	=	=	SYM
ajlm-89	51	69	25	25	NUM
ajlm-89	51	70	)	)	PUNCT
ajlm-89	51	71	older	old	ADJ
ajlm-89	51	72	than	than	ADP
ajlm-89	51	73	60	60	NUM
ajlm-89	51	74	.	.	PUNCT
ajlm-89	52	1	the	the	DET
ajlm-89	52	2	male	male	NOUN
ajlm-89	52	3	-	-	PUNCT
ajlm-89	52	4	to	to	ADP
ajlm-89	52	5	-	-	PUNCT
ajlm-89	52	6	female	female	ADJ
ajlm-89	52	7	ratio	ratio	NOUN
ajlm-89	52	8	was	be	AUX
ajlm-89	52	9	1.12:1	1.12:1	NUM
ajlm-89	52	10	.	.	PUNCT
ajlm-89	53	1	all	all	DET
ajlm-89	53	2	patients	patient	NOUN
ajlm-89	53	3	were	be	AUX
ajlm-89	53	4	admitted	admit	VERB
ajlm-89	53	5	for	for	ADP
ajlm-89	53	6	hospitalisation	hospitalisation	NOUN
ajlm-89	53	7	:	:	PUNCT
ajlm-89	53	8	39.7	39.7	NUM
ajlm-89	53	9	%	%	NOUN
ajlm-89	53	10	(	(	PUNCT
ajlm-89	53	11	n	n	NOUN
ajlm-89	53	12	=	=	SYM
ajlm-89	53	13	89	89	NUM
ajlm-89	53	14	)	)	PUNCT
ajlm-89	53	15	for	for	ADP
ajlm-89	53	16	11–20	11–20	NUM
ajlm-89	53	17	days	day	NOUN
ajlm-89	53	18	and	and	CCONJ
ajlm-89	53	19	17.8	17.8	NUM
ajlm-89	53	20	%	%	NOUN
ajlm-89	53	21	(	(	PUNCT
ajlm-89	53	22	n	n	NOUN
ajlm-89	53	23	=	=	SYM
ajlm-89	53	24	42	42	NUM
ajlm-89	53	25	)	)	PUNCT
ajlm-89	53	26	for	for	ADP
ajlm-89	53	27	more	more	ADJ
ajlm-89	53	28	than	than	ADP
ajlm-89	53	29	30	30	NUM
ajlm-89	53	30	days	day	NOUN
ajlm-89	53	31	(	(	PUNCT
ajlm-89	53	32	table	table	NOUN
ajlm-89	53	33	1	1	NUM
ajlm-89	53	34	)	)	PUNCT
ajlm-89	53	35	.	.	PUNCT
ajlm-89	54	1	seven	seven	NUM
ajlm-89	54	2	percent	percent	NOUN
ajlm-89	54	3	(	(	PUNCT
ajlm-89	54	4	n	n	NOUN
ajlm-89	54	5	=	=	SYM
ajlm-89	54	6	16	16	NUM
ajlm-89	54	7	)	)	PUNCT
ajlm-89	54	8	of	of	ADP
ajlm-89	54	9	the	the	DET
ajlm-89	54	10	patients	patient	NOUN
ajlm-89	54	11	underwent	undergo	VERB
ajlm-89	54	12	more	more	ADJ
ajlm-89	54	13	than	than	ADP
ajlm-89	54	14	one	one	NUM
ajlm-89	54	15	operation	operation	NOUN
ajlm-89	54	16	(	(	PUNCT
ajlm-89	54	17	table	table	NOUN
ajlm-89	54	18	2	2	NUM
ajlm-89	54	19	)	)	PUNCT
ajlm-89	54	20	.	.	PUNCT
ajlm-89	55	1	most	most	ADJ
ajlm-89	55	2	of	of	ADP
ajlm-89	55	3	the	the	DET
ajlm-89	55	4	study	study	NOUN
ajlm-89	55	5	population	population	NOUN
ajlm-89	55	6	(	(	PUNCT
ajlm-89	55	7	97.4	97.4	NUM
ajlm-89	55	8	%	%	NOUN
ajlm-89	55	9	;	;	PUNCT
ajlm-89	55	10	n	n	PROPN
ajlm-89	55	11	=	=	SYM
ajlm-89	55	12	224	224	NUM
ajlm-89	55	13	)	)	PUNCT
ajlm-89	55	14	were	be	AUX
ajlm-89	55	15	treated	treat	VERB
ajlm-89	55	16	with	with	ADP
ajlm-89	55	17	broad	broad	ADJ
ajlm-89	55	18	-	-	PUNCT
ajlm-89	55	19	spectrum	spectrum	NOUN
ajlm-89	55	20	antibiotics	antibiotic	NOUN
ajlm-89	55	21	;	;	PUNCT
ajlm-89	55	22	45.7	45.7	NUM
ajlm-89	55	23	%	%	NOUN
ajlm-89	55	24	(	(	PUNCT
ajlm-89	55	25	n	n	NOUN
ajlm-89	55	26	=	=	SYM
ajlm-89	55	27	105	105	NUM
ajlm-89	55	28	)	)	PUNCT
ajlm-89	55	29	of	of	ADP
ajlm-89	55	30	these	these	PRON
ajlm-89	55	31	received	receive	VERB
ajlm-89	55	32	11–20	11–20	NUM
ajlm-89	55	33	days	day	NOUN
ajlm-89	55	34	of	of	ADP
ajlm-89	55	35	different	different	ADJ
ajlm-89	55	36	combination	combination	NOUN
ajlm-89	55	37	of	of	ADP
ajlm-89	55	38	broad	broad	ADJ
ajlm-89	55	39	-	-	PUNCT
ajlm-89	55	40	spectrum	spectrum	NOUN
ajlm-89	55	41	antibiotics	antibiotic	NOUN
ajlm-89	55	42	.	.	PUNCT
ajlm-89	56	1	the	the	DET
ajlm-89	56	2	median	median	ADJ
ajlm-89	56	3	duration	duration	NOUN
ajlm-89	56	4	of	of	ADP
ajlm-89	56	5	antibiotic	antibiotic	ADJ
ajlm-89	56	6	use	use	NOUN
ajlm-89	56	7	was	be	AUX
ajlm-89	56	8	15.5	15.5	NUM
ajlm-89	56	9	days	day	NOUN
ajlm-89	56	10	,	,	PUNCT
ajlm-89	56	11	with	with	ADP
ajlm-89	56	12	only	only	ADV
ajlm-89	56	13	11.7	11.7	NUM
ajlm-89	56	14	%	%	NOUN
ajlm-89	56	15	(	(	PUNCT
ajlm-89	56	16	n	n	NOUN
ajlm-89	56	17	=	=	SYM
ajlm-89	56	18	27	27	NUM
ajlm-89	56	19	)	)	PUNCT
ajlm-89	56	20	of	of	ADP
ajlm-89	56	21	patients	patient	NOUN
ajlm-89	56	22	receiving	receive	VERB
ajlm-89	56	23	antibiotic	antibiotic	ADJ
ajlm-89	56	24	treatment	treatment	NOUN
ajlm-89	56	25	for	for	ADP
ajlm-89	56	26	more	more	ADJ
ajlm-89	56	27	than	than	ADP
ajlm-89	56	28	21	21	NUM
ajlm-89	56	29	days	day	NOUN
ajlm-89	56	30	(	(	PUNCT
ajlm-89	56	31	table	table	NOUN
ajlm-89	56	32	2	2	NUM
ajlm-89	56	33	)	)	PUNCT
ajlm-89	56	34	.	.	PUNCT
ajlm-89	57	1	most	most	ADJ
ajlm-89	57	2	patients	patient	NOUN
ajlm-89	57	3	had	have	VERB
ajlm-89	57	4	at	at	ADV
ajlm-89	57	5	least	least	ADV
ajlm-89	57	6	one	one	NUM
ajlm-89	57	7	invasive	invasive	ADJ
ajlm-89	57	8	procedure	procedure	NOUN
ajlm-89	57	9	during	during	ADP
ajlm-89	57	10	their	their	PRON
ajlm-89	57	11	admission	admission	NOUN
ajlm-89	57	12	,	,	PUNCT
ajlm-89	57	13	with	with	ADP
ajlm-89	57	14	92.2	92.2	NUM
ajlm-89	57	15	%	%	NOUN
ajlm-89	57	16	(	(	PUNCT
ajlm-89	57	17	n	n	NOUN
ajlm-89	57	18	=	=	SYM
ajlm-89	57	19	212	212	NUM
ajlm-89	57	20	)	)	PUNCT
ajlm-89	57	21	undergoing	undergo	VERB
ajlm-89	57	22	intravenous	intravenous	ADJ
ajlm-89	57	23	cannulation	cannulation	NOUN
ajlm-89	57	24	and	and	CCONJ
ajlm-89	57	25	8.7	8.7	NUM
ajlm-89	57	26	%	%	NOUN
ajlm-89	57	27	(	(	PUNCT
ajlm-89	57	28	n	n	NOUN
ajlm-89	57	29	=	=	SYM
ajlm-89	57	30	7	7	X
ajlm-89	57	31	)	)	PUNCT
ajlm-89	57	32	undergoing	undergo	VERB
ajlm-89	57	33	venous	venous	ADJ
ajlm-89	57	34	cutdown	cutdown	NOUN
ajlm-89	57	35	(	(	PUNCT
ajlm-89	57	36	table	table	NOUN
ajlm-89	57	37	2	2	NUM
ajlm-89	57	38	)	)	PUNCT
ajlm-89	57	39	.	.	PUNCT
ajlm-89	58	1	other	other	ADJ
ajlm-89	58	2	treatments	treatment	NOUN
ajlm-89	58	3	used	use	VERB
ajlm-89	58	4	in	in	ADP
ajlm-89	58	5	this	this	DET
ajlm-89	58	6	population	population	NOUN
ajlm-89	58	7	included	include	VERB
ajlm-89	58	8	antifungal	antifungal	ADJ
ajlm-89	58	9	therapy	therapy	NOUN
ajlm-89	58	10	for	for	ADP
ajlm-89	58	11	non	non	ADJ
ajlm-89	58	12	-	-	ADJ
ajlm-89	58	13	invasive	invasive	ADJ
ajlm-89	58	14	candidiasis	candidiasis	NOUN
ajlm-89	58	15	,	,	PUNCT
ajlm-89	58	16	anti	anti	ADJ
ajlm-89	58	17	-	-	ADJ
ajlm-89	58	18	cancer	cancer	ADJ
ajlm-89	58	19	chemotherapy	chemotherapy	NOUN
ajlm-89	58	20	,	,	PUNCT
ajlm-89	58	21	radiotherapy	radiotherapy	NOUN
ajlm-89	58	22	,	,	PUNCT
ajlm-89	58	23	steroids	steroid	NOUN
ajlm-89	58	24	and	and	CCONJ
ajlm-89	58	25	highly	highly	ADV
ajlm-89	58	26	-	-	PUNCT
ajlm-89	58	27	active	active	ADJ
ajlm-89	58	28	antiretroviral	antiretroviral	ADJ
ajlm-89	58	29	therapy	therapy	NOUN
ajlm-89	58	30	(	(	PUNCT
ajlm-89	58	31	haart	haart	PROPN
ajlm-89	58	32	)	)	PUNCT
ajlm-89	58	33	.	.	PUNCT
ajlm-89	59	1	table	table	NOUN
ajlm-89	59	2	2	2	NUM
ajlm-89	59	3	:	:	PUNCT
ajlm-89	59	4	treatment	treatment	NOUN
ajlm-89	59	5	history	history	NOUN
ajlm-89	59	6	of	of	ADP
ajlm-89	59	7	patients	patient	NOUN
ajlm-89	59	8	in	in	ADP
ajlm-89	59	9	the	the	DET
ajlm-89	59	10	study	study	NOUN
ajlm-89	59	11	.	.	PUNCT
ajlm-89	60	1	the	the	DET
ajlm-89	60	2	distribution	distribution	NOUN
ajlm-89	60	3	pattern	pattern	NOUN
ajlm-89	60	4	of	of	ADP
ajlm-89	60	5	isolates	isolate	NOUN
ajlm-89	60	6	from	from	ADP
ajlm-89	60	7	blood	blood	NOUN
ajlm-89	60	8	culture	culture	NOUN
ajlm-89	60	9	samples	sample	NOUN
ajlm-89	60	10	showed	show	VERB
ajlm-89	60	11	that	that	SCONJ
ajlm-89	60	12	staphylococcus	staphylococcus	NOUN
ajlm-89	60	13	aureus	aureus	NOUN
ajlm-89	60	14	(	(	PUNCT
ajlm-89	60	15	42.9	42.9	NUM
ajlm-89	60	16	%	%	NOUN
ajlm-89	60	17	;	;	PUNCT
ajlm-89	60	18	n	n	PROPN
ajlm-89	60	19	=	=	SYM
ajlm-89	60	20	30	30	NUM
ajlm-89	60	21	)	)	PUNCT
ajlm-89	60	22	and	and	CCONJ
ajlm-89	60	23	klebsiella	klebsiella	PROPN
ajlm-89	60	24	spp	spp	PROPN
ajlm-89	60	25	.	.	PUNCT
ajlm-89	61	1	(	(	PUNCT
ajlm-89	61	2	20.0	20.0	NUM
ajlm-89	61	3	%	%	NOUN
ajlm-89	61	4	;	;	PUNCT
ajlm-89	61	5	n	n	PROPN
ajlm-89	61	6	=	=	SYM
ajlm-89	61	7	14	14	NUM
ajlm-89	61	8	)	)	PUNCT
ajlm-89	61	9	were	be	AUX
ajlm-89	61	10	the	the	DET
ajlm-89	61	11	most	most	ADV
ajlm-89	61	12	common	common	ADJ
ajlm-89	61	13	pathogens	pathogen	NOUN
ajlm-89	61	14	,	,	PUNCT
ajlm-89	61	15	followed	follow	VERB
ajlm-89	61	16	by	by	ADP
ajlm-89	61	17	candida	candida	PROPN
ajlm-89	61	18	spp	spp	PROPN
ajlm-89	61	19	.	.	PUNCT
ajlm-89	62	1	(	(	PUNCT
ajlm-89	62	2	17.1	17.1	NUM
ajlm-89	62	3	%	%	NOUN
ajlm-89	62	4	;	;	PUNCT
ajlm-89	62	5	n	n	NOUN
ajlm-89	62	6	=	=	NUM
ajlm-89	62	7	12	12	NUM
ajlm-89	62	8	)	)	PUNCT
ajlm-89	62	9	(	(	PUNCT
ajlm-89	62	10	figure	figure	NOUN
ajlm-89	62	11	1	1	NUM
ajlm-89	62	12	)	)	PUNCT
ajlm-89	62	13	.	.	PUNCT
ajlm-89	63	1	of	of	ADP
ajlm-89	63	2	the	the	DET
ajlm-89	63	3	enrolled	enrol	VERB
ajlm-89	63	4	patients	patient	NOUN
ajlm-89	63	5	,	,	PUNCT
ajlm-89	63	6	12	12	NUM
ajlm-89	63	7	(	(	PUNCT
ajlm-89	63	8	5.2	5.2	NUM
ajlm-89	63	9	%	%	NOUN
ajlm-89	63	10	)	)	PUNCT
ajlm-89	63	11	had	have	VERB
ajlm-89	63	12	candidaemia	candidaemia	NOUN
ajlm-89	63	13	.	.	PUNCT
ajlm-89	64	1	c.	c.	PROPN
ajlm-89	64	2	tropicalis	tropicalis	PROPN
ajlm-89	64	3	(	(	PUNCT
ajlm-89	64	4	n	n	NOUN
ajlm-89	64	5	=	=	SYM
ajlm-89	64	6	6	6	NUM
ajlm-89	64	7	;	;	PUNCT
ajlm-89	64	8	50	50	NUM
ajlm-89	64	9	%	%	NOUN
ajlm-89	64	10	)	)	PUNCT
ajlm-89	64	11	was	be	AUX
ajlm-89	64	12	the	the	DET
ajlm-89	64	13	most	most	ADV
ajlm-89	64	14	frequently	frequently	ADV
ajlm-89	64	15	-	-	PUNCT
ajlm-89	64	16	identified	identify	VERB
ajlm-89	64	17	candida	candida	PROPN
ajlm-89	64	18	spp	spp	NOUN
ajlm-89	64	19	.	.	PUNCT
ajlm-89	65	1	(	(	PUNCT
ajlm-89	65	2	figure	figure	NOUN
ajlm-89	65	3	2	2	NUM
ajlm-89	65	4	)	)	PUNCT
ajlm-89	65	5	.	.	PUNCT
ajlm-89	66	1	based	base	VERB
ajlm-89	66	2	on	on	ADP
ajlm-89	66	3	chromagar	chromagar	ADJ
ajlm-89	66	4	candida	candida	NOUN
ajlm-89	66	5	phenotypes	phenotype	NOUN
ajlm-89	66	6	,	,	PUNCT
ajlm-89	66	7	one	one	NUM
ajlm-89	66	8	patient	patient	NOUN
ajlm-89	66	9	had	have	VERB
ajlm-89	66	10	a	a	DET
ajlm-89	66	11	polymicrobial	polymicrobial	ADJ
ajlm-89	66	12	infection	infection	NOUN
ajlm-89	66	13	with	with	ADP
ajlm-89	66	14	both	both	PRON
ajlm-89	66	15	c.	c.	NOUN
ajlm-89	66	16	albicans	albican	NOUN
ajlm-89	66	17	and	and	CCONJ
ajlm-89	66	18	c.	c.	PROPN
ajlm-89	66	19	tropicalis	tropicalis	PROPN
ajlm-89	66	20	.	.	PUNCT
ajlm-89	67	1	candida	candida	PROPN
ajlm-89	67	2	spp	spp	PROPN
ajlm-89	67	3	.	.	PROPN
ajlm-89	67	4	was	be	AUX
ajlm-89	67	5	also	also	ADV
ajlm-89	67	6	isolated	isolate	VERB
ajlm-89	67	7	from	from	ADP
ajlm-89	67	8	non	non	ADJ
ajlm-89	67	9	-	-	ADJ
ajlm-89	67	10	venous	venous	ADJ
ajlm-89	67	11	,	,	PUNCT
ajlm-89	67	12	invasive	invasive	ADJ
ajlm-89	67	13	sites	site	NOUN
ajlm-89	67	14	in	in	ADP
ajlm-89	67	15	11	11	NUM
ajlm-89	67	16	(	(	PUNCT
ajlm-89	67	17	91.7	91.7	NUM
ajlm-89	67	18	%	%	NOUN
ajlm-89	67	19	)	)	PUNCT
ajlm-89	67	20	of	of	ADP
ajlm-89	67	21	the	the	DET
ajlm-89	67	22	12	12	NUM
ajlm-89	67	23	patients	patient	NOUN
ajlm-89	67	24	(	(	PUNCT
ajlm-89	67	25	figure	figure	NOUN
ajlm-89	67	26	3	3	NUM
ajlm-89	67	27	)	)	PUNCT
ajlm-89	67	28	.	.	PUNCT
ajlm-89	68	1	all	all	DET
ajlm-89	68	2	candida	candida	PROPN
ajlm-89	68	3	spp	spp	PROPN
ajlm-89	68	4	.	.	PUNCT
ajlm-89	69	1	isolates	isolate	NOUN
ajlm-89	69	2	were	be	AUX
ajlm-89	69	3	susceptible	susceptible	ADJ
ajlm-89	69	4	to	to	ADP
ajlm-89	69	5	fluconazole	fluconazole	NOUN
ajlm-89	69	6	(	(	PUNCT
ajlm-89	69	7	mic	mic	ADJ
ajlm-89	69	8	<	<	X
ajlm-89	69	9	8	8	NUM
ajlm-89	69	10	mg	mg	NUM
ajlm-89	69	11	/	/	SYM
ajlm-89	69	12	ml	ml	NOUN
ajlm-89	69	13	)	)	PUNCT
ajlm-89	69	14	.	.	PUNCT
ajlm-89	70	1	in	in	ADP
ajlm-89	70	2	addition	addition	NOUN
ajlm-89	70	3	,	,	PUNCT
ajlm-89	70	4	the	the	DET
ajlm-89	70	5	api	api	NOUN
ajlm-89	70	6	20c	20c	X
ajlm-89	70	7	aux	aux	PROPN
ajlm-89	70	8	and	and	CCONJ
ajlm-89	70	9	i	i	PROPN
ajlm-89	70	10	d	d	PROPN
ajlm-89	70	11	32c	32c	NOUN
ajlm-89	70	12	identification	identification	NOUN
ajlm-89	70	13	of	of	ADP
ajlm-89	70	14	the	the	DET
ajlm-89	70	15	candida	candida	PROPN
ajlm-89	70	16	spp	spp	PROPN
ajlm-89	70	17	.	.	PUNCT
ajlm-89	70	18	were	be	AUX
ajlm-89	70	19	in	in	ADP
ajlm-89	70	20	concordance	concordance	NOUN
ajlm-89	70	21	with	with	ADP
ajlm-89	70	22	one	one	NUM
ajlm-89	70	23	another	another	DET
ajlm-89	70	24	.	.	PUNCT
ajlm-89	71	1	figure	figure	NOUN
ajlm-89	71	2	1	1	NUM
ajlm-89	71	3	:	:	PUNCT
ajlm-89	71	4	bar	bar	NOUN
ajlm-89	71	5	chart	chart	NOUN
ajlm-89	71	6	showing	show	VERB
ajlm-89	71	7	distribution	distribution	NOUN
ajlm-89	71	8	of	of	ADP
ajlm-89	71	9	pathogens	pathogen	NOUN
ajlm-89	71	10	causing	cause	VERB
ajlm-89	71	11	bloodstream	bloodstream	NOUN
ajlm-89	71	12	infections	infection	NOUN
ajlm-89	71	13	.	.	PUNCT
ajlm-89	72	1	figure	figure	NOUN
ajlm-89	72	2	2	2	NUM
ajlm-89	72	3	:	:	PUNCT
ajlm-89	72	4	bar	bar	NOUN
ajlm-89	72	5	chart	chart	NOUN
ajlm-89	72	6	showing	show	VERB
ajlm-89	72	7	distribution	distribution	NOUN
ajlm-89	72	8	of	of	ADP
ajlm-89	72	9	candida	candida	PROPN
ajlm-89	72	10	spp	spp	NOUN
ajlm-89	72	11	.	.	PUNCT
ajlm-89	73	1	causing	cause	VERB
ajlm-89	73	2	bloodstream	bloodstream	NOUN
ajlm-89	73	3	infections	infection	NOUN
ajlm-89	73	4	.	.	PUNCT
ajlm-89	74	1	figure	figure	VERB
ajlm-89	74	2	3	3	NUM
ajlm-89	74	3	:	:	PUNCT
ajlm-89	74	4	of	of	ADP
ajlm-89	74	5	the	the	DET
ajlm-89	74	6	12	12	NUM
ajlm-89	74	7	(	(	PUNCT
ajlm-89	74	8	5.2	5.2	NUM
ajlm-89	74	9	%	%	NOUN
ajlm-89	74	10	)	)	PUNCT
ajlm-89	74	11	patients	patient	NOUN
ajlm-89	74	12	with	with	ADP
ajlm-89	74	13	candidaemia	candidaemia	NOUN
ajlm-89	74	14	in	in	ADP
ajlm-89	74	15	this	this	DET
ajlm-89	74	16	study	study	NOUN
ajlm-89	74	17	,	,	PUNCT
ajlm-89	74	18	age	age	NOUN
ajlm-89	74	19	(	(	PUNCT
ajlm-89	74	20	p	p	NOUN
ajlm-89	74	21	=	=	NOUN
ajlm-89	74	22	0.8	0.8	NUM
ajlm-89	74	23	)	)	PUNCT
ajlm-89	74	24	and	and	CCONJ
ajlm-89	74	25	sex	sex	NOUN
ajlm-89	74	26	(	(	PUNCT
ajlm-89	74	27	p	p	X
ajlm-89	74	28	=	=	SYM
ajlm-89	74	29	0.16	0.16	NUM
ajlm-89	74	30	)	)	PUNCT
ajlm-89	74	31	distributions	distribution	NOUN
ajlm-89	74	32	were	be	AUX
ajlm-89	74	33	not	not	PART
ajlm-89	74	34	of	of	ADP
ajlm-89	74	35	statistical	statistical	ADJ
ajlm-89	74	36	significance	significance	NOUN
ajlm-89	74	37	.	.	PUNCT
ajlm-89	75	1	these	these	DET
ajlm-89	75	2	patients	patient	NOUN
ajlm-89	75	3	’	’	PART
ajlm-89	75	4	underlying	underlie	VERB
ajlm-89	75	5	diseases	disease	NOUN
ajlm-89	75	6	included	include	VERB
ajlm-89	75	7	solid	solid	ADJ
ajlm-89	75	8	tumours	tumour	NOUN
ajlm-89	75	9	,	,	PUNCT
ajlm-89	75	10	diabetes	diabetes	NOUN
ajlm-89	75	11	,	,	PUNCT
ajlm-89	75	12	hiv	hiv	PROPN
ajlm-89	75	13	,	,	PUNCT
ajlm-89	75	14	infective	infective	ADJ
ajlm-89	75	15	endocarditis	endocarditis	NOUN
ajlm-89	75	16	,	,	PUNCT
ajlm-89	75	17	haematological	haematological	ADJ
ajlm-89	75	18	malignancy	malignancy	NOUN
ajlm-89	75	19	,	,	PUNCT
ajlm-89	75	20	vlbw	vlbw	NOUN
ajlm-89	75	21	,	,	PUNCT
ajlm-89	75	22	severe	severe	ADJ
ajlm-89	75	23	head	head	NOUN
ajlm-89	75	24	injury	injury	NOUN
ajlm-89	75	25	and	and	CCONJ
ajlm-89	75	26	sepsis	sepsis	NOUN
ajlm-89	75	27	.	.	PUNCT
ajlm-89	76	1	there	there	PRON
ajlm-89	76	2	was	be	VERB
ajlm-89	76	3	no	no	DET
ajlm-89	76	4	significant	significant	ADJ
ajlm-89	76	5	relationship	relationship	NOUN
ajlm-89	76	6	(	(	PUNCT
ajlm-89	76	7	p	p	X
ajlm-89	76	8	=	=	NOUN
ajlm-89	76	9	0.18	0.18	NUM
ajlm-89	76	10	)	)	PUNCT
ajlm-89	76	11	between	between	ADP
ajlm-89	76	12	underlying	underlie	VERB
ajlm-89	76	13	disease	disease	NOUN
ajlm-89	76	14	and	and	CCONJ
ajlm-89	76	15	the	the	DET
ajlm-89	76	16	various	various	ADJ
ajlm-89	76	17	candida	candida	PROPN
ajlm-89	76	18	spp	spp	NOUN
ajlm-89	76	19	.	.	PUNCT
ajlm-89	77	1	detected	detect	VERB
ajlm-89	77	2	.	.	PUNCT
ajlm-89	78	1	using	use	VERB
ajlm-89	78	2	chi	chi	ADJ
ajlm-89	78	3	-	-	PUNCT
ajlm-89	78	4	square	square	NOUN
ajlm-89	78	5	analysis	analysis	NOUN
ajlm-89	78	6	,	,	PUNCT
ajlm-89	78	7	diarrhoea	diarrhoea	NOUN
ajlm-89	78	8	(	(	PUNCT
ajlm-89	78	9	p	p	X
ajlm-89	78	10	=	=	NOUN
ajlm-89	78	11	0.017	0.017	NUM
ajlm-89	78	12	)	)	PUNCT
ajlm-89	78	13	and	and	CCONJ
ajlm-89	78	14	oral	oral	ADJ
ajlm-89	78	15	thrush	thrush	NOUN
ajlm-89	78	16	(	(	PUNCT
ajlm-89	78	17	mucositis	mucositis	NOUN
ajlm-89	78	18	)	)	PUNCT
ajlm-89	78	19	(	(	PUNCT
ajlm-89	78	20	p	p	X
ajlm-89	78	21	=	=	NOUN
ajlm-89	78	22	0.019	0.019	NUM
ajlm-89	78	23	)	)	PUNCT
ajlm-89	78	24	were	be	AUX
ajlm-89	78	25	the	the	DET
ajlm-89	78	26	only	only	ADJ
ajlm-89	78	27	statistically	statistically	ADV
ajlm-89	78	28	-	-	PUNCT
ajlm-89	78	29	significant	significant	ADJ
ajlm-89	78	30	symptoms	symptom	NOUN
ajlm-89	78	31	(	(	PUNCT
ajlm-89	78	32	table	table	NOUN
ajlm-89	78	33	3	3	NUM
ajlm-89	78	34	)	)	PUNCT
ajlm-89	78	35	.	.	PUNCT
ajlm-89	79	1	the	the	DET
ajlm-89	79	2	crude	crude	ADJ
ajlm-89	79	3	mortality	mortality	NOUN
ajlm-89	79	4	rate	rate	NOUN
ajlm-89	79	5	was	be	AUX
ajlm-89	79	6	91.7	91.7	NUM
ajlm-89	79	7	%	%	NOUN
ajlm-89	79	8	(	(	PUNCT
ajlm-89	79	9	11	11	NUM
ajlm-89	79	10	out	out	ADP
ajlm-89	79	11	of	of	ADP
ajlm-89	79	12	12	12	NUM
ajlm-89	79	13	patients	patient	NOUN
ajlm-89	79	14	)	)	PUNCT
ajlm-89	79	15	.	.	PUNCT
ajlm-89	80	1	table	table	NOUN
ajlm-89	80	2	3	3	NUM
ajlm-89	80	3	:	:	PUNCT
ajlm-89	80	4	association	association	NOUN
ajlm-89	80	5	of	of	ADP
ajlm-89	80	6	symptoms	symptom	NOUN
ajlm-89	80	7	of	of	ADP
ajlm-89	80	8	immunosuppression	immunosuppression	NOUN
ajlm-89	80	9	in	in	ADP
ajlm-89	80	10	patients	patient	NOUN
ajlm-89	80	11	who	who	PRON
ajlm-89	80	12	developed	develop	VERB
ajlm-89	80	13	candidaemia	candidaemia	NOUN
ajlm-89	80	14	.	.	PUNCT
ajlm-89	81	1	ethical	ethical	ADJ
ajlm-89	81	2	considerations	consideration	NOUN
ajlm-89	81	3	top	top	VERB
ajlm-89	81	4	↑	↑	PROPN
ajlm-89	81	5	ethical	ethical	ADJ
ajlm-89	81	6	approval	approval	NOUN
ajlm-89	81	7	for	for	ADP
ajlm-89	81	8	the	the	DET
ajlm-89	81	9	study	study	NOUN
ajlm-89	81	10	was	be	AUX
ajlm-89	81	11	obtained	obtain	VERB
ajlm-89	81	12	from	from	ADP
ajlm-89	81	13	the	the	DET
ajlm-89	81	14	national	national	PROPN
ajlm-89	81	15	health	health	PROPN
ajlm-89	81	16	research	research	PROPN
ajlm-89	81	17	ethics	ethic	NOUN
ajlm-89	81	18	committee	committee	PROPN
ajlm-89	81	19	(	(	PUNCT
ajlm-89	81	20	nhrec/	nhrec/	NUM
ajlm-89	81	21	05/01/2008a	05/01/2008a	NOUN
ajlm-89	81	22	)	)	PUNCT
ajlm-89	81	23	and	and	CCONJ
ajlm-89	81	24	,	,	PUNCT
ajlm-89	81	25	in	in	ADP
ajlm-89	81	26	keeping	keep	VERB
ajlm-89	81	27	with	with	ADP
ajlm-89	81	28	ethical	ethical	ADJ
ajlm-89	81	29	procedures	procedure	NOUN
ajlm-89	81	30	,	,	PUNCT
ajlm-89	81	31	the	the	DET
ajlm-89	81	32	patients	patient	NOUN
ajlm-89	81	33	or	or	CCONJ
ajlm-89	81	34	their	their	PRON
ajlm-89	81	35	immediate	immediate	ADJ
ajlm-89	81	36	relatives	relative	NOUN
ajlm-89	81	37	provided	provide	VERB
ajlm-89	81	38	informed	informed	ADJ
ajlm-89	81	39	written	write	VERB
ajlm-89	81	40	consent	consent	NOUN
ajlm-89	81	41	.	.	PUNCT
ajlm-89	82	1	potential	potential	ADJ
ajlm-89	82	2	benefits	benefit	NOUN
ajlm-89	82	3	and	and	CCONJ
ajlm-89	82	4	hazards	hazard	VERB
ajlm-89	82	5	the	the	DET
ajlm-89	82	6	sample	sample	NOUN
ajlm-89	82	7	collection	collection	NOUN
ajlm-89	82	8	is	be	AUX
ajlm-89	82	9	a	a	DET
ajlm-89	82	10	minimum	minimum	ADJ
ajlm-89	82	11	risk	risk	NOUN
ajlm-89	82	12	procedure	procedure	NOUN
ajlm-89	82	13	(	(	PUNCT
ajlm-89	82	14	venipuncture	venipuncture	NOUN
ajlm-89	82	15	under	under	ADP
ajlm-89	82	16	standard	standard	ADJ
ajlm-89	82	17	precautions	precaution	NOUN
ajlm-89	82	18	)	)	PUNCT
ajlm-89	82	19	.	.	PUNCT
ajlm-89	83	1	benefits	benefit	NOUN
ajlm-89	83	2	to	to	ADP
ajlm-89	83	3	the	the	DET
ajlm-89	83	4	participants	participant	NOUN
ajlm-89	83	5	included	include	VERB
ajlm-89	83	6	free	free	ADJ
ajlm-89	83	7	blood	blood	NOUN
ajlm-89	83	8	culture	culture	NOUN
ajlm-89	83	9	and	and	CCONJ
ajlm-89	83	10	feedback	feedback	NOUN
ajlm-89	83	11	of	of	ADP
ajlm-89	83	12	results	result	NOUN
ajlm-89	83	13	to	to	ADP
ajlm-89	83	14	the	the	DET
ajlm-89	83	15	managing	manage	VERB
ajlm-89	83	16	clinicians	clinician	NOUN
ajlm-89	83	17	.	.	PUNCT
ajlm-89	84	1	trustworthiness	trustworthiness	NOUN
ajlm-89	84	2	top	top	PROPN
ajlm-89	84	3	↑	↑	NOUN
ajlm-89	84	4	confidentiality	confidentiality	NOUN
ajlm-89	84	5	was	be	AUX
ajlm-89	84	6	ensured	ensure	VERB
ajlm-89	84	7	by	by	ADP
ajlm-89	84	8	the	the	DET
ajlm-89	84	9	identification	identification	NOUN
ajlm-89	84	10	of	of	ADP
ajlm-89	84	11	participants	participant	NOUN
ajlm-89	84	12	with	with	ADP
ajlm-89	84	13	code	code	NOUN
ajlm-89	84	14	numbers	number	NOUN
ajlm-89	84	15	.	.	PUNCT
ajlm-89	85	1	other	other	ADJ
ajlm-89	85	2	personal	personal	ADJ
ajlm-89	85	3	details	detail	NOUN
ajlm-89	85	4	of	of	ADP
ajlm-89	85	5	the	the	DET
ajlm-89	85	6	participants	participant	NOUN
ajlm-89	85	7	were	be	AUX
ajlm-89	85	8	kept	keep	VERB
ajlm-89	85	9	in	in	ADP
ajlm-89	85	10	safe	safe	ADJ
ajlm-89	85	11	keeping	keeping	NOUN
ajlm-89	85	12	with	with	ADP
ajlm-89	85	13	the	the	DET
ajlm-89	85	14	lead	lead	ADJ
ajlm-89	85	15	researcher	researcher	NOUN
ajlm-89	85	16	for	for	ADP
ajlm-89	85	17	5	5	NUM
ajlm-89	85	18	years	year	NOUN
ajlm-89	85	19	in	in	ADP
ajlm-89	85	20	a	a	DET
ajlm-89	85	21	secured	secure	VERB
ajlm-89	85	22	file	file	NOUN
ajlm-89	85	23	.	.	PUNCT
ajlm-89	86	1	discussion	discussion	NOUN
ajlm-89	86	2	top	top	PROPN
ajlm-89	86	3	↑	↑	PROPN
ajlm-89	86	4	candidaemia	candidaemia	PROPN
ajlm-89	86	5	is	be	AUX
ajlm-89	86	6	a	a	DET
ajlm-89	86	7	nosocomial	nosocomial	ADJ
ajlm-89	86	8	infection	infection	NOUN
ajlm-89	86	9	commonly	commonly	ADV
ajlm-89	86	10	seen	see	VERB
ajlm-89	86	11	in	in	ADP
ajlm-89	86	12	critically	critically	ADV
ajlm-89	86	13	-	-	PUNCT
ajlm-89	86	14	ill	ill	ADJ
ajlm-89	86	15	patients	patient	NOUN
ajlm-89	86	16	and	and	CCONJ
ajlm-89	86	17	those	those	PRON
ajlm-89	86	18	with	with	ADP
ajlm-89	86	19	haematological	haematological	ADJ
ajlm-89	86	20	malignancies.1,2,4,6,19	malignancies.1,2,4,6,19	NOUN
ajlm-89	86	21	in	in	ADP
ajlm-89	86	22	this	this	DET
ajlm-89	86	23	study	study	NOUN
ajlm-89	86	24	,	,	PUNCT
ajlm-89	86	25	candida	candida	PROPN
ajlm-89	86	26	spp	spp	PROPN
ajlm-89	86	27	.	.	PUNCT
ajlm-89	87	1	ranked	rank	VERB
ajlm-89	87	2	third	third	ADV
ajlm-89	87	3	among	among	ADP
ajlm-89	87	4	pathogens	pathogen	NOUN
ajlm-89	87	5	causing	cause	VERB
ajlm-89	87	6	blood	blood	NOUN
ajlm-89	87	7	stream	stream	NOUN
ajlm-89	87	8	infections	infection	NOUN
ajlm-89	87	9	(	(	PUNCT
ajlm-89	87	10	bsis	bsis	NOUN
ajlm-89	87	11	)	)	PUNCT
ajlm-89	87	12	in	in	ADP
ajlm-89	87	13	hospitalised	hospitalise	VERB
ajlm-89	87	14	patients	patient	NOUN
ajlm-89	87	15	admitted	admit	VERB
ajlm-89	87	16	to	to	ADP
ajlm-89	87	17	the	the	DET
ajlm-89	87	18	study	study	NOUN
ajlm-89	87	19	centre	centre	NOUN
ajlm-89	87	20	.	.	PUNCT
ajlm-89	88	1	findings	finding	NOUN
ajlm-89	88	2	from	from	ADP
ajlm-89	88	3	north	north	PROPN
ajlm-89	88	4	american	american	ADJ
ajlm-89	88	5	and	and	CCONJ
ajlm-89	88	6	european	european	ADJ
ajlm-89	88	7	surveillance	surveillance	NOUN
ajlm-89	88	8	programmes	programme	NOUN
ajlm-89	88	9	of	of	ADP
ajlm-89	88	10	hospital	hospital	NOUN
ajlm-89	88	11	-	-	PUNCT
ajlm-89	88	12	acquired	acquire	VERB
ajlm-89	88	13	infections	infection	NOUN
ajlm-89	88	14	showed	show	VERB
ajlm-89	88	15	that	that	SCONJ
ajlm-89	88	16	isolates	isolate	NOUN
ajlm-89	88	17	of	of	ADP
ajlm-89	88	18	candida	candida	PROPN
ajlm-89	88	19	spp	spp	PROPN
ajlm-89	88	20	.	.	PUNCT
ajlm-89	88	21	were	be	AUX
ajlm-89	88	22	the	the	DET
ajlm-89	88	23	fourth	fourth	ADJ
ajlm-89	88	24	most	most	ADV
ajlm-89	88	25	common	common	ADJ
ajlm-89	88	26	cause	cause	NOUN
ajlm-89	88	27	,	,	PUNCT
ajlm-89	88	28	accounting	account	VERB
ajlm-89	88	29	for	for	ADP
ajlm-89	88	30	8	8	NUM
ajlm-89	88	31	%	%	NOUN
ajlm-89	88	32	–	–	PUNCT
ajlm-89	88	33	10	10	NUM
ajlm-89	88	34	%	%	NOUN
ajlm-89	88	35	of	of	ADP
ajlm-89	88	36	nosocomial	nosocomial	ADJ
ajlm-89	88	37	bsis.19	bsis.19	NOUN
ajlm-89	88	38	this	this	DET
ajlm-89	88	39	difference	difference	NOUN
ajlm-89	88	40	could	could	AUX
ajlm-89	88	41	exist	exist	VERB
ajlm-89	88	42	because	because	SCONJ
ajlm-89	88	43	all	all	PRON
ajlm-89	88	44	of	of	ADP
ajlm-89	88	45	the	the	DET
ajlm-89	88	46	participants	participant	NOUN
ajlm-89	88	47	in	in	ADP
ajlm-89	88	48	this	this	DET
ajlm-89	88	49	study	study	NOUN
ajlm-89	88	50	were	be	AUX
ajlm-89	88	51	immunosuppressed	immunosuppressed	ADJ
ajlm-89	88	52	;	;	PUNCT
ajlm-89	88	53	not	not	PART
ajlm-89	88	54	all	all	PRON
ajlm-89	88	55	presented	present	VERB
ajlm-89	88	56	with	with	ADP
ajlm-89	88	57	bsis	bsis	NOUN
ajlm-89	88	58	;	;	PUNCT
ajlm-89	88	59	and	and	CCONJ
ajlm-89	88	60	the	the	DET
ajlm-89	88	61	developed	develop	VERB
ajlm-89	88	62	world	world	NOUN
ajlm-89	88	63	has	have	AUX
ajlm-89	88	64	established	establish	VERB
ajlm-89	88	65	protocols	protocol	NOUN
ajlm-89	88	66	and	and	CCONJ
ajlm-89	88	67	guidelines	guideline	NOUN
ajlm-89	88	68	for	for	ADP
ajlm-89	88	69	the	the	DET
ajlm-89	88	70	diagnosis	diagnosis	NOUN
ajlm-89	88	71	,	,	PUNCT
ajlm-89	88	72	management	management	NOUN
ajlm-89	88	73	and	and	CCONJ
ajlm-89	88	74	prevention	prevention	NOUN
ajlm-89	88	75	of	of	ADP
ajlm-89	88	76	invasive	invasive	ADJ
ajlm-89	88	77	fungal	fungal	ADJ
ajlm-89	88	78	infections.the	infections.the	DET
ajlm-89	88	79	hospital	hospital	NOUN
ajlm-89	88	80	-	-	PUNCT
ajlm-89	88	81	based	base	VERB
ajlm-89	88	82	frequency	frequency	NOUN
ajlm-89	88	83	of	of	ADP
ajlm-89	88	84	candidaemia	candidaemia	NOUN
ajlm-89	88	85	in	in	ADP
ajlm-89	88	86	this	this	DET
ajlm-89	88	87	study	study	NOUN
ajlm-89	88	88	was	be	AUX
ajlm-89	88	89	5.2	5.2	NUM
ajlm-89	88	90	%	%	NOUN
ajlm-89	88	91	,	,	PUNCT
ajlm-89	88	92	which	which	PRON
ajlm-89	88	93	could	could	AUX
ajlm-89	88	94	possibly	possibly	ADV
ajlm-89	88	95	be	be	AUX
ajlm-89	88	96	a	a	DET
ajlm-89	88	97	result	result	NOUN
ajlm-89	88	98	of	of	ADP
ajlm-89	88	99	nigeria	nigeria	PROPN
ajlm-89	88	100	’s	’s	PART
ajlm-89	88	101	progressive	progressive	ADJ
ajlm-89	88	102	changes	change	NOUN
ajlm-89	88	103	in	in	ADP
ajlm-89	88	104	the	the	DET
ajlm-89	88	105	medical	medical	ADJ
ajlm-89	88	106	and	and	CCONJ
ajlm-89	88	107	surgical	surgical	ADJ
ajlm-89	88	108	management	management	NOUN
ajlm-89	88	109	of	of	ADP
ajlm-89	88	110	patients	patient	NOUN
ajlm-89	88	111	over	over	ADP
ajlm-89	88	112	the	the	DET
ajlm-89	88	113	last	last	ADJ
ajlm-89	88	114	five	five	NUM
ajlm-89	88	115	years	year	NOUN
ajlm-89	88	116	.	.	PUNCT
ajlm-89	89	1	these	these	DET
ajlm-89	89	2	improvements	improvement	NOUN
ajlm-89	89	3	have	have	AUX
ajlm-89	89	4	reduced	reduce	VERB
ajlm-89	89	5	the	the	DET
ajlm-89	89	6	vulnerability	vulnerability	NOUN
ajlm-89	89	7	of	of	ADP
ajlm-89	89	8	critically	critically	ADV
ajlm-89	89	9	-	-	PUNCT
ajlm-89	89	10	ill	ill	ADJ
ajlm-89	89	11	patients	patient	NOUN
ajlm-89	89	12	to	to	ADP
ajlm-89	89	13	haematogenous	haematogenous	ADJ
ajlm-89	89	14	dissemination	dissemination	NOUN
ajlm-89	89	15	of	of	ADP
ajlm-89	89	16	candida	candida	PROPN
ajlm-89	89	17	spp	spp	NOUN
ajlm-89	89	18	.	.	PUNCT
ajlm-89	90	1	whereas	whereas	SCONJ
ajlm-89	90	2	previously	previously	ADV
ajlm-89	90	3	,	,	PUNCT
ajlm-89	90	4	bacterial	bacterial	ADJ
ajlm-89	90	5	and/or	and/or	CCONJ
ajlm-89	90	6	viral	viral	ADJ
ajlm-89	90	7	infections	infection	NOUN
ajlm-89	90	8	often	often	ADV
ajlm-89	90	9	resulted	result	VERB
ajlm-89	90	10	in	in	ADP
ajlm-89	90	11	fatalities	fatality	NOUN
ajlm-89	90	12	.	.	PUNCT
ajlm-89	91	1	conversely	conversely	ADV
ajlm-89	91	2	,	,	PUNCT
ajlm-89	91	3	antifungal	antifungal	ADJ
ajlm-89	91	4	drugs	drug	NOUN
ajlm-89	91	5	are	be	AUX
ajlm-89	91	6	not	not	PART
ajlm-89	91	7	administered	administer	VERB
ajlm-89	91	8	routinely	routinely	ADV
ajlm-89	91	9	,	,	PUNCT
ajlm-89	91	10	either	either	CCONJ
ajlm-89	91	11	empirically	empirically	ADV
ajlm-89	91	12	or	or	CCONJ
ajlm-89	91	13	as	as	ADP
ajlm-89	91	14	prophylaxis	prophylaxis	ADJ
ajlm-89	91	15	,	,	PUNCT
ajlm-89	91	16	in	in	ADP
ajlm-89	91	17	the	the	DET
ajlm-89	91	18	management	management	NOUN
ajlm-89	91	19	of	of	ADP
ajlm-89	91	20	high	high	ADJ
ajlm-89	91	21	-	-	PUNCT
ajlm-89	91	22	risk	risk	NOUN
ajlm-89	91	23	patients	patient	NOUN
ajlm-89	91	24	in	in	ADP
ajlm-89	91	25	nigeria	nigeria	PROPN
ajlm-89	91	26	,	,	PUNCT
ajlm-89	91	27	which	which	PRON
ajlm-89	91	28	could	could	AUX
ajlm-89	91	29	possibly	possibly	ADV
ajlm-89	91	30	explain	explain	VERB
ajlm-89	91	31	the	the	DET
ajlm-89	91	32	high	high	ADJ
ajlm-89	91	33	mortality	mortality	NOUN
ajlm-89	91	34	rates	rate	NOUN
ajlm-89	91	35	from	from	ADP
ajlm-89	91	36	candidaemia	candidaemia	NOUN
ajlm-89	91	37	.	.	PUNCT
ajlm-89	92	1	several	several	ADJ
ajlm-89	92	2	risk	risk	NOUN
ajlm-89	92	3	factors	factor	NOUN
ajlm-89	92	4	for	for	ADP
ajlm-89	92	5	candidaemia	candidaemia	NOUN
ajlm-89	92	6	have	have	AUX
ajlm-89	92	7	been	be	AUX
ajlm-89	92	8	shown	show	VERB
ajlm-89	92	9	in	in	ADP
ajlm-89	92	10	previous	previous	ADJ
ajlm-89	92	11	studies	study	NOUN
ajlm-89	92	12	and	and	CCONJ
ajlm-89	92	13	confirmed	confirm	VERB
ajlm-89	92	14	in	in	ADP
ajlm-89	92	15	this	this	DET
ajlm-89	92	16	study	study	NOUN
ajlm-89	92	17	.	.	PUNCT
ajlm-89	93	1	in	in	ADP
ajlm-89	93	2	this	this	DET
ajlm-89	93	3	study	study	NOUN
ajlm-89	93	4	,	,	PUNCT
ajlm-89	93	5	patients	patient	NOUN
ajlm-89	93	6	under	under	ADP
ajlm-89	93	7	the	the	DET
ajlm-89	93	8	age	age	NOUN
ajlm-89	93	9	of	of	ADP
ajlm-89	93	10	one	one	NUM
ajlm-89	93	11	(	(	PUNCT
ajlm-89	93	12	n	n	NOUN
ajlm-89	93	13	=	=	SYM
ajlm-89	93	14	63	63	NUM
ajlm-89	93	15	)	)	PUNCT
ajlm-89	93	16	accounted	account	VERB
ajlm-89	93	17	for	for	ADP
ajlm-89	93	18	27.5	27.5	NUM
ajlm-89	93	19	%	%	NOUN
ajlm-89	93	20	of	of	ADP
ajlm-89	93	21	the	the	DET
ajlm-89	93	22	study	study	NOUN
ajlm-89	93	23	population	population	NOUN
ajlm-89	93	24	and	and	CCONJ
ajlm-89	93	25	25	25	NUM
ajlm-89	93	26	%	%	NOUN
ajlm-89	93	27	of	of	ADP
ajlm-89	93	28	patients	patient	NOUN
ajlm-89	93	29	with	with	ADP
ajlm-89	93	30	candidaemia	candidaemia	NOUN
ajlm-89	93	31	.	.	PUNCT
ajlm-89	94	1	this	this	PRON
ajlm-89	94	2	is	be	AUX
ajlm-89	94	3	consistent	consistent	ADJ
ajlm-89	94	4	with	with	ADP
ajlm-89	94	5	findings	finding	NOUN
ajlm-89	94	6	by	by	ADP
ajlm-89	94	7	saiman	saiman	PROPN
ajlm-89	94	8	et	et	PROPN
ajlm-89	94	9	al	al	PROPN
ajlm-89	94	10	.	.	PROPN
ajlm-89	94	11	which	which	PRON
ajlm-89	94	12	showed	show	VERB
ajlm-89	94	13	that	that	SCONJ
ajlm-89	94	14	infants	infant	NOUN
ajlm-89	94	15	,	,	PUNCT
ajlm-89	94	16	especially	especially	ADV
ajlm-89	94	17	premature	premature	ADJ
ajlm-89	94	18	,	,	PUNCT
ajlm-89	94	19	vlbw	vlbw	NOUN
ajlm-89	94	20	babies	baby	NOUN
ajlm-89	94	21	,	,	PUNCT
ajlm-89	94	22	have	have	VERB
ajlm-89	94	23	a	a	DET
ajlm-89	94	24	higher	high	ADJ
ajlm-89	94	25	risk	risk	NOUN
ajlm-89	94	26	of	of	ADP
ajlm-89	94	27	candidaemia	candidaemia	NOUN
ajlm-89	94	28	because	because	SCONJ
ajlm-89	94	29	of	of	ADP
ajlm-89	94	30	their	their	PRON
ajlm-89	94	31	immature	immature	ADJ
ajlm-89	94	32	immune	immune	ADJ
ajlm-89	94	33	systems	system	NOUN
ajlm-89	94	34	and	and	CCONJ
ajlm-89	94	35	frequent	frequent	ADJ
ajlm-89	94	36	intubation.20	intubation.20	NOUN
ajlm-89	94	37	patients	patient	NOUN
ajlm-89	94	38	over	over	ADP
ajlm-89	94	39	the	the	DET
ajlm-89	94	40	age	age	NOUN
ajlm-89	94	41	of	of	ADP
ajlm-89	94	42	60	60	NUM
ajlm-89	94	43	(	(	PUNCT
ajlm-89	94	44	n	n	NOUN
ajlm-89	94	45	=	=	SYM
ajlm-89	94	46	25	25	NUM
ajlm-89	94	47	)	)	PUNCT
ajlm-89	94	48	accounted	account	VERB
ajlm-89	94	49	for	for	ADP
ajlm-89	94	50	10.9	10.9	NUM
ajlm-89	94	51	%	%	NOUN
ajlm-89	94	52	of	of	ADP
ajlm-89	94	53	the	the	DET
ajlm-89	94	54	studied	study	VERB
ajlm-89	94	55	population	population	NOUN
ajlm-89	94	56	and	and	CCONJ
ajlm-89	94	57	16.7	16.7	NUM
ajlm-89	94	58	%	%	NOUN
ajlm-89	94	59	of	of	ADP
ajlm-89	94	60	the	the	DET
ajlm-89	94	61	cases	case	NOUN
ajlm-89	94	62	of	of	ADP
ajlm-89	94	63	candidaemia	candidaemia	NOUN
ajlm-89	94	64	,	,	PUNCT
ajlm-89	94	65	which	which	PRON
ajlm-89	94	66	is	be	AUX
ajlm-89	94	67	relatively	relatively	ADV
ajlm-89	94	68	high	high	ADJ
ajlm-89	94	69	,	,	PUNCT
ajlm-89	94	70	but	but	CCONJ
ajlm-89	94	71	not	not	PART
ajlm-89	94	72	of	of	ADP
ajlm-89	94	73	statistical	statistical	ADJ
ajlm-89	94	74	significance	significance	NOUN
ajlm-89	94	75	;	;	PUNCT
ajlm-89	94	76	however	however	ADV
ajlm-89	94	77	,	,	PUNCT
ajlm-89	94	78	schelenz	schelenz	PROPN
ajlm-89	94	79	found	find	VERB
ajlm-89	94	80	that	that	SCONJ
ajlm-89	94	81	old	old	ADJ
ajlm-89	94	82	age	age	NOUN
ajlm-89	94	83	was	be	AUX
ajlm-89	94	84	an	an	DET
ajlm-89	94	85	independent	independent	ADJ
ajlm-89	94	86	risk	risk	NOUN
ajlm-89	94	87	factor	factor	NOUN
ajlm-89	94	88	for	for	ADP
ajlm-89	94	89	candidaemia.21	candidaemia.21	PROPN
ajlm-89	94	90	two	two	NUM
ajlm-89	94	91	of	of	ADP
ajlm-89	94	92	the	the	DET
ajlm-89	94	93	patients	patient	NOUN
ajlm-89	94	94	had	have	VERB
ajlm-89	94	95	infective	infective	ADJ
ajlm-89	94	96	endocarditis	endocarditis	NOUN
ajlm-89	94	97	,	,	PUNCT
ajlm-89	94	98	one	one	NUM
ajlm-89	94	99	of	of	ADP
ajlm-89	94	100	whom	whom	PRON
ajlm-89	94	101	had	have	AUX
ajlm-89	94	102	undergone	undergo	VERB
ajlm-89	94	103	cardiac	cardiac	ADJ
ajlm-89	94	104	surgery	surgery	NOUN
ajlm-89	94	105	,	,	PUNCT
ajlm-89	94	106	a	a	DET
ajlm-89	94	107	high	high	ADJ
ajlm-89	94	108	-	-	PUNCT
ajlm-89	94	109	risk	risk	NOUN
ajlm-89	94	110	factor	factor	NOUN
ajlm-89	94	111	for	for	ADP
ajlm-89	94	112	fungal	fungal	ADJ
ajlm-89	94	113	endocarditis	endocarditis	NOUN
ajlm-89	94	114	,	,	PUNCT
ajlm-89	94	115	with	with	ADP
ajlm-89	94	116	an	an	DET
ajlm-89	94	117	infection	infection	NOUN
ajlm-89	94	118	rate	rate	NOUN
ajlm-89	94	119	of	of	ADP
ajlm-89	94	120	0.23	0.23	NUM
ajlm-89	94	121	%	%	NOUN
ajlm-89	94	122	–	–	PUNCT
ajlm-89	94	123	1.0%.22,23	1.0%.22,23	NUM
ajlm-89	94	124	another	another	DET
ajlm-89	94	125	known	know	VERB
ajlm-89	94	126	risk	risk	NOUN
ajlm-89	94	127	factor	factor	NOUN
ajlm-89	94	128	for	for	ADP
ajlm-89	94	129	candidaemia	candidaemia	NOUN
ajlm-89	94	130	is	be	AUX
ajlm-89	94	131	long	long	ADJ
ajlm-89	94	132	-	-	PUNCT
ajlm-89	94	133	term	term	NOUN
ajlm-89	94	134	hospital	hospital	NOUN
ajlm-89	94	135	stays	stay	NOUN
ajlm-89	94	136	,	,	PUNCT
ajlm-89	94	137	especially	especially	ADV
ajlm-89	94	138	in	in	ADP
ajlm-89	94	139	icu	icu	PROPN
ajlm-89	94	140	settings.22	settings.22	NOUN
ajlm-89	94	141	there	there	PRON
ajlm-89	94	142	was	be	VERB
ajlm-89	94	143	a	a	DET
ajlm-89	94	144	correlation	correlation	NOUN
ajlm-89	94	145	between	between	ADP
ajlm-89	94	146	length	length	NOUN
ajlm-89	94	147	of	of	ADP
ajlm-89	94	148	hospital	hospital	NOUN
ajlm-89	94	149	stay	stay	NOUN
ajlm-89	94	150	and	and	CCONJ
ajlm-89	94	151	frequency	frequency	NOUN
ajlm-89	94	152	of	of	ADP
ajlm-89	94	153	candidaemia	candidaemia	NOUN
ajlm-89	94	154	,	,	PUNCT
ajlm-89	94	155	further	far	ADV
ajlm-89	94	156	confirming	confirm	VERB
ajlm-89	94	157	the	the	DET
ajlm-89	94	158	nosocomial	nosocomial	ADJ
ajlm-89	94	159	source	source	NOUN
ajlm-89	94	160	of	of	ADP
ajlm-89	94	161	the	the	DET
ajlm-89	94	162	infection	infection	NOUN
ajlm-89	94	163	and	and	CCONJ
ajlm-89	94	164	that	that	SCONJ
ajlm-89	94	165	prolonged	prolonged	ADJ
ajlm-89	94	166	hospital	hospital	NOUN
ajlm-89	94	167	stays	stay	NOUN
ajlm-89	94	168	are	be	AUX
ajlm-89	94	169	risk	risk	NOUN
ajlm-89	94	170	factors.2,3,19	factors.2,3,19	ADP
ajlm-89	94	171	broad	broad	ADJ
ajlm-89	94	172	-	-	PUNCT
ajlm-89	94	173	spectrum	spectrum	NOUN
ajlm-89	94	174	antibiotic	antibiotic	ADJ
ajlm-89	94	175	use	use	NOUN
ajlm-89	94	176	is	be	AUX
ajlm-89	94	177	a	a	DET
ajlm-89	94	178	major	major	ADJ
ajlm-89	94	179	risk	risk	NOUN
ajlm-89	94	180	factor	factor	NOUN
ajlm-89	94	181	for	for	ADP
ajlm-89	94	182	the	the	DET
ajlm-89	94	183	development	development	NOUN
ajlm-89	94	184	of	of	ADP
ajlm-89	94	185	candidaemia	candidaemia	NOUN
ajlm-89	94	186	because	because	SCONJ
ajlm-89	94	187	these	these	DET
ajlm-89	94	188	medications	medication	NOUN
ajlm-89	94	189	eliminate	eliminate	VERB
ajlm-89	94	190	the	the	DET
ajlm-89	94	191	bacterial	bacterial	ADJ
ajlm-89	94	192	gut	gut	NOUN
ajlm-89	94	193	flora	flora	NOUN
ajlm-89	94	194	and	and	CCONJ
ajlm-89	94	195	encourage	encourage	VERB
ajlm-89	94	196	the	the	DET
ajlm-89	94	197	overgrowth	overgrowth	NOUN
ajlm-89	94	198	and	and	CCONJ
ajlm-89	94	199	dissemination	dissemination	NOUN
ajlm-89	94	200	of	of	ADP
ajlm-89	94	201	gastrointestinal	gastrointestinal	ADJ
ajlm-89	94	202	fungal	fungal	NOUN
ajlm-89	95	1	commensals.1921	commensals.1921	X
ajlm-89	95	2	almost	almost	ADV
ajlm-89	95	3	all	all	PRON
ajlm-89	95	4	of	of	ADP
ajlm-89	95	5	the	the	DET
ajlm-89	95	6	enrolled	enrol	VERB
ajlm-89	95	7	patients	patient	NOUN
ajlm-89	95	8	with	with	ADP
ajlm-89	95	9	candidaemia	candidaemia	NOUN
ajlm-89	95	10	were	be	AUX
ajlm-89	95	11	taking	take	VERB
ajlm-89	95	12	several	several	ADJ
ajlm-89	95	13	antibiotics	antibiotic	NOUN
ajlm-89	95	14	,	,	PUNCT
ajlm-89	95	15	for	for	ADP
ajlm-89	95	16	a	a	DET
ajlm-89	95	17	median	median	ADJ
ajlm-89	95	18	period	period	NOUN
ajlm-89	95	19	of	of	ADP
ajlm-89	95	20	15.5	15.5	NUM
ajlm-89	95	21	days	day	NOUN
ajlm-89	95	22	.	.	PUNCT
ajlm-89	96	1	most	most	ADJ
ajlm-89	96	2	patients	patient	NOUN
ajlm-89	96	3	had	have	VERB
ajlm-89	96	4	intravenous	intravenous	ADJ
ajlm-89	96	5	lines	line	NOUN
ajlm-89	96	6	in	in	ADP
ajlm-89	96	7	situ	situ	NOUN
ajlm-89	96	8	,	,	PUNCT
ajlm-89	96	9	but	but	CCONJ
ajlm-89	96	10	only	only	ADV
ajlm-89	96	11	13.6	13.6	NUM
ajlm-89	96	12	%	%	NOUN
ajlm-89	96	13	(	(	PUNCT
ajlm-89	96	14	n	n	NOUN
ajlm-89	96	15	=	=	SYM
ajlm-89	96	16	7	7	X
ajlm-89	96	17	)	)	PUNCT
ajlm-89	96	18	underwent	undergo	VERB
ajlm-89	96	19	intravenous	intravenous	ADJ
ajlm-89	96	20	cutdown	cutdown	NOUN
ajlm-89	96	21	(	(	PUNCT
ajlm-89	96	22	femoral	femoral	ADJ
ajlm-89	96	23	vein	vein	NOUN
ajlm-89	96	24	)	)	PUNCT
ajlm-89	96	25	.	.	PUNCT
ajlm-89	97	1	11	11	NUM
ajlm-89	97	2	of	of	ADP
ajlm-89	97	3	the	the	DET
ajlm-89	97	4	12	12	NUM
ajlm-89	97	5	patients	patient	NOUN
ajlm-89	97	6	with	with	ADP
ajlm-89	97	7	candidaemia	candidaemia	NOUN
ajlm-89	97	8	had	have	VERB
ajlm-89	97	9	the	the	DET
ajlm-89	97	10	same	same	ADJ
ajlm-89	97	11	candida	candida	PROPN
ajlm-89	97	12	spp	spp	NOUN
ajlm-89	97	13	.	.	PUNCT
ajlm-89	98	1	isolated	isolate	VERB
ajlm-89	98	2	from	from	ADP
ajlm-89	98	3	other	other	ADJ
ajlm-89	98	4	sites	site	NOUN
ajlm-89	98	5	.	.	PUNCT
ajlm-89	99	1	symptoms	symptom	NOUN
ajlm-89	99	2	associated	associate	VERB
ajlm-89	99	3	with	with	ADP
ajlm-89	99	4	candidaemia	candidaemia	NOUN
ajlm-89	99	5	were	be	AUX
ajlm-89	99	6	mucositis	mucositis	NOUN
ajlm-89	99	7	(	(	PUNCT
ajlm-89	99	8	p	p	X
ajlm-89	99	9	=	=	NOUN
ajlm-89	99	10	0.019	0.019	NUM
ajlm-89	99	11	)	)	PUNCT
ajlm-89	99	12	and	and	CCONJ
ajlm-89	99	13	diarrhoea	diarrhoea	NOUN
ajlm-89	99	14	(	(	PUNCT
ajlm-89	99	15	p	p	X
ajlm-89	99	16	=	=	NOUN
ajlm-89	99	17	0.017	0.017	NUM
ajlm-89	99	18	)	)	PUNCT
ajlm-89	99	19	.	.	PUNCT
ajlm-89	100	1	these	these	DET
ajlm-89	100	2	findings	finding	NOUN
ajlm-89	100	3	are	be	AUX
ajlm-89	100	4	consistent	consistent	ADJ
ajlm-89	100	5	with	with	ADP
ajlm-89	100	6	those	those	PRON
ajlm-89	100	7	of	of	ADP
ajlm-89	100	8	other	other	ADJ
ajlm-89	100	9	reports	report	NOUN
ajlm-89	100	10	showing	show	VERB
ajlm-89	100	11	mucosal	mucosal	ADJ
ajlm-89	100	12	colonisation	colonisation	NOUN
ajlm-89	100	13	to	to	PART
ajlm-89	100	14	be	be	AUX
ajlm-89	100	15	an	an	DET
ajlm-89	100	16	independent	independent	ADJ
ajlm-89	100	17	risk	risk	NOUN
ajlm-89	100	18	factor	factor	NOUN
ajlm-89	100	19	for	for	ADP
ajlm-89	100	20	candidaemia;21,24	candidaemia;21,24	NOUN
ajlm-89	100	21	however	however	ADV
ajlm-89	100	22	,	,	PUNCT
ajlm-89	100	23	there	there	PRON
ajlm-89	100	24	are	be	VERB
ajlm-89	100	25	no	no	DET
ajlm-89	100	26	previous	previous	ADJ
ajlm-89	100	27	studies	study	NOUN
ajlm-89	100	28	citing	cite	VERB
ajlm-89	100	29	any	any	DET
ajlm-89	100	30	relationship	relationship	NOUN
ajlm-89	100	31	between	between	ADP
ajlm-89	100	32	candidaemia	candidaemia	NOUN
ajlm-89	100	33	and	and	CCONJ
ajlm-89	100	34	diarrhoea	diarrhoea	NOUN
ajlm-89	100	35	.	.	PUNCT
ajlm-89	101	1	the	the	DET
ajlm-89	101	2	high	high	ADJ
ajlm-89	101	3	proportion	proportion	NOUN
ajlm-89	101	4	of	of	ADP
ajlm-89	101	5	c.	c.	PROPN
ajlm-89	101	6	tropicalis	tropicalis	PROPN
ajlm-89	101	7	(	(	PUNCT
ajlm-89	101	8	50	50	NUM
ajlm-89	101	9	%	%	NOUN
ajlm-89	101	10	)	)	PUNCT
ajlm-89	101	11	reported	report	VERB
ajlm-89	101	12	here	here	ADV
ajlm-89	101	13	is	be	AUX
ajlm-89	101	14	consistent	consistent	ADJ
ajlm-89	101	15	with	with	ADP
ajlm-89	101	16	a	a	DET
ajlm-89	101	17	study	study	NOUN
ajlm-89	101	18	in	in	ADP
ajlm-89	101	19	india	india	PROPN
ajlm-89	101	20	by	by	ADP
ajlm-89	101	21	verma	verma	PROPN
ajlm-89	101	22	et	et	PROPN
ajlm-89	101	23	al	al	PROPN
ajlm-89	101	24	.	.	PROPN
ajlm-89	102	1	where	where	SCONJ
ajlm-89	102	2	the	the	DET
ajlm-89	102	3	proportion	proportion	NOUN
ajlm-89	102	4	was	be	AUX
ajlm-89	102	5	46%.25	46%.25	NUM
ajlm-89	102	6	the	the	DET
ajlm-89	102	7	crude	crude	ADJ
ajlm-89	102	8	mortality	mortality	NOUN
ajlm-89	102	9	rate	rate	NOUN
ajlm-89	102	10	in	in	ADP
ajlm-89	102	11	our	our	PRON
ajlm-89	102	12	study	study	NOUN
ajlm-89	102	13	was	be	AUX
ajlm-89	102	14	91.7	91.7	NUM
ajlm-89	102	15	%	%	NOUN
ajlm-89	102	16	(	(	PUNCT
ajlm-89	102	17	11	11	NUM
ajlm-89	102	18	out	out	ADP
ajlm-89	102	19	of	of	ADP
ajlm-89	102	20	12	12	NUM
ajlm-89	102	21	patients	patient	NOUN
ajlm-89	102	22	)	)	PUNCT
ajlm-89	102	23	compared	compare	VERB
ajlm-89	102	24	with	with	ADP
ajlm-89	102	25	the	the	DET
ajlm-89	102	26	35	35	NUM
ajlm-89	102	27	%	%	NOUN
ajlm-89	102	28	–	–	PUNCT
ajlm-89	102	29	75	75	NUM
ajlm-89	102	30	%	%	NOUN
ajlm-89	102	31	crude	crude	NOUN
ajlm-89	102	32	mortality	mortality	NOUN
ajlm-89	102	33	rates	rate	NOUN
ajlm-89	102	34	reported	report	VERB
ajlm-89	102	35	in	in	ADP
ajlm-89	102	36	other	other	ADJ
ajlm-89	102	37	studies.23	studies.23	NOUN
ajlm-89	102	38	this	this	PRON
ajlm-89	102	39	could	could	AUX
ajlm-89	102	40	be	be	AUX
ajlm-89	102	41	attributed	attribute	VERB
ajlm-89	102	42	to	to	ADP
ajlm-89	102	43	small	small	ADJ
ajlm-89	102	44	sample	sample	NOUN
ajlm-89	102	45	sizes	size	NOUN
ajlm-89	102	46	,	,	PUNCT
ajlm-89	102	47	as	as	ADV
ajlm-89	102	48	well	well	ADV
ajlm-89	102	49	as	as	ADP
ajlm-89	102	50	to	to	ADP
ajlm-89	102	51	the	the	DET
ajlm-89	102	52	fact	fact	NOUN
ajlm-89	102	53	that	that	SCONJ
ajlm-89	102	54	the	the	DET
ajlm-89	102	55	clinicians	clinician	NOUN
ajlm-89	102	56	at	at	ADP
ajlm-89	102	57	the	the	DET
ajlm-89	102	58	study	study	NOUN
ajlm-89	102	59	site	site	NOUN
ajlm-89	102	60	did	do	AUX
ajlm-89	102	61	not	not	PART
ajlm-89	102	62	administer	administer	VERB
ajlm-89	102	63	antifungal	antifungal	ADJ
ajlm-89	102	64	drugs	drug	NOUN
ajlm-89	102	65	routinely	routinely	ADV
ajlm-89	102	66	,	,	PUNCT
ajlm-89	102	67	either	either	CCONJ
ajlm-89	102	68	on	on	ADP
ajlm-89	102	69	an	an	DET
ajlm-89	102	70	empirical	empirical	ADJ
ajlm-89	102	71	or	or	CCONJ
ajlm-89	102	72	a	a	DET
ajlm-89	102	73	prophylactic	prophylactic	ADJ
ajlm-89	102	74	basis	basis	NOUN
ajlm-89	102	75	,	,	PUNCT
ajlm-89	102	76	for	for	ADP
ajlm-89	102	77	the	the	DET
ajlm-89	102	78	management	management	NOUN
ajlm-89	102	79	or	or	CCONJ
ajlm-89	102	80	prevention	prevention	NOUN
ajlm-89	102	81	of	of	ADP
ajlm-89	102	82	candidaemia	candidaemia	NOUN
ajlm-89	102	83	.	.	PUNCT
ajlm-89	103	1	clinicians	clinician	NOUN
ajlm-89	103	2	may	may	AUX
ajlm-89	103	3	not	not	PART
ajlm-89	103	4	consider	consider	VERB
ajlm-89	103	5	candidaemia	candidaemia	NOUN
ajlm-89	103	6	as	as	ADP
ajlm-89	103	7	a	a	DET
ajlm-89	103	8	cause	cause	NOUN
ajlm-89	103	9	of	of	ADP
ajlm-89	103	10	infection	infection	NOUN
ajlm-89	103	11	because	because	SCONJ
ajlm-89	103	12	of	of	ADP
ajlm-89	103	13	limited	limited	ADJ
ajlm-89	103	14	training	training	NOUN
ajlm-89	103	15	in	in	ADP
ajlm-89	103	16	nosocomial	nosocomial	ADJ
ajlm-89	103	17	diseases	disease	NOUN
ajlm-89	103	18	,	,	PUNCT
ajlm-89	103	19	the	the	DET
ajlm-89	103	20	absence	absence	NOUN
ajlm-89	103	21	of	of	ADP
ajlm-89	103	22	knowledge	knowledge	NOUN
ajlm-89	103	23	of	of	ADP
ajlm-89	103	24	disease	disease	NOUN
ajlm-89	103	25	prevalence	prevalence	NOUN
ajlm-89	103	26	(	(	PUNCT
ajlm-89	103	27	ncbi	ncbi	PROPN
ajlm-89	103	28	pubmed	pubmed	PROPN
ajlm-89	103	29	searches	search	NOUN
ajlm-89	103	30	reveal	reveal	VERB
ajlm-89	103	31	few	few	ADJ
ajlm-89	103	32	publications	publication	NOUN
ajlm-89	103	33	in	in	ADP
ajlm-89	103	34	the	the	DET
ajlm-89	103	35	field	field	NOUN
ajlm-89	103	36	from	from	ADP
ajlm-89	103	37	nigeria	nigeria	PROPN
ajlm-89	103	38	)	)	PUNCT
ajlm-89	103	39	and	and	CCONJ
ajlm-89	103	40	the	the	DET
ajlm-89	103	41	lack	lack	NOUN
ajlm-89	103	42	of	of	ADP
ajlm-89	103	43	an	an	DET
ajlm-89	103	44	established	establish	VERB
ajlm-89	103	45	infrastructure	infrastructure	NOUN
ajlm-89	103	46	for	for	ADP
ajlm-89	103	47	high	high	ADJ
ajlm-89	103	48	-	-	PUNCT
ajlm-89	103	49	quality	quality	NOUN
ajlm-89	103	50	laboratory	laboratory	NOUN
ajlm-89	103	51	testing	testing	NOUN
ajlm-89	103	52	.	.	PUNCT
ajlm-89	104	1	limitations	limitation	NOUN
ajlm-89	104	2	of	of	ADP
ajlm-89	104	3	the	the	DET
ajlm-89	104	4	study	study	NOUN
ajlm-89	104	5	top	top	PROPN
ajlm-89	104	6	↑	↑	PROPN
ajlm-89	104	7	limitations	limitation	NOUN
ajlm-89	104	8	of	of	ADP
ajlm-89	104	9	this	this	DET
ajlm-89	104	10	study	study	NOUN
ajlm-89	104	11	include	include	VERB
ajlm-89	104	12	the	the	DET
ajlm-89	104	13	small	small	ADJ
ajlm-89	104	14	sample	sample	NOUN
ajlm-89	104	15	size	size	NOUN
ajlm-89	104	16	and	and	CCONJ
ajlm-89	104	17	generalised	generalise	VERB
ajlm-89	104	18	study	study	NOUN
ajlm-89	104	19	population	population	NOUN
ajlm-89	104	20	.	.	PUNCT
ajlm-89	105	1	conclusion	conclusion	NOUN
ajlm-89	105	2	top	top	ADJ
ajlm-89	105	3	↑	↑	PROPN
ajlm-89	105	4	this	this	DET
ajlm-89	105	5	study	study	NOUN
ajlm-89	105	6	highlights	highlight	VERB
ajlm-89	105	7	the	the	DET
ajlm-89	105	8	clinical	clinical	ADJ
ajlm-89	105	9	significance	significance	NOUN
ajlm-89	105	10	of	of	ADP
ajlm-89	105	11	nosocomial	nosocomial	ADJ
ajlm-89	105	12	candidaemia	candidaemia	NOUN
ajlm-89	105	13	and	and	CCONJ
ajlm-89	105	14	the	the	DET
ajlm-89	105	15	need	need	NOUN
ajlm-89	105	16	for	for	ADP
ajlm-89	105	17	proactive	proactive	ADJ
ajlm-89	105	18	investigation	investigation	NOUN
ajlm-89	105	19	for	for	ADP
ajlm-89	105	20	possible	possible	ADJ
ajlm-89	105	21	invasive	invasive	ADJ
ajlm-89	105	22	candidiasis	candidiasis	NOUN
ajlm-89	105	23	.	.	PUNCT
ajlm-89	106	1	this	this	PRON
ajlm-89	106	2	is	be	AUX
ajlm-89	106	3	particularly	particularly	ADV
ajlm-89	106	4	needed	need	VERB
ajlm-89	106	5	in	in	ADP
ajlm-89	106	6	nigeria	nigeria	PRON
ajlm-89	106	7	where	where	SCONJ
ajlm-89	106	8	patients	patient	NOUN
ajlm-89	106	9	have	have	VERB
ajlm-89	106	10	to	to	PART
ajlm-89	106	11	pay	pay	VERB
ajlm-89	106	12	for	for	ADP
ajlm-89	106	13	every	every	DET
ajlm-89	106	14	laboratory	laboratory	NOUN
ajlm-89	106	15	investigation	investigation	NOUN
ajlm-89	106	16	carried	carry	VERB
ajlm-89	106	17	out	out	ADP
ajlm-89	106	18	in	in	ADP
ajlm-89	106	19	the	the	DET
ajlm-89	106	20	hospital	hospital	NOUN
ajlm-89	106	21	;	;	PUNCT
ajlm-89	106	22	as	as	ADP
ajlm-89	106	23	a	a	DET
ajlm-89	106	24	result	result	NOUN
ajlm-89	106	25	,	,	PUNCT
ajlm-89	106	26	clinicians	clinician	NOUN
ajlm-89	106	27	can	can	AUX
ajlm-89	106	28	not	not	PART
ajlm-89	106	29	proactively	proactively	ADV
ajlm-89	106	30	and/or	and/or	CCONJ
ajlm-89	106	31	repeatedly	repeatedly	ADV
ajlm-89	106	32	request	request	VERB
ajlm-89	106	33	tests	test	NOUN
ajlm-89	106	34	or	or	CCONJ
ajlm-89	106	35	cultures	culture	NOUN
ajlm-89	106	36	.	.	PUNCT
ajlm-89	107	1	this	this	DET
ajlm-89	107	2	study	study	NOUN
ajlm-89	107	3	highlights	highlight	VERB
ajlm-89	107	4	the	the	DET
ajlm-89	107	5	need	need	NOUN
ajlm-89	107	6	for	for	ADP
ajlm-89	107	7	affordable	affordable	ADJ
ajlm-89	107	8	laboratory	laboratory	NOUN
ajlm-89	107	9	tests	test	NOUN
ajlm-89	107	10	and	and	CCONJ
ajlm-89	107	11	an	an	DET
ajlm-89	107	12	improved	improved	ADJ
ajlm-89	107	13	understanding	understanding	NOUN
ajlm-89	107	14	of	of	ADP
ajlm-89	107	15	the	the	DET
ajlm-89	107	16	dangers	danger	NOUN
ajlm-89	107	17	of	of	ADP
ajlm-89	107	18	untreated	untreated	ADJ
ajlm-89	107	19	candidaemia	candidaemia	NOUN
ajlm-89	107	20	.	.	PUNCT
ajlm-89	108	1	finally	finally	ADV
ajlm-89	108	2	,	,	PUNCT
ajlm-89	108	3	improved	improve	VERB
ajlm-89	108	4	communication	communication	NOUN
ajlm-89	108	5	and	and	CCONJ
ajlm-89	108	6	collaboration	collaboration	NOUN
ajlm-89	108	7	between	between	ADP
ajlm-89	108	8	clinicians	clinician	NOUN
ajlm-89	108	9	and	and	CCONJ
ajlm-89	108	10	clinical	clinical	ADJ
ajlm-89	108	11	microbiologists	microbiologist	NOUN
ajlm-89	108	12	is	be	AUX
ajlm-89	108	13	essential	essential	ADJ
ajlm-89	108	14	for	for	ADP
ajlm-89	108	15	the	the	DET
ajlm-89	108	16	development	development	NOUN
ajlm-89	108	17	of	of	ADP
ajlm-89	108	18	measures	measure	NOUN
ajlm-89	108	19	to	to	PART
ajlm-89	108	20	control	control	VERB
ajlm-89	108	21	the	the	DET
ajlm-89	108	22	emerging	emerge	VERB
ajlm-89	108	23	threat	threat	NOUN
ajlm-89	108	24	of	of	ADP
ajlm-89	108	25	nosocomial	nosocomial	ADJ
ajlm-89	108	26	candidaemia	candidaemia	NOUN
ajlm-89	108	27	.	.	PUNCT
ajlm-89	109	1	acknowledgements	acknowledgement	NOUN
ajlm-89	109	2	top	top	PROPN
ajlm-89	109	3	↑	↑	NOUN
ajlm-89	109	4	the	the	DET
ajlm-89	109	5	authors	author	NOUN
ajlm-89	109	6	would	would	AUX
ajlm-89	109	7	like	like	VERB
ajlm-89	109	8	to	to	PART
ajlm-89	109	9	acknowledge	acknowledge	VERB
ajlm-89	109	10	prof	prof	PROPN
ajlm-89	109	11	.	.	PUNCT
ajlm-89	110	1	marianna	marianna	PROPN
ajlm-89	110	2	viviani	viviani	PROPN
ajlm-89	110	3	for	for	ADP
ajlm-89	110	4	her	her	PRON
ajlm-89	110	5	contribution	contribution	NOUN
ajlm-89	110	6	with	with	ADP
ajlm-89	110	7	the	the	DET
ajlm-89	110	8	eccm	eccm	NOUN
ajlm-89	110	9	icu	icu	PROPN
ajlm-89	110	10	form	form	NOUN
ajlm-89	110	11	and	and	CCONJ
ajlm-89	110	12	her	her	PRON
ajlm-89	110	13	advice	advice	NOUN
ajlm-89	110	14	on	on	ADP
ajlm-89	110	15	specimen	speciman	NOUN
ajlm-89	110	16	storage	storage	NOUN
ajlm-89	110	17	and	and	CCONJ
ajlm-89	110	18	transportation	transportation	NOUN
ajlm-89	110	19	,	,	PUNCT
ajlm-89	110	20	as	as	ADV
ajlm-89	110	21	well	well	ADV
ajlm-89	110	22	as	as	ADP
ajlm-89	110	23	drs	drs	ADJ
ajlm-89	110	24	olubunmi	olubunmi	NOUN
ajlm-89	110	25	olubanwo	olubanwo	ADJ
ajlm-89	110	26	and	and	CCONJ
ajlm-89	110	27	victor	victor	PROPN
ajlm-89	110	28	uwadike	uwadike	PROPN
ajlm-89	110	29	for	for	ADP
ajlm-89	110	30	their	their	PRON
ajlm-89	110	31	help	help	NOUN
ajlm-89	110	32	in	in	ADP
ajlm-89	110	33	sample	sample	NOUN
ajlm-89	110	34	collection	collection	NOUN
ajlm-89	110	35	and	and	CCONJ
ajlm-89	110	36	data	datum	NOUN
ajlm-89	110	37	collation	collation	NOUN
ajlm-89	110	38	.	.	PUNCT
ajlm-89	111	1	competing	compete	VERB
ajlm-89	111	2	interests	interest	NOUN
ajlm-89	111	3	prof	prof	NOUN
ajlm-89	111	4	.	.	PUNCT
ajlm-89	112	1	malcolm	malcolm	PROPN
ajlm-89	112	2	richardson	richardson	PROPN
ajlm-89	112	3	has	have	AUX
ajlm-89	112	4	received	receive	VERB
ajlm-89	112	5	research	research	NOUN
ajlm-89	112	6	funding	funding	NOUN
ajlm-89	112	7	and	and	CCONJ
ajlm-89	112	8	speaker	speaker	NOUN
ajlm-89	112	9	fees	fee	NOUN
ajlm-89	112	10	from	from	ADP
ajlm-89	112	11	gilead	gilead	ADJ
ajlm-89	112	12	science	science	NOUN
ajlm-89	112	13	,	,	PUNCT
ajlm-89	112	14	pfizer	pfizer	NOUN
ajlm-89	112	15	,	,	PUNCT
ajlm-89	112	16	msd	msd	NOUN
ajlm-89	112	17	and	and	CCONJ
ajlm-89	112	18	astellas	astella	NOUN
ajlm-89	112	19	.	.	PUNCT
ajlm-89	113	1	the	the	DET
ajlm-89	113	2	other	other	ADJ
ajlm-89	113	3	authors	author	NOUN
ajlm-89	113	4	declare	declare	VERB
ajlm-89	113	5	that	that	SCONJ
ajlm-89	113	6	they	they	PRON
ajlm-89	113	7	have	have	VERB
ajlm-89	113	8	no	no	DET
ajlm-89	113	9	financial	financial	ADJ
ajlm-89	113	10	or	or	CCONJ
ajlm-89	113	11	personal	personal	ADJ
ajlm-89	113	12	relationship(s	relationship(s	NOUN
ajlm-89	113	13	)	)	PUNCT
ajlm-89	113	14	that	that	PRON
ajlm-89	113	15	may	may	AUX
ajlm-89	113	16	have	have	AUX
ajlm-89	113	17	inappropriately	inappropriately	ADV
ajlm-89	113	18	influenced	influence	VERB
ajlm-89	113	19	them	they	PRON
ajlm-89	113	20	in	in	ADP
ajlm-89	113	21	writing	write	VERB
ajlm-89	113	22	this	this	DET
ajlm-89	113	23	article	article	NOUN
ajlm-89	113	24	.	.	PUNCT
ajlm-89	114	1	authors	author	NOUN
ajlm-89	114	2	’	’	PART
ajlm-89	114	3	contributions	contribution	NOUN
ajlm-89	114	4	r.o.o	r.o.o	PROPN
ajlm-89	114	5	.	.	PUNCT
ajlm-89	115	1	(	(	PUNCT
ajlm-89	115	2	university	university	NOUN
ajlm-89	115	3	college	college	NOUN
ajlm-89	115	4	hospital	hospital	NOUN
ajlm-89	115	5	,	,	PUNCT
ajlm-89	115	6	nigeria	nigeria	PROPN
ajlm-89	115	7	)	)	PUNCT
ajlm-89	115	8	was	be	AUX
ajlm-89	115	9	involved	involve	VERB
ajlm-89	115	10	in	in	ADP
ajlm-89	115	11	the	the	DET
ajlm-89	115	12	conception	conception	NOUN
ajlm-89	115	13	and	and	CCONJ
ajlm-89	115	14	design	design	NOUN
ajlm-89	115	15	of	of	ADP
ajlm-89	115	16	the	the	DET
ajlm-89	115	17	study	study	NOUN
ajlm-89	115	18	,	,	PUNCT
ajlm-89	115	19	as	as	ADV
ajlm-89	115	20	well	well	ADV
ajlm-89	115	21	as	as	ADP
ajlm-89	115	22	with	with	ADP
ajlm-89	115	23	the	the	DET
ajlm-89	115	24	acquisition	acquisition	NOUN
ajlm-89	115	25	,	,	PUNCT
ajlm-89	115	26	analysis	analysis	NOUN
ajlm-89	115	27	and	and	CCONJ
ajlm-89	115	28	interpretation	interpretation	NOUN
ajlm-89	115	29	of	of	ADP
ajlm-89	115	30	the	the	DET
ajlm-89	115	31	data	datum	NOUN
ajlm-89	115	32	.	.	PUNCT
ajlm-89	116	1	she	she	PRON
ajlm-89	116	2	also	also	ADV
ajlm-89	116	3	wrote	write	VERB
ajlm-89	116	4	the	the	DET
ajlm-89	116	5	article	article	NOUN
ajlm-89	116	6	.	.	PUNCT
ajlm-89	117	1	r.a.b	r.a.b	PROPN
ajlm-89	117	2	.	.	PUNCT
ajlm-89	118	1	(	(	PUNCT
ajlm-89	118	2	university	university	NOUN
ajlm-89	118	3	college	college	NOUN
ajlm-89	118	4	hospital	hospital	NOUN
ajlm-89	118	5	,	,	PUNCT
ajlm-89	118	6	nigeria	nigeria	PROPN
ajlm-89	118	7	)	)	PUNCT
ajlm-89	118	8	was	be	AUX
ajlm-89	118	9	involved	involve	VERB
ajlm-89	118	10	in	in	ADP
ajlm-89	118	11	the	the	DET
ajlm-89	118	12	conception	conception	NOUN
ajlm-89	118	13	and	and	CCONJ
ajlm-89	118	14	design	design	NOUN
ajlm-89	118	15	of	of	ADP
ajlm-89	118	16	the	the	DET
ajlm-89	118	17	study	study	NOUN
ajlm-89	118	18	,	,	PUNCT
ajlm-89	118	19	as	as	ADV
ajlm-89	118	20	well	well	ADV
ajlm-89	118	21	as	as	ADP
ajlm-89	118	22	the	the	DET
ajlm-89	118	23	write	write	NOUN
ajlm-89	118	24	up	up	ADP
ajlm-89	118	25	.	.	PUNCT
ajlm-89	119	1	m.r	m.r	PROPN
ajlm-89	119	2	.	.	PROPN
ajlm-89	120	1	(	(	PUNCT
ajlm-89	120	2	university	university	PROPN
ajlm-89	120	3	of	of	ADP
ajlm-89	120	4	manchester	manchester	PROPN
ajlm-89	120	5	)	)	PUNCT
ajlm-89	120	6	had	have	VERB
ajlm-89	120	7	substantial	substantial	ADJ
ajlm-89	120	8	involvement	involvement	NOUN
ajlm-89	120	9	in	in	ADP
ajlm-89	120	10	the	the	DET
ajlm-89	120	11	revision	revision	NOUN
ajlm-89	120	12	of	of	ADP
ajlm-89	120	13	the	the	DET
ajlm-89	120	14	article	article	NOUN
ajlm-89	120	15	and	and	CCONJ
ajlm-89	120	16	performed	perform	VERB
ajlm-89	120	17	the	the	DET
ajlm-89	120	18	expert	expert	NOUN
ajlm-89	120	19	review	review	NOUN
ajlm-89	120	20	prior	prior	ADV
ajlm-89	120	21	to	to	ADP
ajlm-89	120	22	submission	submission	NOUN
ajlm-89	120	23	.	.	PUNCT
ajlm-89	121	1	o.o.o	o.o.o	PROPN
ajlm-89	121	2	.	.	PUNCT
ajlm-89	122	1	(	(	PUNCT
ajlm-89	122	2	university	university	NOUN
ajlm-89	122	3	of	of	ADP
ajlm-89	122	4	lagos	lagos	PROPN
ajlm-89	122	5	,	,	PUNCT
ajlm-89	122	6	nigeria	nigeria	PRON
ajlm-89	122	7	)	)	PUNCT
ajlm-89	122	8	was	be	AUX
ajlm-89	122	9	involved	involve	VERB
ajlm-89	122	10	in	in	ADP
ajlm-89	122	11	the	the	DET
ajlm-89	122	12	conception	conception	NOUN
ajlm-89	122	13	of	of	ADP
ajlm-89	122	14	the	the	DET
ajlm-89	122	15	article	article	NOUN
ajlm-89	122	16	,	,	PUNCT
ajlm-89	122	17	as	as	ADV
ajlm-89	122	18	well	well	ADV
ajlm-89	122	19	as	as	ADP
ajlm-89	122	20	the	the	DET
ajlm-89	122	21	data	data	NOUN
ajlm-89	122	22	collection	collection	NOUN
ajlm-89	122	23	and	and	CCONJ
ajlm-89	122	24	analysis	analysis	NOUN
ajlm-89	122	25	.	.	PUNCT
ajlm-89	123	1	m.a.p	m.a.p	ADJ
ajlm-89	123	2	.	.	PUNCT
ajlm-89	124	1	(	(	PUNCT
ajlm-89	124	2	hammersmith	hammersmith	PROPN
ajlm-89	124	3	hospital	hospital	NOUN
ajlm-89	124	4	)	)	PUNCT
ajlm-89	124	5	was	be	AUX
ajlm-89	124	6	involved	involve	VERB
ajlm-89	124	7	in	in	ADP
ajlm-89	124	8	the	the	DET
ajlm-89	124	9	design	design	NOUN
ajlm-89	124	10	of	of	ADP
ajlm-89	124	11	the	the	DET
ajlm-89	124	12	study	study	NOUN
ajlm-89	124	13	,	,	PUNCT
ajlm-89	124	14	as	as	ADV
ajlm-89	124	15	well	well	ADV
ajlm-89	124	16	as	as	ADP
ajlm-89	124	17	in	in	ADP
ajlm-89	124	18	laboratory	laboratory	NOUN
ajlm-89	124	19	analysis	analysis	NOUN
ajlm-89	124	20	of	of	ADP
ajlm-89	124	21	the	the	DET
ajlm-89	124	22	isolates	isolate	NOUN
ajlm-89	124	23	and	and	CCONJ
ajlm-89	124	24	write	write	VERB
ajlm-89	124	25	up	up	ADP
ajlm-89	124	26	of	of	ADP
ajlm-89	124	27	the	the	DET
ajlm-89	124	28	manuscript	manuscript	NOUN
ajlm-89	124	29	.	.	PUNCT
ajlm-89	125	1	references	reference	NOUN
ajlm-89	125	2	top	top	VERB
ajlm-89	125	3	↑	↑	PROPN
ajlm-89	125	4	1.wisplinghoff	1.wisplinghoff	NUM
ajlm-89	125	5	h	h	NOUN
ajlm-89	125	6	,	,	PUNCT
ajlm-89	125	7	bischoff	bischoff	PROPN
ajlm-89	125	8	t	t	PROPN
ajlm-89	125	9	,	,	PUNCT
ajlm-89	125	10	tallent	tallent	NOUN
ajlm-89	125	11	sm	sm	PROPN
ajlm-89	125	12	,	,	PUNCT
ajlm-89	125	13	et	et	PROPN
ajlm-89	125	14	al	al	PROPN
ajlm-89	125	15	.	.	PUNCT
ajlm-89	126	1	nosocomial	nosocomial	ADJ
ajlm-89	126	2	bloodstream	bloodstream	NOUN
ajlm-89	126	3	infections	infection	NOUN
ajlm-89	126	4	in	in	ADP
ajlm-89	126	5	us	us	PROPN
ajlm-89	126	6	hospitals	hospital	NOUN
ajlm-89	126	7	:	:	PUNCT
ajlm-89	126	8	analysis	analysis	NOUN
ajlm-89	126	9	of	of	ADP
ajlm-89	126	10	24,179	24,179	NUM
ajlm-89	126	11	cases	case	NOUN
ajlm-89	126	12	from	from	ADP
ajlm-89	126	13	a	a	DET
ajlm-89	126	14	prospective	prospective	ADJ
ajlm-89	126	15	nationwide	nationwide	ADJ
ajlm-89	126	16	surveillance	surveillance	NOUN
ajlm-89	126	17	study	study	NOUN
ajlm-89	126	18	.	.	PUNCT
ajlm-89	127	1	clin	clin	PROPN
ajlm-89	127	2	infect	infect	PROPN
ajlm-89	127	3	dis	dis	PROPN
ajlm-89	127	4	.	.	PUNCT
ajlm-89	128	1	2004;39(3):309–317	2004;39(3):309–317	PROPN
ajlm-89	128	2	.	.	PUNCT
ajlm-89	129	1	http://dx.doi.org/10.1086/421946	http://dx.doi.org/10.1086/421946	PROPN
ajlm-89	129	2	2.bassetti	2.bassetti	NUM
ajlm-89	129	3	m	m	PROPN
ajlm-89	129	4	,	,	PUNCT
ajlm-89	129	5	righi	righi	PROPN
ajlm-89	129	6	e	e	NOUN
ajlm-89	129	7	,	,	PUNCT
ajlm-89	129	8	costa	costa	PROPN
ajlm-89	129	9	a	a	X
ajlm-89	129	10	,	,	PUNCT
ajlm-89	129	11	et	et	PROPN
ajlm-89	129	12	al	al	PROPN
ajlm-89	129	13	.	.	PUNCT
ajlm-89	129	14	epidemiology	epidemiology	NOUN
ajlm-89	129	15	trends	trend	NOUN
ajlm-89	129	16	in	in	ADP
ajlm-89	129	17	nosocomial	nosocomial	ADJ
ajlm-89	129	18	candidemia	candidemia	NOUN
ajlm-89	129	19	in	in	ADP
ajlm-89	129	20	intensive	intensive	ADJ
ajlm-89	129	21	care	care	NOUN
ajlm-89	129	22	.	.	PUNCT
ajlm-89	130	1	bmc	bmc	PROPN
ajlm-89	130	2	infect	infect	PROPN
ajlm-89	130	3	dis	dis	PROPN
ajlm-89	130	4	.	.	PUNCT
ajlm-89	130	5	2006;6:21	2006;6:21	PROPN
ajlm-89	130	6	.	.	PUNCT
ajlm-89	131	1	http://dx.doi.org/10.1186/1471-2334-6-21	http://dx.doi.org/10.1186/1471-2334-6-21	PROPN
ajlm-89	131	2	3.davis	3.davis	NUM
ajlm-89	131	3	sl	sl	PROPN
ajlm-89	131	4	,	,	PUNCT
ajlm-89	131	5	vazquez	vazquez	PROPN
ajlm-89	131	6	ja	ja	PROPN
ajlm-89	131	7	,	,	PUNCT
ajlm-89	131	8	mckinnon	mckinnon	PROPN
ajlm-89	131	9	ps	ps	PROPN
ajlm-89	131	10	.	.	PROPN
ajlm-89	131	11	epidemiology	epidemiology	NOUN
ajlm-89	131	12	,	,	PUNCT
ajlm-89	131	13	risk	risk	NOUN
ajlm-89	131	14	factors	factor	NOUN
ajlm-89	131	15	,	,	PUNCT
ajlm-89	131	16	and	and	CCONJ
ajlm-89	131	17	outcomes	outcome	NOUN
ajlm-89	131	18	of	of	ADP
ajlm-89	131	19	candida	candida	PROPN
ajlm-89	131	20	albicans	albican	NOUN
ajlm-89	131	21	versus	versus	ADP
ajlm-89	131	22	non	non	ADJ
ajlm-89	131	23	-	-	ADJ
ajlm-89	131	24	albicans	albican	NOUN
ajlm-89	131	25	candidemia	candidemia	NOUN
ajlm-89	131	26	in	in	ADP
ajlm-89	131	27	non	non	ADJ
ajlm-89	131	28	-	-	ADJ
ajlm-89	131	29	neutropenic	neutropenic	ADJ
ajlm-89	131	30	patients	patient	NOUN
ajlm-89	131	31	.	.	PUNCT
ajlm-89	132	1	ann	ann	PROPN
ajlm-89	132	2	pharmacother	pharmacother	PROPN
ajlm-89	132	3	.	.	PUNCT
ajlm-89	133	1	2007;41(4):568–573	2007;41(4):568–573	X
ajlm-89	133	2	.	.	PUNCT
ajlm-89	133	3	http://dx.doi.org/10.1345/aph.1h516	http://dx.doi.org/10.1345/aph.1h516	PROPN
ajlm-89	134	1	4.pfaller	4.pfaller	NUM
ajlm-89	134	2	ma	ma	PROPN
ajlm-89	134	3	,	,	PUNCT
ajlm-89	134	4	diekema	diekema	PROPN
ajlm-89	134	5	dj	dj	PROPN
ajlm-89	134	6	,	,	PUNCT
ajlm-89	134	7	jones	jones	PROPN
ajlm-89	134	8	rn	rn	PROPN
ajlm-89	134	9	,	,	PUNCT
ajlm-89	134	10	et	et	PROPN
ajlm-89	134	11	al	al	PROPN
ajlm-89	134	12	.	.	PUNCT
ajlm-89	135	1	international	international	ADJ
ajlm-89	135	2	surveillance	surveillance	NOUN
ajlm-89	135	3	of	of	ADP
ajlm-89	135	4	bloodstream	bloodstream	NOUN
ajlm-89	135	5	infections	infection	NOUN
ajlm-89	135	6	due	due	ADJ
ajlm-89	135	7	to	to	ADP
ajlm-89	135	8	candida	candida	PROPN
ajlm-89	135	9	species	specie	NOUN
ajlm-89	135	10	:	:	PUNCT
ajlm-89	135	11	frequency	frequency	NOUN
ajlm-89	135	12	of	of	ADP
ajlm-89	135	13	occurrence	occurrence	NOUN
ajlm-89	135	14	and	and	CCONJ
ajlm-89	135	15	in	in	ADP
ajlm-89	135	16	vitro	vitro	X
ajlm-89	135	17	susceptibilities	susceptibility	NOUN
ajlm-89	135	18	to	to	ADP
ajlm-89	135	19	fluconazole	fluconazole	NOUN
ajlm-89	135	20	,	,	PUNCT
ajlm-89	135	21	ravuconazole	ravuconazole	NOUN
ajlm-89	135	22	,	,	PUNCT
ajlm-89	135	23	and	and	CCONJ
ajlm-89	135	24	voriconazole	voriconazole	NOUN
ajlm-89	135	25	of	of	ADP
ajlm-89	135	26	isolates	isolate	NOUN
ajlm-89	135	27	collected	collect	VERB
ajlm-89	135	28	from	from	ADP
ajlm-89	135	29	1997	1997	NUM
ajlm-89	135	30	through	through	ADP
ajlm-89	135	31	1999	1999	NUM
ajlm-89	135	32	in	in	ADP
ajlm-89	135	33	the	the	DET
ajlm-89	135	34	sentry	sentry	NOUN
ajlm-89	135	35	antimicrobial	antimicrobial	ADJ
ajlm-89	135	36	surveillance	surveillance	NOUN
ajlm-89	135	37	program	program	NOUN
ajlm-89	135	38	.	.	PUNCT
ajlm-89	136	1	j	j	PROPN
ajlm-89	136	2	clin	clin	PROPN
ajlm-89	136	3	microbiol	microbiol	PROPN
ajlm-89	136	4	.	.	PUNCT
ajlm-89	137	1	2001;39(9):3254–3259	2001;39(9):3254–3259	NOUN
ajlm-89	137	2	.	.	PUNCT
ajlm-89	137	3	http://dx.doi.org/10.1128/jcm.39.9.3254-3259.2001	http://dx.doi.org/10.1128/jcm.39.9.3254-3259.2001	X
ajlm-89	138	1	5.martin	5.martin	NUM
ajlm-89	138	2	gs	gs	NOUN
ajlm-89	138	3	,	,	PUNCT
ajlm-89	138	4	mannino	mannino	PROPN
ajlm-89	138	5	dm	dm	PROPN
ajlm-89	138	6	,	,	PUNCT
ajlm-89	138	7	eaton	eaton	PROPN
ajlm-89	138	8	s	s	PROPN
ajlm-89	138	9	,	,	PUNCT
ajlm-89	138	10	et	et	PROPN
ajlm-89	138	11	al	al	PROPN
ajlm-89	138	12	.	.	PUNCT
ajlm-89	139	1	epidemiology	epidemiology	NOUN
ajlm-89	139	2	of	of	ADP
ajlm-89	139	3	sepsis	sepsis	NOUN
ajlm-89	139	4	in	in	ADP
ajlm-89	139	5	the	the	DET
ajlm-89	139	6	united	united	PROPN
ajlm-89	139	7	states	states	PROPN
ajlm-89	139	8	from	from	ADP
ajlm-89	139	9	1979	1979	NUM
ajlm-89	139	10	through	through	ADP
ajlm-89	139	11	2000	2000	NUM
ajlm-89	139	12	.	.	PUNCT
ajlm-89	140	1	n	n	PROPN
ajlm-89	140	2	engl	engl	PROPN
ajlm-89	140	3	j	j	PROPN
ajlm-89	140	4	med	med	PROPN
ajlm-89	140	5	.	.	PUNCT
ajlm-89	141	1	2003;348(16):1546–1554	2003;348(16):1546–1554	NUM
ajlm-89	141	2	.	.	PUNCT
ajlm-89	142	1	http://dx.doi.org/10.1056/nejmoa022139	http://dx.doi.org/10.1056/nejmoa022139	PROPN
ajlm-89	143	1	6.pappas	6.pappas	NUM
ajlm-89	143	2	pg	pg	PROPN
ajlm-89	143	3	,	,	PUNCT
ajlm-89	143	4	kauffman	kauffman	PROPN
ajlm-89	143	5	ca	ca	PROPN
ajlm-89	143	6	,	,	PUNCT
ajlm-89	143	7	andes	andes	PROPN
ajlm-89	143	8	d	d	PROPN
ajlm-89	143	9	,	,	PUNCT
ajlm-89	143	10	et	et	PROPN
ajlm-89	143	11	al	al	PROPN
ajlm-89	143	12	.	.	PROPN
ajlm-89	144	1	clinical	clinical	ADJ
ajlm-89	144	2	practice	practice	NOUN
ajlm-89	144	3	guidelines	guideline	NOUN
ajlm-89	144	4	for	for	ADP
ajlm-89	144	5	the	the	DET
ajlm-89	144	6	management	management	NOUN
ajlm-89	144	7	of	of	ADP
ajlm-89	144	8	candidiasis	candidiasis	NOUN
ajlm-89	144	9	:	:	PUNCT
ajlm-89	144	10	2009	2009	NUM
ajlm-89	144	11	update	update	NOUN
ajlm-89	144	12	by	by	ADP
ajlm-89	144	13	infectious	infectious	ADJ
ajlm-89	144	14	diseases	disease	NOUN
ajlm-89	144	15	society	society	NOUN
ajlm-89	144	16	of	of	ADP
ajlm-89	144	17	america	america	PROPN
ajlm-89	144	18	.	.	PUNCT
ajlm-89	145	1	clin	clin	PROPN
ajlm-89	145	2	infect	infect	PROPN
ajlm-89	145	3	dis	dis	PROPN
ajlm-89	145	4	.	.	PUNCT
ajlm-89	146	1	2009;48(5):503–535	2009;48(5):503–535	NUM
ajlm-89	146	2	.	.	PUNCT
ajlm-89	147	1	http://dx.doi.org/10.1086/596757	http://dx.doi.org/10.1086/596757	PROPN
ajlm-89	148	1	7.gudlaugsson	7.gudlaugsson	NUM
ajlm-89	148	2	o	o	NOUN
ajlm-89	148	3	,	,	PUNCT
ajlm-89	148	4	gillespie	gillespie	PROPN
ajlm-89	148	5	s	s	PROPN
ajlm-89	148	6	,	,	PUNCT
ajlm-89	148	7	lee	lee	PROPN
ajlm-89	148	8	k	k	PROPN
ajlm-89	148	9	,	,	PUNCT
ajlm-89	148	10	et	et	PROPN
ajlm-89	148	11	al	al	PROPN
ajlm-89	148	12	.	.	PROPN
ajlm-89	148	13	attributable	attributable	ADJ
ajlm-89	148	14	mortality	mortality	NOUN
ajlm-89	148	15	of	of	ADP
ajlm-89	148	16	nosocomial	nosocomial	ADJ
ajlm-89	148	17	candidemia	candidemia	NOUN
ajlm-89	148	18	,	,	PUNCT
ajlm-89	148	19	revisited	revisit	VERB
ajlm-89	148	20	.	.	PUNCT
ajlm-89	149	1	clin	clin	PROPN
ajlm-89	149	2	infect	infect	PROPN
ajlm-89	149	3	dis	dis	PROPN
ajlm-89	149	4	.	.	PUNCT
ajlm-89	150	1	2003;37(9):1172–1177	2003;37(9):1172–1177	NUM
ajlm-89	150	2	.	.	PUNCT
ajlm-89	151	1	http://dx.doi.org/10.1086/378745	http://dx.doi.org/10.1086/378745	PROPN
ajlm-89	151	2	8.chen	8.chen	NUM
ajlm-89	151	3	ly	ly	PROPN
ajlm-89	151	4	,	,	PUNCT
ajlm-89	151	5	liao	liao	PROPN
ajlm-89	151	6	sy	sy	PROPN
ajlm-89	151	7	,	,	PUNCT
ajlm-89	151	8	kuo	kuo	PROPN
ajlm-89	151	9	sc	sc	PROPN
ajlm-89	151	10	,	,	PUNCT
ajlm-89	151	11	et	et	PROPN
ajlm-89	151	12	al	al	PROPN
ajlm-89	151	13	.	.	PROPN
ajlm-89	151	14	changes	change	NOUN
ajlm-89	151	15	in	in	ADP
ajlm-89	151	16	the	the	DET
ajlm-89	151	17	incidence	incidence	NOUN
ajlm-89	151	18	of	of	ADP
ajlm-89	151	19	candidaemia	candidaemia	NOUN
ajlm-89	151	20	during	during	ADP
ajlm-89	151	21	2000–2008	2000–2008	NUM
ajlm-89	151	22	in	in	ADP
ajlm-89	151	23	a	a	DET
ajlm-89	151	24	tertiary	tertiary	ADJ
ajlm-89	151	25	medical	medical	ADJ
ajlm-89	151	26	centre	centre	NOUN
ajlm-89	151	27	in	in	ADP
ajlm-89	151	28	northern	northern	ADJ
ajlm-89	151	29	taiwan	taiwan	PROPN
ajlm-89	151	30	.	.	PUNCT
ajlm-89	152	1	j	j	PROPN
ajlm-89	152	2	hosp	hosp	PROPN
ajlm-89	152	3	infect	infect	PROPN
ajlm-89	152	4	.	.	PUNCT
ajlm-89	153	1	2011;78	2011;78	NUM
ajlm-89	153	2	(	(	PUNCT
ajlm-89	153	3	1):50–53	1):50–53	NUM
ajlm-89	153	4	.	.	PUNCT
ajlm-89	154	1	http://dx.doi.org/10.1016/j.jhin.2010.12.007	http://dx.doi.org/10.1016/j.jhin.2010.12.007	PROPN
ajlm-89	154	2	9.horn	9.horn	NUM
ajlm-89	154	3	dl	dl	PROPN
ajlm-89	154	4	,	,	PUNCT
ajlm-89	154	5	neofytos	neofytos	ADP
ajlm-89	154	6	d	d	PROPN
ajlm-89	154	7	,	,	PUNCT
ajlm-89	154	8	anaissie	anaissie	PROPN
ajlm-89	154	9	ej	ej	PROPN
ajlm-89	154	10	,	,	PUNCT
ajlm-89	154	11	et	et	PROPN
ajlm-89	154	12	al	al	PROPN
ajlm-89	154	13	.	.	PUNCT
ajlm-89	154	14	epidemiology	epidemiology	NOUN
ajlm-89	154	15	and	and	CCONJ
ajlm-89	154	16	outcomes	outcome	NOUN
ajlm-89	154	17	of	of	ADP
ajlm-89	154	18	candidemia	candidemia	NOUN
ajlm-89	154	19	in	in	ADP
ajlm-89	154	20	2019	2019	NUM
ajlm-89	154	21	patients	patient	NOUN
ajlm-89	154	22	:	:	PUNCT
ajlm-89	154	23	data	datum	NOUN
ajlm-89	154	24	from	from	ADP
ajlm-89	154	25	the	the	DET
ajlm-89	154	26	prospective	prospective	ADJ
ajlm-89	154	27	antifungal	antifungal	PROPN
ajlm-89	154	28	therapy	therapy	NOUN
ajlm-89	154	29	alliance	alliance	NOUN
ajlm-89	154	30	registry	registry	PROPN
ajlm-89	154	31	.	.	PUNCT
ajlm-89	155	1	clin	clin	PROPN
ajlm-89	155	2	infect	infect	PROPN
ajlm-89	155	3	dis	dis	PROPN
ajlm-89	155	4	.	.	PUNCT
ajlm-89	156	1	2009;48(12):1695–1703	2009;48(12):1695–1703	X
ajlm-89	156	2	.	.	PUNCT
ajlm-89	156	3	http://dx.doi.org/10.1086/599039	http://dx.doi.org/10.1086/599039	PROPN
ajlm-89	156	4	10.bedini	10.bedini	NUM
ajlm-89	156	5	a	a	X
ajlm-89	156	6	,	,	PUNCT
ajlm-89	156	7	venturelli	venturelli	NOUN
ajlm-89	156	8	c	c	NOUN
ajlm-89	156	9	,	,	PUNCT
ajlm-89	156	10	mussini	mussini	PROPN
ajlm-89	156	11	c	c	NOUN
ajlm-89	156	12	,	,	PUNCT
ajlm-89	156	13	et	et	PROPN
ajlm-89	156	14	al	al	PROPN
ajlm-89	156	15	.	.	PUNCT
ajlm-89	157	1	epidemiology	epidemiology	NOUN
ajlm-89	157	2	of	of	ADP
ajlm-89	157	3	candidaemia	candidaemia	NOUN
ajlm-89	157	4	and	and	CCONJ
ajlm-89	157	5	antifungal	antifungal	ADJ
ajlm-89	157	6	susceptibility	susceptibility	NOUN
ajlm-89	157	7	patterns	pattern	NOUN
ajlm-89	157	8	in	in	ADP
ajlm-89	157	9	an	an	DET
ajlm-89	157	10	italian	italian	ADJ
ajlm-89	157	11	tertiary	tertiary	ADJ
ajlm-89	157	12	-	-	PUNCT
ajlm-89	157	13	care	care	NOUN
ajlm-89	157	14	hospital	hospital	NOUN
ajlm-89	157	15	.	.	PUNCT
ajlm-89	158	1	clin	clin	PROPN
ajlm-89	158	2	microbiol	microbiol	PROPN
ajlm-89	158	3	infect	infect	VERB
ajlm-89	158	4	.	.	PUNCT
ajlm-89	159	1	2006;12(1):75–80	2006;12(1):75–80	X
ajlm-89	159	2	.	.	PUNCT
ajlm-89	159	3	http://dx.doi.org/10.1111/j.1469-0691.2005.01310.x	http://dx.doi.org/10.1111/j.1469-0691.2005.01310.x	PROPN
ajlm-89	159	4	11.pappas	11.pappas	NUM
ajlm-89	159	5	pg	pg	PROPN
ajlm-89	159	6	,	,	PUNCT
ajlm-89	159	7	rex	rex	PROPN
ajlm-89	159	8	jh	jh	PROPN
ajlm-89	159	9	,	,	PUNCT
ajlm-89	159	10	lee	lee	PROPN
ajlm-89	159	11	j	j	PROPN
ajlm-89	159	12	,	,	PUNCT
ajlm-89	159	13	et	et	PROPN
ajlm-89	159	14	al	al	PROPN
ajlm-89	159	15	.	.	PUNCT
ajlm-89	160	1	a	a	DET
ajlm-89	160	2	prospective	prospective	ADJ
ajlm-89	160	3	observational	observational	ADJ
ajlm-89	160	4	study	study	NOUN
ajlm-89	160	5	of	of	ADP
ajlm-89	160	6	candidemia	candidemia	NOUN
ajlm-89	160	7	:	:	PUNCT
ajlm-89	160	8	epidemiology	epidemiology	NOUN
ajlm-89	160	9	,	,	PUNCT
ajlm-89	160	10	therapy	therapy	NOUN
ajlm-89	160	11	,	,	PUNCT
ajlm-89	160	12	and	and	CCONJ
ajlm-89	160	13	influences	influence	NOUN
ajlm-89	160	14	on	on	ADP
ajlm-89	160	15	mortality	mortality	NOUN
ajlm-89	160	16	in	in	ADP
ajlm-89	160	17	hospitalized	hospitalize	VERB
ajlm-89	160	18	adult	adult	NOUN
ajlm-89	160	19	and	and	CCONJ
ajlm-89	160	20	pediatric	pediatric	ADJ
ajlm-89	160	21	patients	patient	NOUN
ajlm-89	160	22	.	.	PUNCT
ajlm-89	161	1	clin	clin	PROPN
ajlm-89	161	2	infect	infect	PROPN
ajlm-89	161	3	dis	dis	PROPN
ajlm-89	161	4	.	.	PUNCT
ajlm-89	162	1	2003;37(5):634–643	2003;37(5):634–643	X
ajlm-89	162	2	.	.	PUNCT
ajlm-89	163	1	http://dx.doi.org/10.1086/376906	http://dx.doi.org/10.1086/376906	PROPN
ajlm-89	163	2	12.trick	12.trick	PUNCT
ajlm-89	163	3	we	we	PRON
ajlm-89	163	4	,	,	PUNCT
ajlm-89	163	5	fridkin	fridkin	NOUN
ajlm-89	163	6	sk	sk	PROPN
ajlm-89	163	7	,	,	PUNCT
ajlm-89	163	8	edwards	edwards	PROPN
ajlm-89	163	9	jr	jr	PROPN
ajlm-89	163	10	,	,	PUNCT
ajlm-89	163	11	et	et	PROPN
ajlm-89	163	12	al	al	PROPN
ajlm-89	163	13	.	.	PUNCT
ajlm-89	164	1	secular	secular	ADJ
ajlm-89	164	2	trend	trend	NOUN
ajlm-89	164	3	of	of	ADP
ajlm-89	164	4	hospital	hospital	NOUN
ajlm-89	164	5	-	-	PUNCT
ajlm-89	164	6	acquired	acquire	VERB
ajlm-89	164	7	candidemia	candidemia	NOUN
ajlm-89	164	8	among	among	ADP
ajlm-89	164	9	intensive	intensive	ADJ
ajlm-89	164	10	care	care	NOUN
ajlm-89	164	11	unit	unit	NOUN
ajlm-89	164	12	patients	patient	NOUN
ajlm-89	164	13	in	in	ADP
ajlm-89	164	14	the	the	DET
ajlm-89	164	15	united	united	PROPN
ajlm-89	164	16	states	states	PROPN
ajlm-89	164	17	during	during	ADP
ajlm-89	164	18	1989	1989	NUM
ajlm-89	164	19	-	-	SYM
ajlm-89	164	20	1999	1999	NUM
ajlm-89	164	21	.	.	PUNCT
ajlm-89	165	1	clin	clin	PROPN
ajlm-89	165	2	infect	infect	PROPN
ajlm-89	165	3	dis	dis	PROPN
ajlm-89	165	4	.	.	PUNCT
ajlm-89	166	1	2002;35(5):627–630	2002;35(5):627–630	X
ajlm-89	166	2	.	.	PUNCT
ajlm-89	166	3	http://dx.doi.org/10.1086/342300	http://dx.doi.org/10.1086/342300	PROPN
ajlm-89	167	1	13.hsu	13.hsu	NUM
ajlm-89	167	2	jl	jl	NOUN
ajlm-89	167	3	,	,	PUNCT
ajlm-89	167	4	ruoss	ruoss	PROPN
ajlm-89	167	5	sj	sj	PROPN
ajlm-89	167	6	,	,	PUNCT
ajlm-89	167	7	bower	bower	PROPN
ajlm-89	167	8	nd	nd	PROPN
ajlm-89	167	9	,	,	PUNCT
ajlm-89	167	10	et	et	PROPN
ajlm-89	167	11	al	al	PROPN
ajlm-89	167	12	.	.	PUNCT
ajlm-89	168	1	diagnosing	diagnose	VERB
ajlm-89	168	2	invasive	invasive	ADJ
ajlm-89	168	3	fungal	fungal	ADJ
ajlm-89	168	4	disease	disease	NOUN
ajlm-89	168	5	in	in	ADP
ajlm-89	168	6	critically	critically	ADV
ajlm-89	168	7	ill	ill	ADJ
ajlm-89	168	8	patients	patient	NOUN
ajlm-89	168	9	.	.	PUNCT
ajlm-89	169	1	crit	crit	PROPN
ajlm-89	169	2	rev	rev	PROPN
ajlm-89	169	3	microbiol	microbiol	PROPN
ajlm-89	169	4	.	.	PUNCT
ajlm-89	170	1	2011;37(4):277–312	2011;37(4):277–312	X
ajlm-89	170	2	.	.	PUNCT
ajlm-89	170	3	http://dx.doi.org/10.3109/1040841x.2011.581223	http://dx.doi.org/10.3109/1040841x.2011.581223	PROPN
ajlm-89	171	1	14.hobson	14.hobson	NUM
ajlm-89	171	2	rp	rp	NOUN
ajlm-89	171	3	.	.	PUNCT
ajlm-89	172	1	the	the	DET
ajlm-89	172	2	global	global	ADJ
ajlm-89	172	3	epidemiology	epidemiology	NOUN
ajlm-89	172	4	of	of	ADP
ajlm-89	172	5	invasive	invasive	ADJ
ajlm-89	172	6	candida	candida	NOUN
ajlm-89	172	7	infections	infection	NOUN
ajlm-89	172	8	–	–	PUNCT
ajlm-89	172	9	is	be	AUX
ajlm-89	172	10	the	the	DET
ajlm-89	172	11	tide	tide	NOUN
ajlm-89	172	12	turning	turn	VERB
ajlm-89	172	13	?	?	PUNCT
ajlm-89	173	1	j	j	PROPN
ajlm-89	173	2	hosp	hosp	PROPN
ajlm-89	173	3	infect	infect	PROPN
ajlm-89	173	4	.	.	PUNCT
ajlm-89	174	1	2003;55(3):159–168	2003;55(3):159–168	X
ajlm-89	174	2	.	.	PUNCT
ajlm-89	175	1	http://dx.doi.org/10.1016/j.jhin	http://dx.doi.org/10.1016/j.jhin	PROPN
ajlm-89	175	2	.	.	PUNCT
ajlm-89	176	1	2003.08.012	2003.08.012	NUM
ajlm-89	176	2	15.guery	15.guery	NUM
ajlm-89	176	3	bp	bp	PROPN
ajlm-89	176	4	,	,	PUNCT
ajlm-89	176	5	arendrup	arendrup	PROPN
ajlm-89	176	6	mc	mc	PROPN
ajlm-89	176	7	,	,	PUNCT
ajlm-89	176	8	auzinger	auzinger	PROPN
ajlm-89	176	9	g	g	PROPN
ajlm-89	176	10	,	,	PUNCT
ajlm-89	176	11	et	et	PROPN
ajlm-89	176	12	al	al	PROPN
ajlm-89	176	13	.	.	PUNCT
ajlm-89	176	14	management	management	NOUN
ajlm-89	176	15	of	of	ADP
ajlm-89	176	16	invasive	invasive	ADJ
ajlm-89	176	17	candidiasis	candidiasis	NOUN
ajlm-89	176	18	and	and	CCONJ
ajlm-89	176	19	candidemia	candidemia	NOUN
ajlm-89	176	20	in	in	ADP
ajlm-89	176	21	adult	adult	NOUN
ajlm-89	176	22	non	non	ADJ
ajlm-89	176	23	-	-	ADJ
ajlm-89	176	24	neutropenic	neutropenic	ADJ
ajlm-89	176	25	intensive	intensive	ADJ
ajlm-89	176	26	care	care	NOUN
ajlm-89	176	27	unit	unit	NOUN
ajlm-89	176	28	patients	patient	NOUN
ajlm-89	176	29	:	:	PUNCT
ajlm-89	176	30	part	part	NOUN
ajlm-89	176	31	i.	i.	PROPN
ajlm-89	176	32	epidemiology	epidemiology	NOUN
ajlm-89	176	33	and	and	CCONJ
ajlm-89	176	34	diagnosis	diagnosis	NOUN
ajlm-89	176	35	.	.	PUNCT
ajlm-89	177	1	intensive	intensive	ADJ
ajlm-89	177	2	care	care	NOUN
ajlm-89	177	3	med	me	VERB
ajlm-89	177	4	.	.	PUNCT
ajlm-89	178	1	2009;35(1):55–62	2009;35(1):55–62	NUM
ajlm-89	178	2	.	.	PUNCT
ajlm-89	178	3	http://dx.doi.org/10.1007/s00134-008-1338-7	http://dx.doi.org/10.1007/s00134-008-1338-7	NUM
ajlm-89	179	1	16.morrell	16.morrell	NUM
ajlm-89	179	2	m	m	PROPN
ajlm-89	179	3	,	,	PUNCT
ajlm-89	179	4	fraser	fraser	PROPN
ajlm-89	179	5	vj	vj	PROPN
ajlm-89	179	6	,	,	PUNCT
ajlm-89	179	7	kollef	kollef	PROPN
ajlm-89	179	8	mh	mh	PROPN
ajlm-89	179	9	.	.	PUNCT
ajlm-89	180	1	delaying	delay	VERB
ajlm-89	180	2	the	the	DET
ajlm-89	180	3	empiric	empiric	ADJ
ajlm-89	180	4	treatment	treatment	NOUN
ajlm-89	180	5	of	of	ADP
ajlm-89	180	6	candida	candida	NOUN
ajlm-89	180	7	bloodstream	bloodstream	NOUN
ajlm-89	180	8	infection	infection	NOUN
ajlm-89	180	9	until	until	SCONJ
ajlm-89	180	10	positive	positive	ADJ
ajlm-89	180	11	blood	blood	NOUN
ajlm-89	180	12	culture	culture	NOUN
ajlm-89	180	13	results	result	NOUN
ajlm-89	180	14	are	be	AUX
ajlm-89	180	15	obtained	obtain	VERB
ajlm-89	180	16	:	:	PUNCT
ajlm-89	180	17	a	a	DET
ajlm-89	180	18	potential	potential	ADJ
ajlm-89	180	19	risk	risk	NOUN
ajlm-89	180	20	factor	factor	NOUN
ajlm-89	180	21	for	for	ADP
ajlm-89	180	22	hospital	hospital	NOUN
ajlm-89	180	23	mortality	mortality	NOUN
ajlm-89	180	24	.	.	PUNCT
ajlm-89	181	1	antimicrob	antimicrob	PROPN
ajlm-89	181	2	agents	agents	PROPN
ajlm-89	181	3	chemother	chemother	PROPN
ajlm-89	181	4	.	.	PUNCT
ajlm-89	182	1	2005;49(9):3640–3645	2005;49(9):3640–3645	ADJ
ajlm-89	182	2	.	.	PUNCT
ajlm-89	183	1	http://dx.doi.org/10.1128/aac.49.9.3640-3645.2005	http://dx.doi.org/10.1128/aac.49.9.3640-3645.2005	X
ajlm-89	184	1	17.desu	17.desu	NUM
ajlm-89	184	2	mm	mm	INTJ
ajlm-89	184	3	,	,	PUNCT
ajlm-89	184	4	raghavarao	raghavarao	PROPN
ajlm-89	184	5	d.	d.	PROPN
ajlm-89	184	6	sample	sample	PROPN
ajlm-89	184	7	size	size	NOUN
ajlm-89	184	8	methodology	methodology	PROPN
ajlm-89	184	9	.	.	PUNCT
ajlm-89	185	1	boston	boston	PROPN
ajlm-89	185	2	:	:	PUNCT
ajlm-89	185	3	academic	academic	ADJ
ajlm-89	185	4	press	press	NOUN
ajlm-89	185	5	;	;	PUNCT
ajlm-89	185	6	1990	1990	NUM
ajlm-89	185	7	.	.	PUNCT
ajlm-89	186	1	18.clinical	18.clinical	NUM
ajlm-89	186	2	and	and	CCONJ
ajlm-89	186	3	laboratory	laboratory	NOUN
ajlm-89	186	4	standards	standards	PROPN
ajlm-89	186	5	institute	institute	PROPN
ajlm-89	186	6	.	.	PUNCT
ajlm-89	187	1	reference	reference	NOUN
ajlm-89	187	2	method	method	NOUN
ajlm-89	187	3	for	for	ADP
ajlm-89	187	4	broth	broth	ADJ
ajlm-89	187	5	dilution	dilution	NOUN
ajlm-89	187	6	antifungal	antifungal	ADJ
ajlm-89	187	7	susceptibility	susceptibility	NOUN
ajlm-89	187	8	testing	testing	NOUN
ajlm-89	187	9	of	of	ADP
ajlm-89	187	10	yeasts	yeast	NOUN
ajlm-89	187	11	;	;	PUNCT
ajlm-89	187	12	approved	approve	VERB
ajlm-89	187	13	standard	standard	ADJ
ajlm-89	187	14	–	–	PUNCT
ajlm-89	187	15	second	second	ADJ
ajlm-89	187	16	edition	edition	NOUN
ajlm-89	187	17	.	.	PUNCT
ajlm-89	188	1	vol	vol	NOUN
ajlm-89	188	2	22	22	NUM
ajlm-89	188	3	,	,	PUNCT
ajlm-89	188	4	doc	doc	PROPN
ajlm-89	188	5	m27	m27	PROPN
ajlm-89	188	6	-	-	PUNCT
ajlm-89	188	7	a2	a2	PROPN
ajlm-89	188	8	.	.	PUNCT
ajlm-89	189	1	wayne	wayne	PROPN
ajlm-89	189	2	,	,	PUNCT
ajlm-89	189	3	pa	pa	PROPN
ajlm-89	189	4	:	:	PUNCT
ajlm-89	189	5	clinical	clinical	ADJ
ajlm-89	189	6	and	and	CCONJ
ajlm-89	189	7	laboratory	laboratory	NOUN
ajlm-89	189	8	standards	standard	NOUN
ajlm-89	189	9	institute	institute	NOUN
ajlm-89	189	10	;	;	PUNCT
ajlm-89	189	11	2002	2002	NUM
ajlm-89	189	12	.	.	PUNCT
ajlm-89	190	1	19.edmond	19.edmond	X
ajlm-89	190	2	mb	mb	ADP
ajlm-89	190	3	,	,	PUNCT
ajlm-89	190	4	wallace	wallace	PROPN
ajlm-89	190	5	se	se	PROPN
ajlm-89	190	6	,	,	PUNCT
ajlm-89	190	7	mcclish	mcclish	PROPN
ajlm-89	190	8	dk	dk	PROPN
ajlm-89	190	9	,	,	PUNCT
ajlm-89	190	10	et	et	PROPN
ajlm-89	190	11	al	al	PROPN
ajlm-89	190	12	.	.	PUNCT
ajlm-89	191	1	nosocomial	nosocomial	ADJ
ajlm-89	191	2	bloodstream	bloodstream	NOUN
ajlm-89	191	3	infections	infection	NOUN
ajlm-89	191	4	in	in	ADP
ajlm-89	191	5	united	united	PROPN
ajlm-89	191	6	states	states	PROPN
ajlm-89	191	7	hospital	hospital	NOUN
ajlm-89	191	8	:	:	PUNCT
ajlm-89	191	9	a	a	DET
ajlm-89	191	10	three	three	NUM
ajlm-89	191	11	-	-	PUNCT
ajlm-89	191	12	year	year	NOUN
ajlm-89	191	13	analysis	analysis	NOUN
ajlm-89	191	14	.	.	PUNCT
ajlm-89	192	1	clin	clin	PROPN
ajlm-89	192	2	infect	infect	PROPN
ajlm-89	192	3	dis	dis	PROPN
ajlm-89	192	4	.	.	PUNCT
ajlm-89	193	1	1999;29(2):239–244	1999;29(2):239–244	X
ajlm-89	193	2	.	.	PUNCT
ajlm-89	194	1	http://dx.doi.org/10.1086/520192	http://dx.doi.org/10.1086/520192	PROPN
ajlm-89	194	2	20.saiman	20.saiman	NUM
ajlm-89	194	3	l	l	NOUN
ajlm-89	194	4	,	,	PUNCT
ajlm-89	194	5	ludington	ludington	PROPN
ajlm-89	194	6	e	e	PROPN
ajlm-89	194	7	,	,	PUNCT
ajlm-89	194	8	pfaller	pfaller	NOUN
ajlm-89	194	9	m	m	PROPN
ajlm-89	194	10	,	,	PUNCT
ajlm-89	194	11	et	et	PROPN
ajlm-89	194	12	al	al	PROPN
ajlm-89	194	13	.	.	PUNCT
ajlm-89	194	14	risk	risk	NOUN
ajlm-89	194	15	factors	factor	NOUN
ajlm-89	194	16	for	for	ADP
ajlm-89	194	17	candidemia	candidemia	NOUN
ajlm-89	194	18	in	in	ADP
ajlm-89	194	19	neonatal	neonatal	ADJ
ajlm-89	194	20	intensive	intensive	ADJ
ajlm-89	194	21	care	care	NOUN
ajlm-89	194	22	unit	unit	NOUN
ajlm-89	194	23	patients	patient	NOUN
ajlm-89	194	24	.	.	PUNCT
ajlm-89	195	1	the	the	DET
ajlm-89	195	2	national	national	ADJ
ajlm-89	195	3	epidemiology	epidemiology	NOUN
ajlm-89	195	4	of	of	ADP
ajlm-89	195	5	mycosis	mycosis	NOUN
ajlm-89	195	6	survey	survey	NOUN
ajlm-89	195	7	study	study	NOUN
ajlm-89	195	8	group	group	NOUN
ajlm-89	195	9	.	.	PUNCT
ajlm-89	196	1	pediatr	pediatr	PROPN
ajlm-89	196	2	infect	infect	VERB
ajlm-89	196	3	dis	dis	PROPN
ajlm-89	196	4	j.	j.	PROPN
ajlm-89	196	5	2000;19(4):319–324	2000;19(4):319–324	NUM
ajlm-89	196	6	.	.	PUNCT
ajlm-89	197	1	http://dx.doi.org/10.1097/	http://dx.doi.org/10.1097/	ADJ
ajlm-89	197	2	00006454	00006454	NUM
ajlm-89	197	3	-	-	SYM
ajlm-89	197	4	200004000	200004000	NUM
ajlm-89	197	5	-	-	SYM
ajlm-89	197	6	00011	00011	NUM
ajlm-89	197	7	21.schelenz	21.schelenz	NUM
ajlm-89	197	8	s.	s.	PROPN
ajlm-89	197	9	management	management	NOUN
ajlm-89	197	10	of	of	ADP
ajlm-89	197	11	candidiasis	candidiasis	NOUN
ajlm-89	197	12	in	in	ADP
ajlm-89	197	13	the	the	DET
ajlm-89	197	14	intensive	intensive	ADJ
ajlm-89	197	15	care	care	NOUN
ajlm-89	197	16	unit	unit	NOUN
ajlm-89	197	17	.	.	PUNCT
ajlm-89	198	1	j	j	PROPN
ajlm-89	198	2	antimicrob	antimicrob	PROPN
ajlm-89	198	3	chemother	chemother	PROPN
ajlm-89	198	4	.	.	PUNCT
ajlm-89	199	1	2008;(61	2008;(61	NUM
ajlm-89	199	2	suppl	suppl	ADJ
ajlm-89	199	3	1):i31	1):i31	NUM
ajlm-89	199	4	–	–	PUNCT
ajlm-89	199	5	i34	i34	NOUN
ajlm-89	199	6	.	.	PUNCT
ajlm-89	200	1	http://dx.doi.org/10.1093/jac/dkm430	http://dx.doi.org/10.1093/jac/dkm430	PROPN
ajlm-89	200	2	22.aspesberro	22.aspesberro	NUM
ajlm-89	200	3	f	f	X
ajlm-89	200	4	,	,	PUNCT
ajlm-89	200	5	beghetti	beghetti	PROPN
ajlm-89	200	6	m	m	PROPN
ajlm-89	200	7	,	,	PUNCT
ajlm-89	200	8	oberhänsli	oberhänsli	PROPN
ajlm-89	200	9	i	i	PRON
ajlm-89	200	10	,	,	PUNCT
ajlm-89	200	11	et	et	PROPN
ajlm-89	200	12	al	al	PROPN
ajlm-89	200	13	.	.	PROPN
ajlm-89	201	1	fungal	fungal	PROPN
ajlm-89	201	2	endocarditis	endocarditis	NOUN
ajlm-89	201	3	in	in	ADP
ajlm-89	201	4	critically	critically	ADV
ajlm-89	201	5	ill	ill	ADJ
ajlm-89	201	6	children	child	NOUN
ajlm-89	201	7	.	.	PUNCT
ajlm-89	202	1	eur	eur	PROPN
ajlm-89	202	2	j	j	PROPN
ajlm-89	202	3	pediatr	pediatr	PROPN
ajlm-89	202	4	.	.	PUNCT
ajlm-89	203	1	1999;158(4):275–280	1999;158(4):275–280	NUM
ajlm-89	203	2	.	.	PUNCT
ajlm-89	204	1	http://dx.doi.org/10.1007/s004310051071	http://dx.doi.org/10.1007/s004310051071	PROPN
ajlm-89	204	2	23.dean	23.dean	NUM
ajlm-89	204	3	da	da	PROPN
ajlm-89	204	4	,	,	PUNCT
ajlm-89	204	5	burchard	burchard	PROPN
ajlm-89	204	6	kw	kw	PROPN
ajlm-89	204	7	.	.	PUNCT
ajlm-89	204	8	fungal	fungal	ADJ
ajlm-89	204	9	infection	infection	NOUN
ajlm-89	204	10	in	in	ADP
ajlm-89	204	11	surgical	surgical	ADJ
ajlm-89	204	12	patients	patient	NOUN
ajlm-89	204	13	.	.	PUNCT
ajlm-89	205	1	am	be	AUX
ajlm-89	205	2	j	j	PROPN
ajlm-89	205	3	surg	surg	NOUN
ajlm-89	205	4	.	.	PUNCT
ajlm-89	206	1	1996;171(3	1996;171(3	NUM
ajlm-89	206	2	):	):	PUNCT
ajlm-89	207	1	374–382	374–382	NUM
ajlm-89	207	2	.	.	PUNCT
ajlm-89	208	1	http://dx.doi.org/10.1016/s0002-9610(97)89647-x	http://dx.doi.org/10.1016/s0002-9610(97)89647-x	PROPN
ajlm-89	208	2	24.jordà	24.jordà	PROPN
ajlm-89	208	3	-	-	PUNCT
ajlm-89	208	4	marcos	marcos	PROPN
ajlm-89	208	5	r	r	PROPN
ajlm-89	208	6	,	,	PUNCT
ajlm-89	208	7	alvarez	alvarez	PROPN
ajlm-89	208	8	-	-	PUNCT
ajlm-89	208	9	lerma	lerma	PROPN
ajlm-89	208	10	f	f	PROPN
ajlm-89	208	11	,	,	PUNCT
ajlm-89	208	12	jurado	jurado	PROPN
ajlm-89	208	13	m	m	PROPN
ajlm-89	208	14	,	,	PUNCT
ajlm-89	208	15	et	et	PROPN
ajlm-89	208	16	al	al	PROPN
ajlm-89	208	17	.	.	PUNCT
ajlm-89	209	1	risk	risk	NOUN
ajlm-89	209	2	factors	factor	NOUN
ajlm-89	209	3	for	for	ADP
ajlm-89	209	4	candidaemia	candidaemia	NOUN
ajlm-89	209	5	in	in	ADP
ajlm-89	209	6	critically	critically	ADV
ajlm-89	209	7	ill	ill	ADJ
ajlm-89	209	8	patients	patient	NOUN
ajlm-89	209	9	:	:	PUNCT
ajlm-89	209	10	a	a	DET
ajlm-89	209	11	prospective	prospective	ADJ
ajlm-89	209	12	surveillance	surveillance	NOUN
ajlm-89	209	13	study	study	NOUN
ajlm-89	209	14	.	.	PUNCT
ajlm-89	210	1	mycoses	mycose	NOUN
ajlm-89	210	2	.	.	PUNCT
ajlm-89	211	1	2007;50(4):302–310	2007;50(4):302–310	NUM
ajlm-89	211	2	.	.	NOUN
ajlm-89	211	3	http://dx.doi.org/10.1111/j.1439-0507.2007.01366.x	http://dx.doi.org/10.1111/j.1439-0507.2007.01366.x	ADJ
ajlm-89	211	4	25.verma	25.verma	NUM
ajlm-89	211	5	ak	ak	PROPN
ajlm-89	211	6	,	,	PUNCT
ajlm-89	211	7	prasad	prasad	PROPN
ajlm-89	211	8	kn	kn	PROPN
ajlm-89	211	9	,	,	PUNCT
ajlm-89	211	10	singh	singh	PROPN
ajlm-89	211	11	m	m	PROPN
ajlm-89	211	12	,	,	PUNCT
ajlm-89	211	13	et	et	PROPN
ajlm-89	211	14	al	al	PROPN
ajlm-89	211	15	.	.	PROPN
ajlm-89	211	16	candidaemia	candidaemia	PROPN
ajlm-89	211	17	in	in	ADP
ajlm-89	211	18	patients	patient	NOUN
ajlm-89	211	19	of	of	ADP
ajlm-89	211	20	a	a	DET
ajlm-89	211	21	tertiary	tertiary	ADJ
ajlm-89	211	22	health	health	NOUN
ajlm-89	211	23	care	care	NOUN
ajlm-89	211	24	hospital	hospital	NOUN
ajlm-89	211	25	from	from	ADP
ajlm-89	211	26	north	north	PROPN
ajlm-89	211	27	india	india	PROPN
ajlm-89	211	28	.	.	PUNCT
ajlm-89	212	1	indian	indian	PROPN
ajlm-89	212	2	j	j	PROPN
ajlm-89	212	3	med	med	PROPN
ajlm-89	212	4	res	re	NOUN
ajlm-89	212	5	.	.	PUNCT
ajlm-89	212	6	2003;117:122–128	2003;117:122–128	NUM
ajlm-89	212	7	.	.	PUNCT